Partial Purification and Characterisation of the Membrane-Associated DAG Kinase of Rat Brain by Paterson, Andrew
Partial Purification and Characterisation of the Membrane- 
Associated DAG Kinase of Rat Brain.
Andrew Paterson
A thesis submitted to the Faculty of Medicine for the degree of Doctor of Philosophy
March 1993
Department of Biochemistry 
University of Glasgow
(c). Copyright 1993, Andrew Paterson.
i
ProQuest Number: 11007724
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 11007724
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
° \4 - $ o
GLASGOW
UNIVERSITY
LIBRARY
Dedicated to Rab (1942 - 1988). 
Still with us in so many ways.
Also, in memory of Andrew and Agnes.
A cknow ledgem ents.
I thank the late Professor R.M. Smellie and Professor M.D. Houslay for the 
facilities provided to myself in the Department of Biochemistry, University of 
Glasgow, over the past seven years. I also thank the lecturing staff of the 
Department between 1985 and 1988 for furnishing a fruitful and entertaining 
undergraduate course. I must also thank the Medical Faculty of the University 
of Glasgow for the award of University of Glasgow Post-Graduate 
Scholarship.
I am indebted to Dr. M.J.O. Wakelam for the opportunity to work towards this 
thesis, also for providing excellent support and encouragement since 1988 and, 
additionally, company in the learning experience of the last four years.
My continued thanks and wishes go out to my family who have always 
provided encouragement and support: to Mum, Helen, Pop, Gran, David,
'Bell, John and especially to the much under-rated Adie.
Endless thanks go out to the lab-mates of A20, past and present: Shireen, . 
Simon and Soop for showing me how not to do it. Caroline Tales of the 
riverbank1 Evans for sharing some unsociable hours. Fergus and Ian for 
manning the barrack-room law department. Fiona Black, Celia, Andy, Allison, 
Liz, 'Less than 5 seconds Currie', Fraser, Brian Lavan, Fiona Mitchell, Markie 
and Grant - for what, I'm not sure - but thanks anyway. To Sand, Plev, Mike 
(again) and Craig for their valued friendship over the past while. A special 
thanks to Graeme for subtle direction and encouragement - more often than not - 
when it was needed. Plev (again) for the deep friendship and compassion 
shown and also for rounding off the education of the last four years, and for 
opening up a new pathway of attitude and direction.
Thanks to the other acquaintances and friendships of the past four years: to Ken 
'Bog* Ross, Langham and Gav, all relics of a bygone era, still valued 
nonetheless.
Finally, I thank Val for her constant presence in my life since Hogmanay last. 
Life has been more of a pleasure than a grind during the production of this 
thesis with her encouragement and distractions.
Acknowledgements (iii) 
Abbreviations (vi)
List of Contents (ix)
List of Figures (xiv)
List of Tables (xviii)
Summary (xix)
v
A bbreviations.
ATP Adenosine 5'-triphosphate.
[Ca2+]i Intracellular calcium concentration.
cDNA Complimentary deoxyribonucleic acid.
CDP-choline Cytidine 5'-diphosphocholine.
c.m.c. Critical micellar concentraton.
CMP Cytidine 5'-monophosphate.
CMP-phosphatidic acid Cytidine 5'-monophosphate-phosphatidic acid, 
cpm. Counts per minute.
CRF Corticotrophin releasing factor.
CTP Cytidine 5'-triphosphate.
DAG sn-1,2-Diacylglycerol.
DAG kinase Diacylglycerol kinase.
DETPAC Diethylenetriaminepentaacetic acid.
E 64 £ra«s-Epoxysuccinyl-L-leucylamido(4-
guanidino)butane.
EDTA Ethylenediaminetetraacteic acid.
EGF Epidermal growth factor.
EGTA [Ethylenebis(oxyethylenenitril)]-tetraacetic acid.
fMet-Leu-Phe A- Form y 1 me thi ony 11 eucy 1 phen y 1 al ani ne.
GLC Gas/liquid chromatography.
GTP Guanosine 5'-triphosphate.
GTPyS Guanosine 5'-0-(3-thiotri phosphate),
h Hour
HPLC High pressure liquid chromaography.
Ins(l)P  D-wyo-inositol 1-monophosphate.
Ins(3)P D-myo-inositol 3-monophosphate.
Ins(4)P D-myoinositol 4-monophosphate.
Ins(l,3)P2 D-myo-inositol 1,3-bisphosphate.
In s(l,4)P2 D-myo-inositol 1,4-bisphosphate.
Ins(3,4)P2 D-/wy0-inositol 3,4-bisphosphate.
In s (l,3 ,4)P3 D-myo-inositol 1,3,4-trisphospahte.
Ins(l,4 ,5)P3 D-z/ryo-inositol 1,4,5-trisphosphate.
In s(l,4 ,5)P3 D-rayo-inositol 1,3,4,5-tetrakisphosphate.
MARCKS protein Myristoylated alanine-rich C-kinase substrate protein
min Minute.
CD Optical Density.
32Pj [32P]orthophosphate.
PA. Phosphatidic acid.
PDBu Phorbol 12,13-dibutyrate.
PDGF Platelet-derived growth factor.
pHi Intracellular pH.
PKC Protein kinase C.
PMA Phorbol 12-myristate 13-acetate.
PMSF Phenylmethylsulfonyl fluoride.
PPH Phsophatidic acid phosphohydrolase.
PtdCho Phosphatidylcholine.
PtdEtn Phosphatidylethanolamine.
Ptdlns Phosphatidylinositiol.
Ptdlns(4)lns Phosphatidylinositol-4-phosphate.
PtdIns(4,5)P2 Phosphatidylinositol-4,5-bisphosphate.
Ptdlns-PLC Phosphoinositide specific phospholipase C.
PtdOH Phosphatidic acid.
PtdSer Phosphatidylserine.
SAG srt- 1 -Stearoyl-2-arachidonyl glycerol.
SD Standard deviation.
sec Second.
vii
t.l.c.
TRH
Thin layer chromatography. 
Thyrotropin-releasing hormone
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Summary
The 5/z- 1,2-Diacyl glycerol produced on receptor-stimulated hydrolysis of 
PtdIns(4 ,5)P2 hydrolysis is metabolised primarily by phosphorylation in a reaction 
catalysed by DAG kinase. The DAG kinase active in this role has been localised to 
the membrane-associated compartment and has been shown to display catalytic 
selectivity towards different s«-1,2-diacyl glycerol s. This study examines the 
purification and characterisation of membrane-associated DAG kinase from rat 
brain.
DAG kinase activity was predominantly associated with the soluble 
component of rat brain homogenate. Incubation of the homogenate with 
phospholipase C {B. cereus) affected a redistribution of the soluble DAG kinase 
activity toward the particulate fraction, thus providing a higher specific activity 
starting material for the purification of the membrane-associated enzyme.
Incubation of such phospholipase C-treated membranes with hypertonic 
concentrations of KCI resulted in the efficient solubilisation of the DAG kinase 
activity. The protein preparation solubilised in this manner was found to contain 
two resolvable enzymes: (1) a KCI-independent DAG kinase which remains soluble 
in the absence of KCI, and (2) a KCl-soluble DAG kinase which requires the 
presence of at least 300 mM KCI for continued solubility.
The purification of the KCl-soluble enzyme was further investigated. It 
was possible to purify this enzyme, in the presence of 300 mM KCI, by successive 
chromatographic separation on AffiGel blue, butyl-Sepharose 4B/phenyl-Sepharose 
CL-4B, Sephacryl S-300 SF, heparin-agarose, and hydroxyapatite. SDS-PAGE 
revealed the Final protein preparation to be heterogeneous. Furthermore, it was not 
possible to identify any proteins which co-migrate with DAG kinase activity on 
hydroxyapatite chromatography of the partially purified protein preparation.. 
Although, the KCl-soluble DAG kinase remains to be purified to homogeneity, it 
migrates on gel filtration with an apparent native molecular mass ozf 160 kDa..
The substrate dependence of the partially purified enzyme was 
characterised by mixed micellar assay methodology. The post gel filtration enzyme 
preparation was found to have a Vniax of 29.9 nmol/min/mg and Km values of 1.7 
mol% and 330 pM for sw-l-stearoyl-2-arachidonylglycerol and ATP, respectively. 
Furthermore, when the Km and Vmax of the KCl-soluble DAG kinase was 
determined with sw-l,2-dioleoylglycerol and s«-l,2-dilaurylglycerol they were 
found not to be significantly altered from the values determined with src-l-stearoyl- 
2-arachidonylglycerol. Therefore, the KCl-soluble enzyme was not found to be 
selective amongst sn- 1,2-diacyl glycerol substrates. The reaction velocity of the 
KCl-soluble DAG kinase is independent of Ca2+ and PtdSer, but the enzyme would 
appear to require 7.0 mM, or greater, free Mg2+ for maximal catalytic rates.
Finally, although the Vmax of the DAG kinase did not alter, its Xm for ATP was 
observed to decrease by greater than 4-fold in the presence of 20 mM potassium 
phosphate.
Chapter 1
Introduction.
1
1.1. Agonist-Stim ulated Turnover of Phosphoinositides.
1.1.1. The Position of Diacylglycerol Kinase in Agonist-Stim ulated  
Turnover of Phosphoinositides.
Agonist-stimulated inositol phospholipid hydrolysis was originally 
observed as the stimulated incorporation of 32Pi into phospholipids on cholinergic 
stimulation of avian pancreas slices (Hokin & Hokin, 1953). The stimulated 
incorporation of 32Pi into phospholipid was found to be confined specifically to the 
phosphoinositides and phosphatidic acid components (Hokin & Hokin, 1958b). 
Phosphatidic acid had only recently been identified in animal cells in vivo (Hokin 
& Hokin, 1958a), yet agonist-stimulated 32Pi incorporation into this lipid was 
observed in parallel with stimulated incorporation of 32P2 into the phosphoinositides 
in both CRF-stimulated rat hypothalamus (Hokin et al., 1958a) and cholinergic- 
stimulated guinea pig adrenal medulla (Hokin et al., 1958b). Moreover, stimulated 
incorporation of 32Pi and pH]inositol into the 'monophosphoinositide' pool was 
observed to occur with near 1:1 stoichiometry and thus independent of de novo 
synthesis of the glycerolipid backbone in cholinergic-stimulated guinea pig brain 
slices (Hokin & Hokin, 1958c).
The effect of these agonists on the synthesis of phosphatidic acid and 
phosphatidylinositol was suggested by Durell et al. (1969) to be secondary to the 
receptor-mediated hydrolysis of phosphoinositides. These workers suggested 
hydrolysis of phosphoinositide in a phospholipase C-catalysed reaction as the initial 
receptor-mediated event. The previously observed incorporation of 32Pi and 
pH]inositol merely identifying the resynthesis of the phosphoinositides via 
phosphorylation of s/i- 1,2-diacyl glycerol and subsequent incorporation of free 
inositol. The nature of the 'Pl-cycle' had been established and, within it, the key 
role of DAG kinase in the resynthesis of phosphoinositide had also been identified.
Agonist-stimulated reduction of the phosphatidylinositol content of cell 
membranes provided further evidence that hydrolysis of phosphoinositide was, 
indeed, the initial receptor-mediated event (Hokin-Neaverson, 1974; Jones &
Michell, 1974), whilst the role of DAG kinase within the cycle was corroborated by 
quantitative production of phosphatidic acid prior to resynthesis of 
phosphatidylinositol. Lapetina et al. (1981) and Rebecchi et al. (1983) observed 
the formation of phosphatidic acid prior to the synthesis of phosphatidylinositol in 
thrombin-stimulated platelets and TRH-stimulated GH3 mammotropic pituitary 
cells, respectively. Furthermore, these workers observed the synthetic events to 
occur after the decrease in cellular phosphatidylinositol content. Additionally, 
Rebecchi et al. (1983) observed a transient accumulation of sn-1,2-diacyl glycerol 
15 sec after stimulation; a time equivalent to the initiation of increased rates of 
phosphatidic acid production. The 'Pl-cycle' had, thus, been confirmed: the initial 
event proving to be the agonist-stimulated hydrolysis of phosphatidylinositol to sn-
1,2-diacyl glycerol and inositol phosphate. Thereafter, the cycle represents the 
biosynthetic pathway employed to resynthesise Ptdlns, with DAG kinase initiating 
the metabolism of thesw- 1,2-diacyl glycerol product (Section 1.1.4).
Implicated in the phosphorylation of agonist-stimulated sn-1,2- 
di acyl glycerol, DAG kinase was to be directly identified in this role. Employing a 
partially purified prepartion of porcine cytosolic DAG kinase, Bishop et al. (1986) 
identified two analogues of s«-l,2-dioctanoylglycerol active as competitive 
inhibitors of the kinase in vitro, i.e. dioctanylethylene glycol and 1- 
monooleoyl glycerol. Both inhibitors resulted in longer-lived sn- 1,2-diacyl glycerol 
accumulation in thrombin-stimulated human platelets. Dioctanoylethylene glycol 
was also observed to elicit decreased production of phosphatidic acid. These 
findings were consistent with an inhibition of DAG kinase-catalysed 
phosphorylation of sn- 1,2-diacyl glycerol produced in response to agonist 
stimulation.
Direct identification of a cellular DAG kinase activity was performed by 
MacDonald et al. (1988a). Prelabelling Swiss 3T3 fibroblasts with 32Pi, these 
workers demonstrated the production of p 2P]phosphatidic acid on PDGF- 
stimulation. Additionally, the enzyme catalysing this phosphorylation event was
3
found to be selective for the sn- 1,2-diacyl glycerol produced endogenously on 
receptor-stimulation. PDGF-stimulation of Swiss 3T3 cells preincubated with sn-
1,2-didecanoylglycerol, a cell-permeable 5«- 1,2-diacylglycerol, resulted in the 
selective phosphorylation of the endogenous lipid (MacDonald et al., 1988a). This 
was also found to be the case when lysates prepared from PDGF-stimulated Swiss 
3T3 fibroblasts that had been pretreated with s«-l,2-didecanoylglycerol were 
incubated with [y-32P]ATP (MacDonald et al., 1988a). Therefore, in vitro evidence 
was now available to confirm that DAG kinase catalysed the phosphorylation of the 
sn- 1,2-diacyl glycerol produced on receptor-stimulation. Furthermore, the enzyme 
active in this role could be identified by its catalytic selectivity towards the sn-1,2- 
diacylglycerols produced endogenously on receptor-stimulation.
1.1.2. Agonist-Stim ulated Hydrolysis of Phosphatidyl-4,5- 
Bisphosphate: The Initial Step of the 'Pl-Cycle'.
Many hormones, neurotransmitters and growth factors are associated with 
receptor-stimulated phosphatidylinositol turnover and elevation of intracellular 
calcium concentrations ([Ca2+]i). Rather than being induced by the receptor- 
mediated elevation of [Ca2+]i, Michell (1975) proposed that agonist-stimulated 
phosphatidylinositol turnover was itself responsible for raising the [Ca2+]i.
Indeed, stimulation of phosphatidylinositol turnover could be achieved in the 
absence of a rise in [Ca2+]i after stimulation of Ca2+-deprived parotid glands (Jones 
& Michell, 1975; Oron et al., 1975). The absolute requirement for 
phosphatidylinositol metabolism in Ca2+ mobilisation was further demonstrated by 
the abrogation of intracellular Ca2+ mobilisation in 5-hydroxytryptamine-stimulated 
blowfly salivary glands in inositol-free medium (Fain & Berridge, 1979a,b).
The phosphoinositides are minor cell phospholipids in eukaryotic cells and 
together constitute only 2 % to 8 % of the cell membrane phospholipid (Majerus et 
al., 1986). Phosphatidylinositol [Ptdlns], phosphatidylinositol 4-monophosphate 
[PtdIns(4)P] and phosphatidylinositol 4,5-bisphosphate [PtdIns(4 ,5)P2] exist in
equilibrium and are freely interconvertible by sequential phosphorylation and 
dephosphorylation reactions catalysed by discrete kinase and phosphatase activities 
(reviewed in Berridge & Irvine, 1989). However, the concentrations of the 
individual lipids are tightly regulated within the phosphoinositide pool.
In response to agonist-stimulation, PtdIns(4 ,5)P2 is specifically hydrolysed 
in a reaction catalysed by phospholipase C, whereas Ptdlns and PtdIns(4)P are not 
substrates for this reaction (Kirk et al., 1981; Michell et al., 1981; Michell & Kirk, 
1981). This is despite PtdIns(4,5)P2 existing as a minor component of the 
phosphoinositide pool, occupying only 1 - 10 % of the phosphoinositide pool 
(Majerus et al., 1986). Yet, such agonist-stimulated hydrolysis of PtdIns(4 ,5)P2 
rather than the more abundant phosphoinositides was further confirmed by 
Arganoff et al. (1983) who observed a thrombin-induced reduction of 
PtdIns(4 ,5)P2 without reduction of Ptdlns content in 32Pr labelled human platelets. 
Similarly, the PtdIns(4,5)P2 content of hepatocytes was also observed to decrease 
on vasopressin-stimulation (Litosch et al., 1983). However, rather than eliciting an 
agonist-stimulated decrease in Ptdlns levels, vasopressin-stimulation of hepatocytes 
was found to be associated with increased synthesis of Ptdlns. Such vasopressin- 
stimulated Ptdlns synthesis was observed in parallel with resynthesis of 
PtdIns(4 ,5)P2and subsequent to the transient accumulation of phosphatidic acid 
(Litosch et al., 1983). The previously observed reduction of Ptdlns in response to 
agonists has since been attributed to its position as a precursor of PtdIns(4 ,5)P2, 
although, this has yet to be widely demonstrated.
The agonist-mediated hydrolysis of PtdIns(4,5)P2 has proven to be 
associated with the initial cellular action of many hormones, neurotransmitters and 
growth factors in a wide range of tissue and cell types, and has been extensively 
reviewed (Downes and Michell, 1985; Berridge, 1987; Berridge & Irvine, 1989; 
and Whitman & Cantley, 1988). Phosphoinositide-specific phospholipase C 
(phosphoinositidase C; suggested by Downes & Michell, 1985) has proven to 
consist of a family of related activities (reviewed by Rhee et al., 1989; Meldrum et
al., 1991). Within the family there are four classes: a , p, y and 6. It should be 
noted that the a  classification is based on the estimated molecular weight of several 
Ptdlns-PLC activities with apparent molecular mass of 60-70 kDa (Rhee et al., 
1989). Only one Ptdlns-PLCa has been cloned to date, although its integrity is in 
doubt as the cDNA clone was unable to support catalytic activity in an expression 
system (Bennet & Crooke, 1987). Additionally, Ptdlns-PLCa has been found to 
possess little structure or sequence similarity with cloned Ptdln-PLCp, y, or 6 
(Meldrum et al., 1991). Of the other member classes (i.e. p, y & 6), Rhee (1989) 
suggested the following classification for the Ptdlns-PLC activities purified from 
bovine brain: pi to correspond to the the 154 kDa activity, yi to the 145 kDa 
activity, and 6 i to refer to the 85 kDa activity. Further purification and cloning has 
revealed yet more members of these three families. Comparison of their deduced 
primary structure and immunoreactivity allows their classification as P2, Y2, &2 and 
63. Although little sequence identity is shared between the members of the p, y and 
6 classes of Ptdlns-PLC, comparison of the primary structures of pi, yi and 61 has 
revealed two highly conserved regions. Ptdlns-PLCpi, -yi and -61 share 43 % 
identity in region I and 33 % identity in region II (Meldrum et al., 1991). The 
degree of homology in these conserved regions between individual members of a 
single class is much higher, e.g. Pi and p2 share 79% identity in region I and 71% 
identity in region II (Meldrum et al., 1991).
Receptor-stimulated PtdIns(4 ,5)P2 hydrolysis, catalysed by Ptdlns-PLC 
activity, is modulated across the plasma membrane by a guanine-nucleotide binding 
protein (reviewed by Cockcroft, 1987). Such guanine-nucleotide binding proteins 
(G-proteins) represent a family of heterotrimeric proteins that regulate the activity of 
a range of intracellular effector enzymes (see Simon et al., 1991). The 
heterotrimeric G-proteins are comprised of a-, p- and y-subunits and have been 
arranged into four families based on the primary sequence identity of their a- 
subunits (Simon et al., 1991). From this classification, the Gccq family members, 
G a n  and Gaq, were initially identified as the G-proteins active in the modulation
of Ptdlns-PLC activity (Gutowski et al., 1991; Taylor et al., 1991; Wu et aL,
1992). Taylor and co-workers (1990) purified a mixture of G a n /G a q, on the 
basis of its ability to activate partially purified Ptdlns-PLC, from GTPyS-treated 
bovine liver membranes. When reconstituted with specific Ptdlns-PLC isoenzymes 
in the presence of GTPyS, the Gan/Gctq mixture specifically activated Ptdlns- 
PLCpi, but not Ptdlns-PLCyi nor Ptdlns-PLCSi (Taylor et al., 1991). Similarly, 
the Gaq (G an) homologue purified from turkey erythrocytes has been shown to 
activate the Ptdlns-PLC purified from the same source (Ptdlns-PLCPi homologue) 
(Waldo et al., 1991). Further investigation of the individual Gaq family members' 
abilities to activate Ptdlns-PLC isoenzymes has revealed a functional division 
between the family members not previously observed. Membranes prepared from 
Cos-7 cells transfected with cDNAs corresponding to all four G a q family members, 
i.e. G a q, G a n ,  G a ^ a n d  G a i6, have been found to stimulate Ptdlns-PLCPi on 
reconstitution with GTPyS (Rhee & Choi, 1992). Membranes prepared from cells 
expressing Ga<j and G ai i were most effective in this role . However, a different 
pattern was observed when PtdIns-PLCp2 was reconstituted with similarly 
transfected Cos-7 cell membranes in the presence of GTPyS. In this instance,
G ai6 was the most potent activator of Ptdlns-PLCP2 activity, with Gc^, G a n  and 
G a i4 far less stimulatory (Rhee & Choi,. 1992).
The receptors for certain polypeptide growth factors, for example EGF and 
PDGF, stimulate PtdlnsPLC activity by a mechanism distinct from that described 
above (reviewed Boyer et al., 1989; Rhee, 1991; Rhee & Choi, 1992). Occupation 
of the growth factor receptor results in increased activity of the receptor tyrosine 
kinase (RTK), which is accompanied by increased phosphorylation of Ptdlns- 
PLCyi. Associated with the increased phosphorylation of Ptdlns-PLCyi is an 
elevated rate of Ptdlns(4,5)P2 hydrolysis catalysed by this enzyme. Thus, receptor 
stimulated Ptdlns-PLC activity is modulated by a pathway independent of 
independent of G-protein involvement.
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To date, neither the receptors nor the transmembrane transduction system 
coupled with the Ptdlns-PLCS family members have been identified.
Of the bona fide cloned Ptdlns-PLC family members: PtdlnsPLCPi and -p2 
possess catalytic specificity for the polyphosphoinositides, catalysing the 
hydrolysis of PtdIns(4)P and PtdIns(4 ,5)P2 with greater reaction velocities than 
Ptdlns. Elevation of the Ca2+ concentration to mM does not result in alteration of 
the catalytic selectivity towards polyphosphoinositides. Similar to the Ptdlns-PLCp 
family members, PtdIns-PLC6i and -62 catalyse the hydrolysis of 
polyphosphoinositides at greater reaction rates than measured with Ptdlns at 
physiological or low Ca2+ concentrations. However, distinct from the Ptdlns- 
PLCp family members, Ptdlns-PLCSi and 62 will hydrolyse Ptdlns with increased 
reaction velocity at mM Ca2+, losing their specificity for polyphosphoinositides. 
Finally, Ptdlns-PLCyi has not been observed to possess catalytic selectivity at 
physiological Ca2+ concentrations, catalysing the hydrolysis of PtdIns(4 ,5)P2 and 
Ptdlns with equal rates (reviewed by Meldrum et al., 1991).
1.1.3. The Products of Ptdlns-PLC-Catalysed Hydrolysis of 
PtdIns(4,5)P2 Are Active as Intracellular Messengers.
The products of Ptdlns-PLC-catalysed hydrolysis of PtdIns(4 ,5)P2 are sn -
1,2-diacyl glycerol and inositol-1,4,5-trisphosphate [Ins(l,4 ,5)P3]. They are both 
active as second messengers. Ins(l,4,5)P3 has been identified as the agent 
responsible for evoking the rise in intracellular Ca2+ (Streb et al., 1983), 
characteristic of the agonists active in stimulating PtdIns(4 ,5)P2 turnover. Binding 
a specific intracellular receptor, Ins(l,4 ,5)P3 evokes release of calcium from the 
hormone-sensitive Ca2+ store located in the smooth endoplasmic reticulum 
(reviewed by Berridge & Irvine, 1984; Berridge & Irvine, 1989). On the other 
hand, acting synergistically with phosphatidylserine and Ca2+, sn-1,2- 
diacylglycerol has been identified as the physiological activator of protein kinase C 
[PKC] (Nishizuka, 1988a; Parker e ta i ,  1989). sn- 1,2-Diacyl glycerol is, thus,
responsible for mediating the increased activity of PKC associated with Ca2+- 
mobilising agonists.
Additionally, Ins(l,4 ,5)P3 is phosphorylated by Ins(l,4 ,5)P3 3-kinase to 
produce inositol 1,3,4,5-tetrakisphosphate [Ins(l,3 ,4 ,5)P4] (see Section 1.1.4), an 
inositol phosphate active in elevating intracellular Ca2+ concentrations by promoting 
entry of extracellular Ca2+ in an Ins(l,4,5)P3-dependent process (Irvine & Moor, 
1986; reviewed by Berridge & Irvine, 1989).
1.1.4. M etabolism of Ins(l,4,5)P3 and sn -l,2-D iacy!gIycerol in 
A gonist-Stim ulated Cells.
Both second messengers, Ins(l,4 ,5)P3 and sw-l,2-diacylglycerol, are 
rapidly metabolised to allow resynthesis of the parent, agonist-sensitive 
phosphoinositide; PtdIns(4 ,5)P2- Ins(l,4,5)P3 is exclusively dephosphorylated by 
the Ins(l,4 ,5)P3/Ins(l,3 ,4 ,5)P45-phosphatase to Ins(l,4)P2- The same catalytic 
activity is able to dephosphorylate Ins(l,3 ,4 ,5)P4 to Ins(l,3 ,4)P3. The combined 
presence of Ins(l,4 ,5)P3 3-kinase and Ins( 1,4,5)P3/Ins( 1,3,4,5)P4 5-phosphatase, 
thus, explains the observed increases in Ins(l,3 ,4 ,5)P4 and Ins(l,4)P2 following 
agonist stimulation. Ins(l,4)P2and Ins(l,3 ,4)P3 are dephosphorylated by the 
Ins(l,3 ,4)P3/Ins(l,4)P2 1-phosphatase to produce Ins(4)P and Ins(3 ,4)P2, 
respectively. Additionally, Ins( 1,3,4)P3 can be dephosphorylated by a 4- 
phosphatase activity that is also active in the dephosphorylation of the Ins(3 ,4)P2 
product of Ins(l,3 ,4)P3/Ins(l,4)P21-phosphatase activity. The Ins(l,3)P2 product 
of the 4-phosphatase activity is metabolised by a 3-phosphatase activity to yield 
Ins(l)P. Collectively, the three monophosphate products, Ins(l)P, Ins(3)P and 
Ins(4)P are substrates for inositol monophosphatase and are dephosphorylated to 
free inositol base. The integrated phosphorylation and dephosphorylation events 
involved in the metabolism of the inositol phosphates and release of free inositol 
prior to resynthesis of PtdIns(4 ,5)P2 have been summarised and reviewed 
elsewhere (Berridge & Irvine, 1989; Shears, 1991).
sn-1,2-Diacyl glycerol, the glycerolipid product of the Ptdlns-PLC-catalysed 
hydrolysis of PtdIns(4 ,5)P2, is metabolised initially by phosphorylation to 
phosphatidic acid (s«-l,2-diacylglycero-3-phosphate). Phosphorylation by DAG 
kinase is the initial and arguably the commited step in the recycling of the intact 
glycerolipid backbone towards the parent phospholipid, PtdIns(4 ,5)P2. 
Phosphatidic acid is condensed with CTP to form CMP-phosphatidate in a reaction 
catalysed by CMP-phosphatidic acid synthetase. Reaction of CMP-phosphatidate 
with the inositol released from the inositol phosphate pool produces the 
phospholipid, Ptdlns, in a reaction catalysed by Ptdlns synthetase. This reaction 
supplies the Ptdlns precursor of the polyphosphoinositides while liberating CMP 
from the lipid pool. The steady-state levels of Ptdlns, PtdIns(4)P and 
PtdIns(4 ,5)P2 are then governed by the integrated action of several activities; Ptdlns 
4-kinase, PtdIns(4)P phosphomonoesterase, PtdIns(4)P 5-kinase, and 
PtdIns(4 ,5)P2 monophosphoesterase (summarised by Majerus et al., 1986;
Berridge & Irvine, 1989). Thus, the 'Pl-cycle' is complete and predicts both the 
removal of Ins(l,4,5)P3 and sn-1,2-diacylglycerol to metabolic intermediates that 
are inactive as second messengers and also the resynthesis of the 
phosphoinositides.
Three exceptions to the accepted dogma of the 'Pl-cycle' should be noted; 
the hydrolysis of Ptdlns and PtdIns(4)P catalysed by Ptdlns-PLC; the accumulation 
of cylic inositol phosphates in receptor-stimulated cells; and the production of 
PtdIns(3)P by Ptdlns 3-kinase. As discussed earlier, both Ptdlns-PLCbi and -62 
will hydrolyse Ptdlns and PtdIns(4 ,5)P2 with similar reaction velocities in the 
presence of mM Ca2+, despite showing marked specificity for the 
polyphosphoinositides at physiological or low Ca2+ concentrations (reviewed 
Meldrum et al., 1991). In parallel it has been suggested that stimulated Ptdlns-PLC 
activity has resulted in the hydrolysis of Ptdlns and PtdIns(4)P, most likely 
secondary to the elevation of intracellular calcium in response to agonist-stimulation 
(Brammer & Weaver, 1989; Baird & Nahorski, 1990). Therefore, hydrolysis of
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phosphoinositides distinct from PtdIns(4 ,5)P2 does occur, albeit secondary to the 
receptor-mediated mobilisation of intracellular Ca2+ stores. The physiological 
significance of this hydrolytic event is not known as Ins(l,4)P2 and Ins(l)P  are not 
active in the role of mobilising intracellular calcium stores. However, the sn-1,2- 
diacylglycerol produced could potentially stimulate PKC activity.
Additionally, the cyclic inositol phosphates, Ins(l:2cyc,4 ,5)P3, 
Ins(l:2cyc,4)P2 and Ins(l:2cyc)P, have been found to accumulate in response to 
agonist stimulation (reviewed Berridge & Irvine, 1989). Formed by Ptdlns-PLC- 
catalysed hydrolysis of the phosphoinositides, they constitute only a minor 
component of the inositol phosphate products. Only 1 - 2 % of phospholipase C- 
catalysed hydrolysis of PtdIns(4 ,5)P2 results in the production of 
Ins(l:2cyc,4,5,)Fb (Hawkins et al., 1987; Wong et al., 1988). It is unlikely that 
the cylic inositol phosphates are physiologically active as Ca2+ mobilising agents, 
since Ins(l:2cyc,4 ,5)P3 possesses 10-fold less efficacy than Ins(l,4 ,5)P3 in this 
role (Willcocks et al., 1989). The sn-1,2-diacylglycerol product would still, 
however, be active in its physiological role.
Finally, Whitman et al. (1988) and Traynor-Kaplan et al. (1988) made the 
novel observation of inositol phospholipids phosphorylated in the 3-position of the 
inositol headgroup. The 3-phosphate containing phosphatidylinositols represent 
only 1 - 2 % of the other phosphatidylinositol polyphosphates (Stephens et al.,
1989). However, preliminary characterisation has shown that PtdIns(3)P and 
PtdIns(3 ,4)P2 are only poor substrates for Ptdlns-PLC while PtdIns(3 ,4 ,5)P3 is 
not a substrate at all (Serunian et al., 1989; Lips et al., 1989). It is unlikely that 
these newly discovered lipids will make a significant contribution to agonist- 
stimulated levels of inositol phosphates or sw-1,2-diacyl glycerols.
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1.2. The Role of s7i-l,2-D iacylglycerol in Agonist-Stim ulated Cells: 
Physiological Activator of PKC.
PKC, the diacylglycerol-activated/Ca2+ and phospholipid-dependent protein 
kinase, is a critical component of the signal transduction system defined by the 
accelerated hydrolysis of PtdIns(4 ,5)P2 (Nishizuka, 1984, 1986). As such, PKC 
directly catalyses many of the intracellular protein phosphorylation events 
associated with cellular activation by Ca2+-mobilising agonists. In this role it is 
directly responsible for the modulation of the intracellular reponse after receptor 
occupation.
In a model recently proposed by Bell & Bums (1991), accumulation of sn-
1,2-diacyl glycerol in the membranes of agonist-stimulated cells results in the 
activation of membrane-associated PKC. PKC resides on the cell membrane by 
interaction with phospholipids, specifically phosphatidylserine, in a calcium- 
dependent manner and is, thus, juxtaposed to the membrane-intercalated sn-1,2- 
diacylglycerol that will modulate its rate of reaction. Apropos to this, PKC resident 
in the cytosol represents an inactive pool, conformationally unable to phosphorylate 
substrate proteins, but with full ability to associate with the membrane in response 
to elevation of intracellular Ca2+ and consequently be activated by increased levels 
of 5n-l,2-diacylglycerol. Similarly, activation of PKC by phorbol 12-myristate 13- 
acetate (PMA), a tumour-promoting phorbol ester, is observed as an alteration of 
the enzyme's intracellular distribution (Nishizuka, 1984, 1986). Inactive cytosolic 
PKC redistributes to the membrane in response to PMA treatment, as would be 
predicted from the above model for a potent activator of PKC. Direct interaction of 
PMA with the 5«- 1,2-diacylglycerol binding site has been demonstrated, showing 
PMA acts as a mimetic of the physiological lipid (Castagna et al., 1982; Sharkey et 
al., 1984).
Originally cloned from bovine brain, PKC was found to be represented by a 
family of distinct isoenzymes sharing a high degree of homology in regions of their 
primary structure (reviewed by Parker et al., 1989). Isolation of the cDNAs
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corresponding to bovine brain PKC revealed four distinct isotypes: a , pi, P2 and y 
(see Parker et a I., 1989). Huang et al. (1986) had observed that a purified 
preparation of PKC activity from bovine brain could be resolved to three 
immunologically distinct peaks of activity on hydroxyapatite chromatography. On 
the basis of both immunoreactivity of the antisera raised against these resolved 
activities and also comparison of cell-type specific expression of immunoreactive 
protein in rat brain, the putative isoenzymes were identified as PKC-a, PKC-P1/P2 
and PKC-y (Huang et al., 1987). Finally, resolved PKC-a, -P1/P2 and -y activities 
were found to be biochemically distinguishable with respect to (a) their 
phospholipid requirements, (b) -s/z-l^-diacylglycerol and phorbol ester activation, 
and (c) Km for different protein substrates, confirming their existence as distinct 
isoenzymes (Huang et al., 1988a).
The deduced primary sequence of PKC-a, -pi/p2 and -y reveals 
considerable sequence homology. Direct sequence comparison has identified four 
highly conserved regions (Cl - C4) surrounded by five regions of variable 
sequence (V 1 - V5) (see Parker et al., 1989; Parker 1992). Oligonucleotide probes 
constructed from the regions of conserved sequence have been employed to screen 
cDNA libraries. This approach has allowed the identification and isolation of 
several cDNA corresponding to novel PKC isoenzymes. As a result, the PKC 
family now consists of 10 members: a ,  p i, P2, y, 6, e, r\> 0 and L (Bell &
Burns, 1991).
Although characterisation of all the putative members is incomplete it is clear 
that the members possess widely variant tissue distribution and biochemical 
characteristics with respect to Ca2+-sensitivity, phospholipid activation and 
substrate specificity (Nishizuka 1988a, b; Marias et al., 1990; Olivier & Parker, 
1991; Schaap & Parker, 1990). However, it should be noted that the isotypes 
originally characterised from bovine brain, i.e. PKC-a, -Pi, -P2 and -y, have 
proved distinct from the other putative members of the PKC family as they 
represent a Ca2+-sensitive sub-division within the family. On the other hand,
PKC-S, -e, -£, -0, -rj and -L lack the C2 region identified as conferring Ca2+- 
sensitivity to PKC-a, -|3i, -P2 and -y. However, PKC-6, -e, -£, -0, -r\ and -L 
display both phorbol ester binding and kinase activities independent of Ca2+
(Parker et al., 1989; Bell & Bums, 1991; Parker et al., 1992). The absence of a 
Ca2+-requirement for phorbol ester binding and protein kinase activities is still 
encompassed by the model of PKC activation suggested by Bell & Bums (1991). 
The possibility of PKC activity binding the phospholipid membrane in a Ca2+- 
independent manner was reconciled and, indeed, PKC-6 has been shown to 
associate with phospholipid in a Ca2+-independent manner (Olivier & Parker,
1991). Furthermore, PKC-£ does not translocate to the cell membrane in response 
to PMA-treatment, i.e. PKC-t, does not accumulate in the catalytically active 
conformation on the cell membrane after treatment with either PMA. Typically, 
chronic exposure of cells to PMA results in association of PKC with the cell 
membrane in a catalytically active conformation that is susceptible to proteolytic 
degradation (Rodriguez-Pena & Rozengurt, 1984; Young et al., 1987). However, 
chronic treatment of U937 cells with PMA neither results in translocation of the 
constitutively exressed PKC-t, to the cell membrane nor increased susceptibility of 
the enzyme to proteolysis (Parker et al., 1992). Conversely, these workers did 
observe translocation and down-regulation of PK C-a,-(3, and -e in U937 cells 
treated with PMA. In conclusion, PKC has been defined as a family of structurally 
related protein kinase activities that can be divided by their fundamental dependence 
on Ca2+ for activity. Until further studies are concluded, the physiological 
requirement for more than one Ca2+-sensitive and one Ca2+-insensitive PKC 
activity will remain unknown. However, it may possible to speculate that tissue- 
specific patterns of expression and also sub-cellular localisation of the divergent 
protein substrates have required the evolution of this growing family of proteins.
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1.3. DAG Kinase Activity in Receptor-Stimulated PtdIns(4,5)P2 
Turnover.
1.3.1. Role of DAG Kinase In Stimulated PtdIns(4,5)P2 Turnover: A 
R eiteration.
PMA is not readily metabolised in the cell and its use, with the exception of 
PKC-£, produces a chronic activation of PKC leading to proteolytic down- 
regulation (see Section 1.2.1). SAi-l,2-Diacylglycerol is, on the other hand, readily 
metabolised and represents an activator species present only transiently within the 
cell, closely coupling PKC activation to receptor-mediated hydrolysis of 
PtdIns(4 ,5)P2 by Ptdlns-PLC (see Section 1.4.1). The activity responsible for 
removal the sn-1,2-diacylglycerol will, in effect, control the longevity of PKC 
activation and the phosphorylation events catalysed by the protein kinase. The 
cellular responses mediated by PKC-catalysed phosphorylation events are 
controlled by the activity responsible for the metabolism and, thus, removal of the 
5Az-l,2-diacylglycerol second messenger.
The tight coupling of PKC-catalysed protein phosphorylation to the 
transient presence of sn- 1,2-diacyl glycerol was demonstrated in thrombin- 
stimulated platelets (Kawahara et al., 1980; Sano et al., 1983; Ieyasu et al., 1982). 
Additionally, the synthetic cell-permeable sn- 1,2-diacyl glycerol analogue, sn-1- 
oleoyl-2-acetylglycerol, was found to promote phosphorylation of the 40 kDa 
PKC-substrate protein in intact platelets (Kaibuchi et al., 1983). Thus, DAG 
kinase was implicated in the regulation of PKC activity when sw-l-oleoyl-2- 
acetylglycerol was found to be rapidly metabolised by phosphorylation to its 
phosphatidic acid derivative (Kaibuchi et al., 1983). It is now widely accepted that 
PKC is regulated by DAG kinase-catalysed phosphorylation of its lipid activator 
(Nishizuka, 1984, 1986). Therefore, DAG kinase plays a key role in modulating 
the receptor-stimulated events mediated by PKC.
The dual role of DAG kinase in the cell signalling pathway associated with 
'Pl-cycle' is now clear: (a) it phosphorylates the s«-l,2-diacylglycerol produced in
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response to receptor occupation, allowing resynthesis of the parent inositol 
phospholipids (see Section 1.1.4), and (b) it initiates the metabolism of PKC's 
physiological activator to metabolites inactive in this role.
1.3.2. The Metabolism of i/i-l,2 -D iacylg lycerol Produced on 
Stim ulated PtdIns(4,5)P2 Turnover: A Caveat.
Diacyl glycerol lipase (DAG lipase) has also been implicated in the 
metabolism of sn- 1,2-diacyl glycerol produced in response to receptor-occupation in 
platelets (Prescott & Majerus, 1983) and Swiss 3T3 fibroblasts (Habenicht et al., 
1981). Bell et al. (1979) originally observed that DAG lipase catalysed the release 
of arachidonate from the sn-2 position of PtdIns(4,5)P2-derived sn- 1,2- 
diacyl glycerol in human platelets. In addition, they argued that the release of the 
acyl-group in the sn- 1 position of the 1-monoacyl glycerol product was also 
catalysed by DAG lipase. The ambiguity of DAG lipase possibly catalysing the 
hydrolysis of both acyl-ester bonds was resolved by Prescott & Majerus (1983). 
These workers demonstrated the initial hydrolytic event to be confined to the sn-l 
position. The previously observed release of arachidonic acid from the sn-2 
position of sn- 1,2-diacyl glycerol was the result of an endogenous 2- 
monoacylglycerol lipase, distinct from DAG lipase, that catalysed the release of free 
fatty acid and glycerol from 2-monoacylglycerol (Prescott & Majerus, 1983).
The presence of phospholipase A2 activity, responsive to receptor-mediated 
events, has interfered with measurement of DAG lipase activity within cells pre­
labelled with radioactive fatty acids, e.g. pH]arachidonic acid or pH]oleic acid. 
Rather than catalysing the release of the fatty-acid esterified at the sn-1 position of 
sn-1,2-diacylglycerol, phospholipase A2 catalyses the release of the sn-2 fatty-acyl 
group from phospholipids. Interpretation of fatty-acid release experiments in 
prelabelled cells in the study of concerted DAG lipase/MAG lipase activity is 
compromised by the presence of phospholipase A2. Although these enzymes act on 
distinct substrates, they catalyse the release of the same fatty acid, i.e. the fatty acyl
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group esterified at thesw-2 position of either phospholipid or the sn-1,2- 
diacylglycerol derived from it. Therefore, interpretation of fatty acid release 
experiments must be accompanied by identification of the non-fatty acid product 
and the enzyme activity responsible for catalysing the hydrolytic event.
Bell et al. (1979) postulated that DAG lipase catalysed the release of 
arachidonate from sn-1 -stearoyl-2-arachidonylglycerol, the major diglyceride 
product of receptor-mediated Ptdlns-PLC activity in thrombin-stimulated platelets. 
However, Lapetina et al. (1981) concluded that the release of arachidonic acid in 
thrombin-stimulated platelets was the result of an event secondary to the production 
of phosphatidic acid, i.e. secondary to the action of DAG kinase and not a product 
of DAG lipase activity. Furthermore, Billah & Lapetina (1982) observed the 
parallel production of arachidonic acid and lysophosphatidic acid in thrombin- 
stimulated platelets, strongly indicating the existence of receptor-modulated 
phospholipase A2 activity.
PDGF-stimulation of Swiss 3T3 fibroblasts results in the accumulation of 
free arachidonic acid subsequent to sn- 1,2-diacyl glycerol production (Habenicht et 
al., 1981). Although this would implicate DAG lipase in the metabolism of sn- 1,2- 
diacyl glycerol in Swiss 3T3 fibroblasts, Currie etal. (1992) observed a 
phospholipase A2-catalysed release of [3H]arachidonate in pre-labelled Swiss 3T3 
fibroblasts stimulated with bombesin. Furthermore, this bombesin-stimulated 
accumulation is maximal after 10 sec of stimulation (Currie et al., 1992), 
suggesting PLA2-catalysed release maybe secondary to Ins(l,4,5)P3 and sn- 1,2- 
diacyl glycerol production in these cells (Cook et al., 1990).
Therefore, in the case of platelets and Swiss 3T3 fibroblasts, the 
contributions of both DAG lipase and agonist-stimulted phospholipase A2 must be 
considered when interpretationg fatty-acid release from pre-labelled cells. 
Nevertheless, the information suggests that receptor-stimulated levels of sn- 1,2- 
diacyl glycerol can be metabolised, in part, by DAG lipase. However, the route of 
sn- 1,2-diacyl glycerol metabolism is most likely split between the DAG lipase and
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DAG kinase pathways. Sagavva et al. (1982) found that both DAG kinase and 
DAG lipase activities were present in human amniotic tissue homogenates, with the 
ratio of kinase:lipase activities altering with both Ca2+ and sn-1,2-diacyl glycerol 
concentrations. Despite the requirement for supra-physiological Ca2+ 
concentrations in vitro, the possibility of alteration in the direction of sn- 1,2- 
diacyl glycerol metabolism in response to receptor-mediated events is evident. 
Bishop & Bell (1986) observed that pH]s/z-l,2-dioctanoylglycerol, a cell 
permeable sn- 1,2-diacyl glycerol analogue, was metabolised primarily by DAG 
kinase in human platelets, although conserted DAG lipase/MAG lipase activity was 
still observed. Inhibition of platelet DAG kinase by either sn-1,2- 
dioctanoylethylene glycol or 1-monoacylglycerol (Bishop et al., 1986) resulted in 
inhibition of phospholipid synthesis and increased [3H]s«-l,2-dioctanoylglycerol 
longevity, consistent with inhibition of DAG kinase (Bishop & Bell, 1986). 
Compensatory elevation of the rate of sn- 1,2-diacyl glycerol metabolism by the 
DAG lipase/MAG lipase pathway was not observed on inhibition of DAG kinase, 
yet an increased production of phospholipid was observed on inhibition of DAG 
lipase by RHC 80267 (Bishop & Bell, 1986). This would serve to confirm the 
accepted view that the DAG kinase route is the major pathway for removal of the 
sn- 1,2-diacyl glycerol product of receptor-mediated PtdIns(4,5)P2 hydrolysis.
1.3.3. The Physiological Importance of Diacylglycerol Kinase 
Activity: Diacylglycerol Kinase in the Diseased State.
Several ras-transformed fibroblast cell lines possess elevated levels of sn-
1,2-diacylglycerol compared to non-transformed cells (Preiss et al., 1986; 
Fleischman et al., 1986; Kato et al., 1988; Huang et al., 1988b). As such, 
sustained elevation of sn- 1,2-diacyl glycerol levels has been suggested to be 
important in the maintenance of the transformed state (Macara, 1985).
Functional PKC activity has been shown to be required for maintenance, 
but not initiation of the ras-transformed state (Lacal et al., 1987; Lloyd et al.,
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1989). As may be expected for cells possessing elevated levels of sn- 1,2- 
diacyl glycerol, ray-transformed fibroblasts exhibit increased cellular PKC activity 
associated with the cell membranes, coincident with depleted cytosolic activity 
(Kamata, 1987; Huang et al., 1988b). The translocation of PKC to the membrane 
in unstimulated transformed cells is also associated with elevated levels of PKC- 
catalysed phosphorylation compared to non-transformed cells (Wolfman & Macara,
1987). Predictably, such chronic activation results in down-regulation of PKC. 
Thus, ras-transformed cells exhibit decreased levels of PMA-stimulated PKC 
activity and reduced PDBu-binding (Wolfman & Macara, 1987; Wolfman et al.,
1987).
Consensus has still to be reached on whether elevated rates of 
phosphoinositide turnover initiates the elevation of sn-1,2-diacylglycerol levels in 
the membranes of ras-transformed cells (Wolfman & Macara, 1987; Huang et al., 
1988b), however the rate of its metabolism by DAG kinase would appear to be 
altered in the transformed state. Although total DAG kinase activity is not altered 
on transformation of rat fibroblasts, decreased membrane-associated and increased 
cytosolic activity is observed in the transformed state (Huang et al., 1988b; Kato et 
al., 1988). It was postulated that disruption of the mechanism by which soluble 
DAG kinase translocates to the membrane, in response to accumulation of sn-1,2- 
diacylglycerol, results in decreased membrane-association in transformed cells 
(Kato et al., 1988). As translocation of cytosolic DAG kinase to the membrane- 
associated compartment has been suggested as a regulatory event in the metabolism 
of 5«-l,2-diacyl glycerol (see Section 1.8.4), loss of the ability to translocate may 
explain the elevated levels of sn- 1,2-diacyl glycerol in ray-transformed cells. This 
could indicate the importance of DAG kinase in maintaining the non-transformed 
state, with disfunction of the enzyme possibly leading to the activation-induced 
down-regulation of PKC observed in ray-transformed fibroblasts (Wolfman & 
Macara, 1987; Wolfman et al., 1987).
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Another example of DAG kinase dysfunction in the diseased state is the 
Drosophila retinal degradation mutant, rdgA (Inoue et al., 1989). rdgA mutant flies 
experience age-dependent retinal degradation in adult life and their retinas possess 
abnormally low levels of PtdOH and DAG kinase activity compared to wild-type 
flies (Yoshioka et al., 1983, 1984). Kinetic analysis of DAG kinase activity in 
heterozygotes of various rdgA mutants revealed that the Km for sn-1,2- 
dioleoylglycerol was unaltered compared to the wild-type, yet the Vmax was 
reduced by 40 % (Inoue et al., 1989). Moreover, the observed DAG kinase activity 
was found to compare with the gene dosage of wild-type rgdA gene with a deletion 
mutant, spanning the rdgA locus, also unable to display DAG kinase activity (Inoue 
et al., 1989). After eclosion from the pupal case, the retinas of mutant flies have 
reduced levels of DAG kinase activity and PtdOH, regardless of age. The 
development of their visual apparatus is also limited at eclosion, with complete 
degeneration ocurring within a few days. A possible causitive role of reduced DAG 
kinase activity in the mechanism of retinal degeneration is indicated.
1.3.4. The Significance of DAG kinase May be Indicated by the 
Specific Inhibitor, R59022.
R59022 was originally described as a DAG kinase inhibitor by Chaffoy de 
Courcelles et al. (1985). It inhibited the DAG kinase-catalysed phosphorylation of 
both endogenous 5«-l,2-diacylglycerol and exogenous 5?z-l-oleoyl-2-acetylglycerol 
in human red blood cell membranes with an IC50 value of approximately 3.0 pM. 
Furthermore, when employed atk 10 pM, these workers observed R59022 to be 
without effect on the of Ptdlns 4-kinase, PtdIns(4)P 5-kinase or the Ca2+- 
stimulated Ptdlns-PLC activities associated with red blood cell membranes. 
Thrombin stimulation of intact platelets in the presence of R59022 elicits a 4-fold 
greater accumulation of sn-1,2-diacylglycerol than thrombin treatment alone 
(Chaffoy de Courcelles et al., 1985). As might be expected, thrombin-stimulation 
in the presence of R59022 was associated with reduced levels of PtdOH compared
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to thrombin treatment alone. Finally, the dose-dependency of thrombin-induced 40 
kDa protein phosphorylation was shifted to the left in the presence of R59022, 
although the magnitude of phosphorylation under maximally stimulating 
concentrations of thrombin was unaltered by the presence of R59022 (Chaffoy de 
Courcelles et al., 1985). In summary, R59022 can be employed in intact platelets 
as a specific inhibitor of DAG kinase to elicit elevation of sn-1,2-diacylglycerol 
levels under conditions of sub-maximal stimulation with thrombin. Such an 
elevation clearly resulted in elevated PKC activity and increased phosphorylation of 
its cellular substrates. Additionally, the inhibitor has further identified the role of 
DAG kinase in modulating PKC activity within the cell. Under sub-maximal 
stimulatory conditions, inhibition of DAG kinase elicits inceased PKC activity; this 
clearly implicates DAG kinase in regulating receptor-stimulated sn- 1,2- 
diacyl glycerol levels immediately after they are produced. Thus, the magnitude of 
stimulated PKC activity is not solely the product of PtdIns(4 ,5)P2 mass 
hydrolysed. It is, however, the product of equilibrium concentrations of sn-1,2- 
diacylglycerol within the cell and these are determined jointly by the rates of 
PtdIns(4 ,5)P2 hydrolysis and s«-l,2-diacylglycerol metabolism. Nevertheless, the 
equilibrium concentration of sn- 1,2-diacyl glycerol can rise sufficiently to become 
saturating, eliciting a maximal rate of PKC activity. Further elevation of sn-1,2- 
diacylglycerol above these levels, by inhibition of DAG kinase, does not result in 
additional protein phosphorylation.
Many examples of R59022 use in the analysis of DAG kinase and PKC 
activity in the agonist-stimulated state have been reported (Nunn & Watson, 1987; 
Muid et al., 1987; Gomez-Cambronero et al., 1987; Morris et al., 1987). Caution 
may, however, need to be excercised in the interpretation of R59022 inhibition 
studies. Yada and co-workers (1990) reported differential inhibition of DAG 
kinase isoenzymes by R59022. The workers described the resolution and 
purification of three cytosolic DAG kinases from human platelets. In vitro, R59022 
inhibited the DAG kinase activity with apparent molecular mass of 75 kDa, partially
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inhibited the 58 kDa activity and was without effect on the 152 kDa enzyme. 
Similarly, Sakane et al. (1989) reported the activity of the 150 kDa porcine thymus 
cytosolic activity to be unaffected by R59022, while the 80 kDa activity was 
inhibited with an IC50 value of 10 pM. The differential inhibition of isoenymes 
may suggest that R59022 inhibitor studies cannot be unilaterally interpreted, 
without prior investigation of the effect of the inhibitor on the individual 
isoenzymes present. Alternatively, the potentiating effect of R59022 on PKC 
activity in thrombin-stimulated platelets (Chaffoy de Coucelles et al., 1985) may 
indicate that an R59022-sensitive DAG kinase isoenzyme is responsible for the 
metabolism of receptor-generated sn- 1,2-diacyl glycerol.
1.4. Receptor-Generated s/i-l,2-D iacylglycerol from Non- 
P td In s(4 ,5 )P 2  Sources.
1.4.1. Alternative Sources of sn -1,2-DiacyIglycerol in Agonist- 
Stim ulated Cells.
The possibility of stimulated production of sn- 1,2-diacyl glycerol from 
sources other than PtdIns(4 ,5)P2 has recently been realised. Receptor-mediated 
hydrolysis of PtdIns(4,5)P2 is of transient nature, limited to the immediate events 
after receptor occupation (Griendling et al., (1986); Plevin et al., 1991a; Plevin & 
Wakelam, 1992). Measurement of Ins(l,4 ,5)P3 formation has identified only 
transient hydrolysis of PtdIns(4 ,5)P2 in response to a variety of agonists in Swiss 
3T3 fibroblasts, Rat-1 fibroblasts and A 10 vascular smooth muscle cells (Plevin et 
al., 1990, 1991a,b; Plevin & Wakelam, 1992). However, measurement of sn- 1,2- 
diacyl glycerol levels in a-thrombin-stimulated IIC9 fibroblasts (Wright et al.,
1988) and bombesin-stimulated Swiss 3T3 fibroblasts (Cook eta l., 1990) has 
revealed a biphasic pattern; an initial transient peak followed by a sustained increase 
in sfl-l,2-diacylglycerol above control levels for up to 4 h (Takuwa et al., 1991). 
The transient formation of s//-l,2-diacylglycerol and Ins(l,4,5)F^ was immediately 
identified as corresponding to the brief receptor-mediated hydrolysis of
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PtdIns(4 ,5)P2, while the secondary phase of elevated sw-l,2-diacylglycerol levels 
has been associated to receptor-mediated hydrolysis of a phospholipid distinct from 
PtdIns(4 ,5)P2. It was soon appreciated that this sustained phase of sn-1,2- 
diacylglycerol formation corresponded to the release of choline and 
phosphocholine, identifying the stimulated hydrolysis of PtdCho in a range of 
agonist-stimulated cells (Besteman et al., 1986a; Cabot et al., 1988; Martin & 
Michaelis, 1988, 1989; Cook & Wakelam, 1989). Comparison of the time-course 
of elevated levels of srt-l,2-diacylglycerol to the time-course of choline and 
phosphocholine mobilisation, although a cogent argument, did not unequivocally 
identify the precursor phospholipid. However, analysis of the acyl-chain molecular 
species present in agonist-stimulated levels of sn- 1,2-diacyl glycerol and 
comparison to those found in individual cellular phospholipids would provide a far 
more convincing identification.
In addition to observing the sole release of choline from IIC9 fibroblasts 
labelled with [3H]choline, [3H]ethanolamine or [3H]serine in response to a -  
thrombin stimulation, Pessin & Raben (1989) employed an elegant 
derivatisation/gas liquid chromatography (GLC) separation method to analyse the 
different acyl-chain species of s«- 1,2-diacyl glycerols present in a-throm bin- 
stimulated IIC9 fibroblasts. Comparison of the stimulated sn- 1,2-diacyl glycerol 
acyl-chain profile to that of Ptdlns, PtdSer, PtdCho and PtdEtn isolated from 
unstimulated cells allowed identification of the precursor phospholipid. These 
workers found phosphoinositides to contribute a large proportion of the sn- 1,2- 
diacyl glycerol present 15 sec after stimulation, as would be expected. However, 
PtdCho was identified as the major source of stimulated sn- 1,2-diacyl glycerol after 
5 min and lh of thrombin-stimulation. PtdCho was also found to be the source of 
stimulated sn- 1,2-diacyl glycerol levels after stimulation of IIC9 fibrobalsts with 
either EGF or PDGF for 5 min or 1 h (Pessin et al., 1990). Although receptor- 
mediated hydrolysis of PtdCho is strongly indicated by such analysis, the 
comparison of acyl-chain species of sn- 1,2-diacyl glycerol and correlation to the
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acyl-chain distribution of the putative precursor phospholipids is limited by its 'best 
match' nature. The role of phospholipids distinct from PtdCho can not be 
overlooked, and their possible contribution to the observed sustained levels of stt-
1.2-diacyl glycerol must be borne in mind (see Section 1.4.3).
Receptor-mediated hydrolysis of PtdCho to produce sn- 1,2-diacyl glycerol
has been reviewed extensively (Pelech & Vance, 1989; Billah & Anthes, 1990; 
Cook & Wakelam, 1991, 1992a). The hydrolysis of PtdCho to produce sn-1,2- 
diacylglycerol can proceed by two routes: directly, by a phospholipase C-catalysed 
reaction; or indirectly, by dephosphorylation of the PtdOH product of 
phospholipase D-catalysed hydrolysis of PtdCho. This dephosphorylation reaction 
being catalysed by phosphatidic acid phosphohydrolase (PPH).
The receptor-mediated hydrolysis of phosphatidylethanolamine (PtdEtn) has 
been reported (reviewed by Billah & Anthes, 1990). However, only a small 
contribution to phosphatidic acid and sn- 1,2-diacyl glycerol formation has been 
attributed to accelerated PtdEtn turnover in agonist-stimulated cells. Indeed no sn-
1.2-diacylglycerol molecular species typical of PtdEtn hydrolysis have been 
detected following bombesin- or PDGF-stimulation of Swiss 3T3 fibroblasts (Pettit 
& Wakelam, 1993; T.R. Pettit, personal communication).
1.4.2. Regulation of Receptor-M ediated PtdCho Hydrolysis.
Entry of extracellular Ca2+ has been implicated in receptor-mediated 
phospholipase D activation in neutrophils (Pai et al., 1988; Billah et al., 1989a). 
Also, depletion of extracellular Ca2+ inhibits 50 % of the phospholipase D response 
in bombesin-stimulated Swiss 3T3 cells (Cook et al., 1991). Although this 
indicates that elevation of [Ca2+]i regulates PtdCho hydrolysis, it is entry of 
extracellular Ca2+ and not the mobilisation of intracellular Ins(l,4,5)P3-sensitive 
stores that is responsible. Agonists such as EGF, interleukin-1 and interleukin-3 
have demonstrated receptor-mediated hydrolysis of PtdCho in the absence of 
stimulated turnover of phosphoinositides (Cook & Wakelam, 1992b; Rosoff et al.,
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1988; Wright et al., 1988), suggesting that Ins(l,4 ,5)P3 production is not a 
prerequisite for PtdCho hydrolysis. Treatment of cells with thapsgaragin, a Ca2+- 
ATPase inhibitor, interrupts the Ca2+ cycle between cytosol and endoplasmic 
reticulum and results in elevation of the [Ca2+]i with concomitant depletion of the 
Ins(l,4 ,5)P3-sensitive pool (Thastrup et al., 1990). Thapsigargin treatment was 
unable to either stimulate phospholipase D activity, or modulate the bombesin- 
stimulated phospholipase D activity of Swiss 3T3 fibrolasts (Cook et al., 1991). 
Additionally, phosphoinositide hydrolysis can be abolished without attenuating 
PtdCho hydrolysis in angiotensin-stimulated vascular smooth muscle cells, a- 
thrombin-stimulated IIC9 fibroblasts, and adrenaline-stimulated MDCK-D1 cells 
(Greindlinger a/., 1986; W rig h ts  al., 1988; Slivka etal., 1988).
PKC has been implicated in the modulation of receptor-mediated PtdCho 
hydrolysis. Phorbol esters have been found to act as potent stimulators of PtdCho 
hydrolysis by either phospholipase C- or phospholipase D-catalysed pathways 
(reviewed by Billah and Anthes, 1990). Activation of PtdCho hydrolysis by cell- 
permeable diacylglycerols in granulocytes and fibroblasts has also been observed 
(Billah et al., 1989a; Muir & Murray, 1987). Activation-induced down-regulation 
of PKC by chronic PMA treatment or inhibition of PKC by the selective inhibitors 
H7, K252a and Ro-31-8220 has been shown to partially inhibit agonist-stimulated 
PtdCho hydrolysis in some cells (Billah et al., 1989a; Besterman et al., 1986a; 
Cooker al., 1991), and inhibit it fully in others (Liscovitch, 1989; Martinson etal., 
1989; Muir & Murray, 1987). In conclusion, the involvement of PKC is clear, the 
extent and, indeed, the hydrolytic activity it modulates would, however, seem to 
follow a cell type-specific pattern. Receptor-mediated PtdCho hydrolysis would 
seem to proceed both by PKC-dependent and -independent pathways.
Additionally, it would appear that the phospholipase C- and phospholipase D- 
catalysed pathways of PtdCho hydrolysis are subject to differential modulation yy 
PKC.
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G-proteins have been implicated in the transmembrane modulation of 
PtdCho hydrolysis in response to receptor occupation. Non-hydrolysable 
analogues of GTP, for example GTPyS, stimulate the activity of phospholipase D- 
catalysed PtdCho hydrolysis in broken cell preparations of rat hepatocytes and 
granulocytes (Bocckino et a l 1987; Anthes et al., 1989). This has also been 
found to be the case for phospholipase C-catalysed PtdCho hydrolysis in rat 
hepatocyte membranes (Irving & Exton, 1987; Bocckino et al., 1987). Direct 
modulation of the enzyme catalysing PtdCho hydrolysis by a G-protein/s is 
implied. This would be analagous to the modulation of Ptdlns-PLC activity by G- 
proteins in receptor-stimulated cells (see Section 1.1.2). However, it is most likely 
that the rate of PtdCho hydrolysis is controlled both by direct and indirect G-protein 
regulation of the phospholipase catalysing the hydrolytic event. The indirect 
pathway would proceed via G-protein stimulation of Ptdlns-PLC, with the 
subsequent activation of PKC modulating the phospholipase (see above).
1.4.3. Alternative Sources of Sustained Levels of s it -1,2- 
D iacylg lycero l.
PtdCho hydrolysis, like PtdIns(4 ,5)P2 hydrolysis, has been found to be 
rapid and transient, limited to the events occuring shortly after receptor occupation 
(Besterman et al., 1986a; Pai et al., 1988; Martin & Michaelis, 1989). The source 
and nature of sustained, elevated sn- 1,2-diacyl glycerol levels in stimulated cells is, 
therefore, called into doubt. Two possibilities could immediately rationalise these 
observations: either these sustained levels originate from slow metabolism of the 
sn-1,2-diacylglycerol produced from transient hydrolysis of PtdCho; or they are 
derived, at least in part, from a source distinct from PtdCho.
Contribution to the sustained phase of sn-1,2-diacylglycerol from a further 
phospholipid source has recently gained attention. Imai & Gershengom (1986) 
originally argued for the existence of sustained Ptdlns hydrolysis after the initial 
transient hydrolysis of PtdIns(4,5)P2 in TRH-stimulated GH3 pituitary cells. In
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cells that had been incubated with 32PX for 1 min prior to stimulation, these workers 
observed continued labelling of PtdIns(4,5)P2 for only 2 min after agonist 
challenge. Continued labelling of Ptdlns and PtdOH was, however, sustained. In 
cells that had been stimulated with TRH for 4 min prior to addition of 32P,, Imai & 
Gershengom (1986) observed that label was incorporated into Ptdlns and PtdOH, 
but not PtdIns(4 ,5)P2. These results indicated the transient hydrolysis and 
resynthesis of PtdIns(4,5)P2 was complete after 4 min, whilst after this time the 
hydrolysis and resynthesis of Ptdlns continues.
Several workers have suggested that continued hydrolysis of Ptdlns and 
PtdIns(4)P after cessation of PtdIns(4 ,5)P2 hydrolysis contributes to the sustained 
phase of sfl-l,2-diacylglycerol (Griendling etal., 1986, 1987; Wilson ef al., 1985; 
Plevin & Wakelam, 1992; Cook et al., 1991). The use of LiCl to inhibit the 
inositol monophosphatase (Hallcher & Sherman, 1980; Gee et al., 1988) has been 
employed to prevent the reincorporation of liberated inositol into the 
phosphoinositide pool (see Section 1.1.4). Pre-labelling cells with [3H]inositol in 
conjunction with LiCl can identify the on-going hydrolysis of any phosphoinositide 
which yields an inositol phosphate product fated to metabolism via inositol 
monophosphatase. Cook et al. (1991) observed a biphasic accumulation of inositol 
phosphates in Swiss 3T3 fibroblasts stimulated with bombesin in the presence of 
LiCl. A very rapid initial accumulation of inositol phosphates in the first minute 
after stimulation was observed, over a time-course equivalent to that of the elevated 
Ins(l,4 ,5)P3 levels in bombesin-stimulated Swiss 3T3 fibroblasts (Plevin et al 
1990; Cook et al., 1990). However, after 1 min of stimulation the rate of inositol 
phosphate accumulation was observed to be one eighth of that observed in the initial 
minute of agonist challenge (Cook et al., 1991). After termination of the initial 
receptor-mediated PtdIns(4,5)P2 hydrolysis, it would seem that an alternative 
inositol phospholipid is undergoing sustained hydrolysis. Similarly, Plevin & 
Wakelam (1992) indicate the sustained hydrolysis of an inositol phospholipid at
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timepoints after the termination of PtdIns(4,5)P2 hydrolysis in vasopressin- 
stimulated A 10 cultured vascular smooth muscle cells.
Although this interpretation of the involvement of phosphoinositides apart 
from PtdIns(4 ,5)P2 would seem correct, it assumes that continued hydrolysis of 
PtdIns(4 ,5)P2 is not occurring. If the accumulation of Ins( 1,4 ,5)P3 on receptor- 
stimulation indicates that the initial step in its metabolism is the rate-limiting step, 
the formation of Ins(l,4 ,5)P3 at a slower rate may not result in such accumulation. 
This is a possibility, provided that the concentration of Ins ( 1,4 ,5)P3 does not rise 
to a level where the rate of metabolism becomes limiting. Although PtdIns(4,5)P2 
levels do not fall in the sustained phase of sn- 1,2-diacyl glycerol (Plevin & 
Wakelam, 1992), the possibility of continued PtdIns(4 ,5)P2 hydrolysis exists.
This problem is augmented by the difficulty in identifying the flux of phospholipid 
between Ptdlns, PtdIns(4)P and PtdIns(4 ,5)P2 in pH]inositol-labelled cells. A 
steady-state concentration of PtdIns(4 ,5)P2 could conceivably be maintained, 
masking a flux state of increased hydrolysis and resynthesis during the sustained 
phase of agonist-stimulated sn- 1,2-diacyl glycerol generation.
In addition to the phospholipase-catalysed liberation of 5 /1- 1,2- 
diacyl glycerol from PtdIns(4 ,5)P2, PtdCho and other phospholipids, for example 
PtdEtn, phospholipase-catalysed hydrolysis of phosphatidylinositol glycan has 
been suggested to be a source of sn- 1,2-diacyl glycerol in insulin-stimulated BC3HI 
myocytes (Saltiel et al.y 1987). Insulin-stimulation of [3H]myristic acid-labelled 
BC3HI cells results in the generation of an sn-1,2-diacylglycerol population distinct 
from that observed on a-adrenergic-stimulation (Saltiel et al.y 1987). Farese and 
co-workers (1985) have also suggested that the sn- 1,2-diacyl glycerol observed to 
accumulate on insulin-stimulation of BC3HI myocytes was the result of agonist- 
enhanced de novo synthesis. Similarly, de novo synthesis was observed to be the 
major source of agonist-stimulated sn-1,2-diacylglycerol in phagocytic neutrophils, 
with PtdIns(4 ,5)P2 and PtdCho barely contributing to the accumulation of the 
messenger (Rossi et al., 1991). Additionally, although the acyl-chain distribution
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of the sustained phase of s«-l,2-diacylglycerol in fibroblasts indicates that it is a 
product of PtdCho hydrolysis (Pessin & Raben, 1989; Pessin et al., 1990), the 
sustained phase could equally be a product of de novo synthesis with only a minor 
contribution from PtdCho.
1.4.4. The Sustained Phase of Elevated s /i- l,2 -D ia cy lg ly c e ro l  
Levels: Effect on PKC Activity.
It is clearly established that sn- 1,2-diacyl glycerol is present at elevated 
levels for some time after agonist stimulation, even after the termination of 
PtdIns(4 ,5)P2 hydrolysis. It is not clear, however, if these sustained levels play a 
role distinct from the PtdIns(4 ,5)P2-derived messenger.
Comparison of the acyl-chain molecular species of sw-l,2-di acyl glycerol 
present after 5 min stimulation of IIC9 fibroblasts with 500 ng/ml a-thrombin to 
those observed in the cellular phospholipids revealed that the agonist-elevated levels 
of srt-l,2-diacylglycerol were most likely derived from PtdCho (Pessin & Raben,
1989). This was also found to be the case when IIC9 fibroblasts were stimulated 
for 5 min with the following mitogens: 500 ng/ml a-thrombin following 
chymotrypsin pretreatment of the cells, 100 pg/ml a-thrombin, EGF, or PDGF 
(Pessin et al., 1990). Early studies of PKC activation by differing molecular 
species of sn- 1,2-diacyl glycerols, although not complete, would suggest that PKC 
can, indeed, be activated by many of the sn-1,2-diacylglycerols encountered on 
receptor-stimulated hydrolysis of PtdCho (Mori et al., 1982; Go et al., 1987). 
Furthermore, sn- 1,2-diacyl glycerol derived from IIC9 fibroblast cellular PtdCho by 
phospholipase C digestion was found to effectively activate cytosolic PKC 
fractionated from these cells (Leach et al., 1991). Prolonged stimulation of PKC 
activity at time-points beyond the transient hydrolysis of PtdIns(4 ,5)P2 would seem 
feasible. Identification of the continued presence of a putative sn- 1,2-diacyl glycerol 
activator would undoubtably enhance the argument.
29
However, observation of PKC activity would suggest that its activation is a 
transient event, dissociated from the prolonged presence of elevated sn- 1,2- 
diacyl glycerol levels. In IIC9 fibroblasts, which express PKC-a and not PKC-p 
or -y, treatment with 100 pg/ml of a-thrombin did not result in an increase in 
membrane-associated PKC-a (Leach et al., 1991). Thus, the translocation of the 
cytosolic PKC, an event often employed as diagnostic of PKC activation, is not 
observed in IIC9 fibroblasts stimulated with 100 pg/ml a-thrombin. Such 
treatment of IIC9 cells, although still mitogenic, is associated with PtdCho but not 
not phosphoinositide hydrolysis. Incubation of these cells with 500 ng/ml a -  
thrombin, a treatment that elicits transient phosphoinositide hydrolysis in addition to 
PtdCho hydrolysis, did result in a depletion of cytosolic PKC-a with concomitant 
increase in both membrane-associated PKC-a and membrane-associated PKC 
activity. This classical PKC translocation/activation event is transient with 
membrane-associated activity reaching maximal values after 30 sec and declining to 
basal levels after 15 min (Leach et a l, 1991). Although PKC activation was 
transient, sustained sn- 1,2-diacyl glycerol levels were found to continue to increase 
over this time-course. Additionally, these workers observed that the decline of 
PKC activity observed after 15 sec was not the result of a activation-induced down- 
regulation but rather the redistribution of PKC back to the inactive cytosolic pool. 
Furthermore, 500 ng/ml a-thrombin stimulated phosphorylation of the 80 kDa 
MARCKS protein in digitonin-permeabilised IIC9 cells, with similar time-course to 
the activation of cellular PKC activity. 100 pg/ml a-thrombin, a treatment that 
stimulates PtdCho hydrolysis without receptor-mediated PtdIns(4 ,5)P2, elicited no 
stimulated phosphorylation of the MARCKS protein (Leach et al., 1991).
Bombesin and PDGF have been shown to stimulate PtdIns(4 ,5)P2 and 
PtdCho hydrolysis in Swiss 3T3 fibroblasts (Cook & Wakelam, 1989; Cook et al., 
1990; Plevin et al., 1991a; Pettit & Wakelam, 1993). Additionally, both these 
agonists stimulate PKC activity in these cells (Isacke et al., 1986). Increased PKC- 
catalysed phosphorylation of the endogenous MARCKS protein was observed in
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these cells 15 min after stimulation with either bombesin or PDGF (Isacke et al., 
1986). Yet, alteration of the MARCKS protein's phosphorylation state in response 
to EGF was not observed (Isacke et al., 1986). Interestingly, EGF does elevate sn-
1.2-diacyl glycerol levels for a sustained period of time (60 min) in Swiss 3T3 cells 
(Cook & Wakelam, 1992b). However, as with other cell types, EGF stimulation 
of Swiss 3T3 fibroblasts is not associated with stimulated hydrolysis of 
PtdIns(4,5)P2 (Cook & Wakelam, 1992b).
Together with the findings of Leach et al., (1991), do these observations 
rule out the prolonged activation of PKC with a longevity equal to the sustained 
phase of sn- 1,2-diacyl glycerol ? The continued presence after 1 min of sn-1,2- 
diacylglycerol derived, at least in part, from PtdCho is not associated with 
prolonged PKC activation, despite possessing the ability to do so in vitro. 
Moreover, the absence of PKC activation in the presence of sn- 1,2-diacyl glycerol is 
not the result of activation-induced down-regulation. Leach et al. (1991) observed 
that IIC9 fibroblasts still possess an inactive cytosolic pool of PKC-a, a Ca2+- 
dependent PKC (see Section 1.2.1), during the a-thrombin-stimulated sustained 
phase of sn-1,2-diacylglycerol. Therefore, it can be concluded that PKC activation 
in response to Ca2+-mobilising agonists is transient, with activation closely 
following the stimulated hydrolysis of PtdIns(4 ,5)P2. It is likely that only the .s/2-
1.2-di acyl glycerol produced on PtdIns(4 ,5)P2 hydrolysis is active in modulating 
cellular PKC activity and that the sn- 1,2-diacyl glycerol which constitutes the 
sustained phase is inactive in this role. This conclusion must, however, be 
qualified: the PKC family has recently expanded to some 10 members, whilst the 
characterisation of PKC activation on cell-stimulation was conducted with 
immunological probes and assay methods developed for the PKC family members 
originally purified from bovine brain, i.e. PKC-a, -Pi/fc and -y. Recently, it has 
become apparent that PKC-6, -e and -£, are widely expressed and differ from the 
originally characterised PKC family members in their Ca2+ dependency, 
phospholipid requirements and reaction velocities towards different protein/peptide
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substrates (see Parker et al., 1989; Schaap et al., 1989; Olivier & Parker, 1991; 
Parker et al., 1992). If the activity of any PKC family member is elevated during 
the sustained phase of sn-1,2-diacylglycerol, it remains to be detected and the 
physiological substrates identified.
Previously, correlation of the biphasic increase of sn-1,2-diacylglycerol in 
bombesin stimulated Swiss 3T3 fibroblasts (Cooke/ al., 1990) with the biphasic 
increase in pHi observed under similar stimulatory conditions (Bierman et al.,
1990) has been employed as a diagnostic indication of sustained PKC activation by 
the sustained phase of s«-l,2-diacylglycerol (Cook & Wakelam, 1992b). Early 
elevation of intracellular pH by activation of the Na+/H+ antiporter has been 
suggested to be a necessary mitogenic signal (Pouyssegur et al., 1984, 1985). In 
the presence of HCO3-, however, mitogenic stimulation fails to elevate pHi (Ganz 
et al., 1989). Therefore, elevation of intracellular pH may not be necessary for 
mitogenesis, but stimulation of the Na+/ H+ antiporter would seem to be required 
and elevation of pHi in HCC^-free medium may be employed as a suitable assay 
for activation of the antiporter.
Although PKC-catalysed phosphorylation is implicated in the activation of 
the Na+/ H+ antiporter (Moolenar et al., 1984), continued activation of PKC may 
not be required for the observed biphasic activation of antiporter activity. EGF- 
stimulated Swiss 3T3 fibroblasts still undergo a sustained alkalinisation (Bierman et 
a l, 1990). Yet, EGF stimulation is not associated with accelerated hydrolysis of 
PtdIns(4,5)P2 or agonist-stimulated PKC activity (Cook & Wakelam, 1992a;
Isacke et al., 1986). Activation-induced down-regulation of PKC by pretreatment 
with PDBu (Rodriguez-Pena & Rozengurt, 1984) abrogated all bombesin- 
stimulated elevation of pHi (Bierman et al., 1990), whereas EGF continued to elicit 
alkalinisation in both PDBu-pretreated and control Swiss 3T3 cells (Bierman et al.,
1990). Both, EGF and bombesin elicit alteration of pH* by activation of the 
Na+/H+ antiporter in Swiss 3T3 cells, yet PKC-catalysed activation is not 
implicated in the regulation of the antiporter in the case of EGF. It would seem fair
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to accept that PKC does modulate the initial transient elevation of pHi observed 
within 2 min of bombesin stimulation, as suggested by Moolenar and co-workers 
(1984). However, there is no evidence of PKC directly modulating the activity of 
the antiporter after this time. Indeed, the sustained increase in pHi is outwith the 
time-course of bombesin-stimulated PKC activity as judged by phosphorylation of 
the endogenous MARCKS protein substrate in Swiss 3T3 fibroblasts (Isacke et al., 
1986). This does not rule out PKC playing some modulatory role on the activity of 
the anti porter as, in fact, PKC down-regulation did also prevent the secondary, 
sustained elevation of pHj in addition to the initial transient increase (Bierman et al.,
1990). It is most likely that the sustained phase of antiporter activity is regulated by 
an event downstream of the transient activation of PKC observed in the first minute 
of stimulation with bombesin. Correspondingly, Sardet et al. (1991) have 
observed that a-thrombin, EGF, and okadaic acid activate the Na+/H+ antiporter by 
increased phosphorylation of a common set of sites by an unidentified serine 
kinase(s). This unidentified kinase(s) controls the activity of the antiporter on 
integration of signals from receptor tyrosine kinases and G protein-coupled 
receptors (Sardet et al., 1991). This immediately reconciles the differential 
modulation of sustained antiporter activity by PKC in EGF- and bombesin- 
stimulated cells.
1.4.5. The Sustained Phase of Elevated sn -1,2-D iacylglycerol 
Levels: Contribution of j/i-l-O -A lkyl -2-acylglycerol and s /i-1 -0 -  
Alkenyl-2-acylglycerol to the Sustained Phase ?
Investigation of the phospholipid source of stimulated levels of sn-1,2- 
diacylglycerol in a-thrombin-stimulated IIC9 fibroblasts clearly illustrated the 
difference between sw-l,2-diacylglycerol derived from Ptdlns and PtdCho (Pessin 
& Raben, 1989; Pessin et al., 1990). It should also be recognised that cellular 
PtdCho further differs from Ptdlns in the nature of the bond at the s a z - 1  position of 
the phospholipid.
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In addition to 5 / 1- l,2-diacylglycero-3-phosphocholine, cellular 
phosphatidylcholine posesses 5 / 1- l-0-alkyl-2-acylglycerol-3-phosphocholine and 
5 / 2- l-alkenyl-2-acylglycerol-3-phosphocholine components. As glycerolipid 
messengers distinct from sn-1,2-diacylglycerol could be generated on receptor- 
stimulated hydrolysis, the role of 5/z-1-0-alkyl-2-acylglycerol-3-phosphocholine 
and 5 / 1- 1 - al keny 1-2-acylgl ycerol -3 - phosphochol i ne must be considered further, sn- 
1 - O- A1 ky 1 - 2-acy 1 glycerol-3-phosphocholine has been found to constitute 30 - 70 % 
of PtdCho in neutrophils, eosinophils and macrophages while 5 / 2- 1-alkenyl-2- 
acylglycerol-3-phosphocholine only represents a very minor component of the 
PtdCho pool (Mueller et al., 1982; Ojima-Uchiyama et al., 1988). Conversely, sn-
l-alkenyl-2-acylglycerol-3-phosphocholine is the major ether-linked component in 
heart tissues, comprising 30 % of the PtdCho (Arthur et al., 1985).
Specific labelling of 5/2- l-0 -alkyl-2-acylglycerol-3-phosphocholine by 
incubation of cells with alkyl-[32P]lysoPtdCho (p 2P] 5 / 2- 1-O-alkyl-2-1 ysogl ycerol - 
3-phoshocholine) has been employed to unequivocally identify phospholipase D- 
catalysed hydrolysis of PtdCho in fMet-Leu-Phe-stimulated HL-60 cells (Pai et a l,
1988). Similarly, phorbol esters, the cell-permeable diacylglycerol OAG, and the 
calcium ionophore A23187 have been shown to increase the rate of PtdCho 
hydrolysis in alkyl-[32P]lysoPtdCho-labelled HL-60 granulocytes by the action of 
phospholipase D alone (Billah et al., 1989a). It would appear that receptor- 
stimulated phospholipase D catalyses the hydrolysis of the PtdCho pool as a whole 
and does not catalyse specifically the hydrolysis of either sn- 1,2-diacylglycero-3- 
phosphocholine or sn- l-(9-alkyl-2-acylglycero-3-phosphocholine. Indeed, Agwu 
et al. (1989) and Tyagi et al. (1989) demonstrated both the production of sn-1,2- 
diacylglycerol and sn- l-(9-alkyl-2-acylglycerol in human neutrophils stimulated 
with fMet-Leu-Phe, PMA and the calcium ionophore A23187. However, 
investigation of phospholipase D activity by labelling the 5 / 2- 1-O-alky 1-2- 
acyl glycerol-3-phosphochol in e component is relevant only in cell-types where this 
phospholipid is present in the PtdCho pool to significant levels. In Swiss 3T3
fibroblasts, for example, PtdCho is wholly of the sw-l,2-diacylglycerol-3- 
phosphocholine species and neither 5/i-l-0 -alkyl-2-acylglycerol nor sn-l-O- 
alkenyl-2-acylglycerol are found to accumulate on bombesin-stimulation (Pettit & 
Wakelam, 1993). Caution must, therefore, be exercised in the interpretation of 
PtdCho hydrolysis in alkyl-p2P]lysoPtdCho-labelled cells and its use in the 
identification of the role of phospholipase D. Nevertheless, labelling of the cellular 
PtdCho pool by specific labelling of the sw-l-O-alkyl-2-acyl glycerol-3- 
phosphocholine component has been adopted in the study of phospholipase D- 
catalysed hydrolysis of PtdCho in widely variant cell models, e.g. human platelets 
(Huang et al., 1991), sea urchin spermatozoa (Domino et al., 1989), and rat brain 
synaptic plasma membranes (Mohn et al., 1992).
The significance of j/i-1-O-alkyl-2-acylglycerol and 5«-1-alkeny 1-2- 
acyl glycerol production concomitant with the sustained phase of sn-1,2- 
diacylglycerol has still to be defined. The physiological action of the vinyl-ether 
diglyceride, sn- l-alkenyl-2-acylgIycerol is still poorly understood. Evidence of the 
ability of 5«-1-O-alkyl-2-acyl glycerol to modulate PKC activity is ambiguous. 
Ganong et al. (1986) and Daniel et al. (1988) concluded that 1-O-alkyl-2- 
acylglycerol inhibits rather than activates PKC activity in vitro. However, Ford et 
al. (1989) reported activation of PKC by 5« -l-0 -alkyl-2-acylglycerol in vitro, but at 
higher Ca2+ concentrations than those required for sn-1,2-diacylglycerol. As 
discussed previously for sustained sn-\,2-di acyl glycerol production from PtdCho 
in fibroblasts, the ability to modulate PKC activity in vitro does not predispose the 
cell to continued, elevated PKC activity during the time-course of 1-O-alky 1-2- 
acyl glycerol generation. The potential for 1-O-alkyl-2-acylglycerol ands«-l- 
alkenyl-2-acylglycerol to act within the cell as a second messenger in a manner 
analagous to sn-1,2-diacylglycerol will be restricted to a cell-type specific pattern. 
Potentially, s/i-l-O-alkyl-2-acylglycerol may play a signalling role in cells of 
myeloid origin. However, stimulated levels of s«-l-0-alkyl-2-acylglycerol have 
not been observed in a-thrombin-stimulated IIC9 fibroblasts (Pessin & Raben,
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1989), nor have stimulated levels of either s/i-l-O-alkyl-2-acylglycerol or s«-l- 
alkenyl-2-acylglycerol been observed in bombesin-stimulated Swiss 3T3 fibroblasts 
(Pettit & Wakelam, 1993).
1.4.6. The Sustained Phase of Elevated fn -l,2 -D ia cy Ig ly cero l  
Levels: A Redefinition.
Recently, problems associated with the quantitation of sn -1,2- 
diacylglycerol levels in cell extracts have come to light. The enzymatic quantitative 
method originally described by Preiss et al. (1986) and modified by Paterson et al. 
(1991) has been found to measure sn- 1,2-diradylglycerols collectively. Under the 
conditions employed, s«-l-<9-alkyl-2-acylglycerol and sn-1 -alkenyl-2-acylglycerol 
in addition to sn- 1,2-diacyl glycerol are phosphorylated and, thus, quantitated by 
this method (Tyagi et al., 1989; Thompson et al., 1990). It is possible to 
determine the individual contribution of each sn- 1,2-diradyl glycerol sub-class to the 
total sn-1,2-diradylglycerol concentration in cell lipid extracts (Tyagi et al., 1989; 
Thompson et al., 1990), but these procedures have not been widely applied. This 
illuminates the possibility of previous erroneous quantitation of collective sn- 1,2- 
diradyl glycerol concentration as sn-1,2-diacylglycerol when determined by the 
enzymatic method. This is especially pertinent in cells which produce elevated 
levels of SH-l-O-alkyl-2-acylglycerol with a time-course coincident with the 
sustained phase of sn- 1,2-diacyl glycerol associated with PtdCho hydrolysis, e.g. 
fMet-Leu-Phe-stimulated neutrophils (Billah et al., 1989b). However, such 
erroneous quantitation of sn-1,2-diacylglycerol will be a cell-type specific 
phenomenon, as stimulated levels of sw-l-O-alkyl-2-acylglycerol andsw-l-alkenyl-
2-acylglycerol have not been observed in a-thrombin-stimulated IIC9 fibroblasts 
(Pessin & Raben, 1989), bombesin-stimulated Swiss 3T3 fibroblasts (Pettit & 
Wakelam, 1993), and TRH-stimulated GH3 pituitary cells (Martin et al., 1990).
For the continued purposes of the discussion within this thesis, in the absence of 
quantitation of individual sn- 1,2-diradyl glycerol components of total cellular sn-
1,2-diacylglycerol pool, no further distinction will be made between the sn- 1,2- 
diacyl glycerol and total sn- 1,2-diradyl glycerol content of cell lipids.
1.4.7. The Sustained Phase of Elevated s /i- l,2 -D ia cy lg ly cero l 
Levels: Route o f Removal.
The sustained phase of elevated sn- 1,2-diacyl glycerol levels has now been 
attributed, in part, to the transient hydrolysis of PtdCho, with possible contribution 
from the sustained hydrolysis of other phospholipids (see Section 1.4.3).
Although it has been clearly established that DAG kinase and DAG lipase are 
responsible for initiating the metabolism of the sn-1,2-diacylglycerol produced on 
PtdIns(4 ,5)P2 hydrolysis (Sections 1. 1.1 & 1.3.2), the metabolism of the sustained 
phase sn-1,2-diacylglycerol is less clear. Transient receptor-mediated hydrolysis of 
PtdCho requires a very slow rate of sn- 1,2-diacyl glycerol metabolism to sustain the 
elevated levels of ^ «-l,2-di acyl glycerol. This is certainly true when the sustained 
phase of sn- 1,2-diacyl glycerol has been solely attributed to PtdCho hydrolysis, e.g. 
a-thrombin-stimulated IIC9 fibroblasts (Pessin & Raben, 1989) and bombesin- 
stimulated Swiss 3T3 fibroblasts (Pettit & Wakelam, 1992).
The possibility of inositol phospholipids contributing to the sustained phase 
of sn- 1,2-diacyl glycerol further complicates the issue. Imai and Gershengom 
(1986) suggested that the hydrolysis of Ptdlns in TRH-stimulated GH3 cells 
continues after the termination of receptor-mediated PtdIns(4 ,5)P2 hydrolysis. 
Ptdlns hydrolysis therefore contributed to the sustained phase of sn- 1,2- 
diacyl glycerol accumulation in these cells. Similarly, TRH-stimulated PtdOH 
production in these cells continued after the cessation of PtdIns(4 ,5)P2 hydrolysis 
(Imai & Gershengom, 1986). This would indicate that the sn-1,2-diacylglycerol 
derived from Ptdlns is phosphorylated by DAG kinase and follows a similar 
metabolic fate to the 5/1-1,2-diacyl glycerol produced transiently from 
PtdIns(4,5)P2. However, the sustained phase of sn- 1,2-diacylglycerol in TRH- 
stimulated GH3 cells is only partly derived from Ptdlns hydrolysis, as Martin et al.
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(1990) have also identified a contribution from stimulated PtdCho hydrolysis. The 
route of PtdCho-deriveds/2- l,2-diacylglycerol metabolism remains to be clearly 
defined, although increased synthesis of PtdCho via incorporation of CDP-choline 
has been observed in TRH-stimulated GH3 cells (Kolesnick, 1987).
Further distinction between the metabolic fates of s/z-l,2-diacylglycerol 
derived from Ptdlns or PtdCho can be observed on PMA stimulation of PtdCho 
hydrolysis. In agonist-stimulated cells, increased degradation and subsequent 
synthesis of both Ptdlns and PtdCho is observed (reviewed Pelech & Vance, 1989; 
Michell, 1975). However, Muir & Murray (1987) observed that PMA-stimulated 
hydrolysis of PtdCho resulted in resynthesis of PtdCho alone, without concomitant 
degradation and resynthesis of Ptdlns. It would seem clear that the sn- 1,2- 
diacyl glycerol derived from stimulated PtdCho hydrolysis is not metabolised by a 
pathway identical to PtdIns(4,5)P2-derived sn-1,2-di acyl glycerol, nor is it 
incorporated into the phosphoinositide pool. Instead, the glycerolipid backbone is 
utilised in the resynthesis of PtdCho via CDP-choline (reviewed Pelech & Vance, 
1989; Shears, 1991).
Diacylglycerol choline phosphotransferase catalyses transfer of the 
phosphocholine moiety of CDP-choline to sn- 1,2-diacyl glycerol, resulting in 
production of PtdCho, thus completing the synthesis of PtdCho from the products 
of receptor-stimulated PtdCho hydrolysis. The water-soluble substrate for this 
enzyme, CDP-choline, is the product of condensation of phosphocholine and CTP 
in a reaction catalysed by CTP:phosphocholine cytidyltransferase. Phosphocholine 
could be produced direct from phospholipase C-catalysed hydrolysis of PtdCho. 
Alternatively, it could be produced from the action of choline kinase on the water- 
soluble product of phospholipase D-catalysed hydrolysis of PtdCho.
Diacylglycerol choline phosphotransferase efficiently catalyses the 
conversion of sn-l,2-diacylgycerol, l-O-alkyl-2-acyl-s/z-glycerol and l-alkenyl-2- 
acyl-s/2-glycerol to PtdCho in vitro (Ford & Gross, 1988, 1990). The 
physiological substrate specificity of this enzyme has still to be determined.
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Interestingly, the ether-linked diradylglycerols are not significantly metabolised by 
DAG kinase or DAG lipase in vitro (Kanoh & Akesson, 1978; Ford & Gross,
1990). It would seem that the cell-type specific production of 1 - O-al ky 1-2-acyl-s«- 
glycerol and l-alkenyl-2-acyl-sw-glycerol in the sustained phase of sn-1,2- 
diacylglycerol is metabolised solely by diacylglycerol choline phosphotransferase. 
This may indicate that the .572- 1,2-diradyl glycerol products of PtdCho hydrolysis are 
metabolised collectively via diacylglycerol choline phosphotransferase. Further 
metabolic compartmentalisation of the sn- 1,2-diradyl glycerol present in the 
sustained phase from the product of transient receptor-mediated PtdIns(4,5)P2 
hydrolysis is indicated.
Diacylglycerol choline phosphotransferase is restricted to the endoplasmic 
reticulum of rat liver (Kanoh & Ohno, 1976; Jelsema & Morre, 1978). CTP: 
phosphocholine cytidyltransferase, the activity catalysing the rate limiting step of 
PtdCho synthesis, partitions between the cytosol and endoplasmic reticulum 
(reviewed: Vance & Pelech, 1984; Pelech & Vance, 1989). However, CTP: 
phosphocholine cytidyltransferase is activated by sn- 1,2-diacyl glycerol (Kolesnick, 
1987, 1990), and it has been suggested that such activation is manifested by an 
accumulation of membrane-bound enzyme and depletion of the soluble reservoir 
(Cornell & Vance, 1987).
Further dissociation between the metabolism of PtdCho- and PtdIns(4,5)P2- 
derived s«-l,2-di acyl glycerol is identified by localisation of the PtdCho synthetic 
apparatus on the endoplasmic reticulum. Plasma membrane-associated DAG kinase 
(see Section 1.8.2) and plasma membrane-associated DAG lipase (Farooqui et al., 
1984; Mauco et al., 1984; Ide et al., 1990) are suitably juxtaposed to the site of sn-
1,2-diacylglycerol production to initiate its metabolism. Similarly, receptor- 
mediated hydrolysis of PtdCho is localised to the plasma membrane (Irving & 
Exton, 1987; Martin, 1988; Gelas et al., 1989) and sn- 1,2-diacyl glycerol, thus 
formed, requires transfer to the membranes of the endoplasmic reticulum. For 
example, TRH-stimulated GH3 pituitary cells experience induction of PtdCho
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synthesis subsequent to stimulated PtdCho hydrolysis (Kolesnick, 1987).
However, TRH-stimulation of these cells results in the sustained accumulation of 
s//-l,2-diacylglycerol specifically in the intracellular membranes, with only transient 
accumulation in the plasma membrane (Martin et al., 1990). Therefore, PtdCho- 
derived sn-1,2-diacylglycerol would appear to be rapidly transferred to intracellular 
membranes, probably those of the endoplasmic reticulum. Indeed, fluorescent sn-
1,2-diacylglycerol analogues present in the plasma membrane have been observed 
to translocate to intracellular membranes (Pagano & Longmuir, 1985).
The hydrolysis of PtdCho at a location distinct from the plasma membrane 
cannot be overlooked. Augert et al. (1989) observed that a substantial contribution 
to agonist-stimulated PtdCho hydrolysis in hepatocytes was the result of Ca2+- 
activated phospholipase activity located on intracellular membranes. The recent 
report of Ca2+-stimulated base-exchange activity in the microsomes of rat liver 
(Siddiqui & Exton, 1992) therefore indicates the need for cautious interpretation of 
choline release studies in the identification of a phospholipase-catalysed hydrolysis 
of PtdCho.
1.5. Phosphatidic Acid as a Second Messenger.
DAG kinase and phospholipase D both catalyse reactions that produce 
phosphatidic acid (PtdOH). It has been suggested that PtdOH performs a signalling 
role quite distinct from that of s/i- 1,2-diacylglycerol. Originally, it was suggested 
that PtdOH acted as a Ca2+ ionophore, mediating the entry of extracellular Ca2+ 
across the plasma membrane of parotid gland cells (Putney et al., 1980). However, 
the ability of PtdOH to act as a Ca2+ ionophore in artificial phospholipid 
membranes is still a matter of contention (Serhan et al., 1981; Holmes & Yoss, 
1983). Additionally, it has recently been postulated that PtdOH mediates Ca2+ 
influx by binding a specific extracellular receptor, with ion transport occurring as a 
secondary event (Murayama & Ui, 1987).
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The possibility that PtdOH and its lyso-derivative, lyso-PtdOH, act as 
mitogenic agonists has recently received much attention. Incubation of fibroblasts 
with exogenous PtdOH or lyso-PtdOH results in PtdIns(4,5)P2 hydrolysis, 
stimulation of PKC activity, inhibition of adenylyl cyclase, and stimulation of DNA 
synthesis (Moolenar et al., 1986; Murayama & Ui, 1987; Van Corven et al., 1989; 
Plevin et al. 1991b). Lyso-PtdOH was found to be 25 times more potent a mitogen 
than lyso-PtdOH-free PtdOH in Balb/c 3T3 cells, being active at 2 pg/ml (Fukami 
& Takenawa, 1992). Moreover, a specific receptor for such extracellular lyso- 
PtdOH has recently been identified (van der Bend et al., 1992). Although the exact 
mechanism for release of PtdOH or its lyso-derivative has still to be defined, it is 
clear that PtdOH does accumulate in the extracellular medium on treatment of rabbit 
platelets with the Ca2+ ionophore A23187, or thrombin (Murayama & Ui, 1987). 
This underscores the possibility of PtdOH/lyso-PtdOH acting as an autocrine or 
paracrine messenger molecule.
In addition PtdOH-dependent protein phosphorylation has been 
demonstrated in the soluble fractions of rat liver, brain, lung and testis (Bocckino 
et al., 1991). These workers observed the PtdOH-dependent phosphorylation to be 
Ca2+-insensitive in heart and stimulated by 360 - 800 nM free Ca2+ in liver . 
Furthermore, the phosphorylation profiles elicited by PtdOH were found to be 
distinct from those ellicited by PtdSer/s/z-1,2-dioleoylglycerol indicating the 
putative PtdOH-dependent protein kinase to be distinct from PKC (Bocckino et al.,
1991). However, the possibility of a novel PKC activity with phospholipid 
requirements distinct from PKC-a, -Pi, -fa  or "Y was not discounted. PtdOH has 
previously been reported to activate PKC in vitro. (Kaibuchi et al., 1981; Sekiguchi 
et al., 1988; Bums et al., 1990). This discrepancy may be explained by the recent 
reports that PKC-£, a Ca2+-independent PKC activity, can employ PtdOH as lipid 
cofactor (D.J. Bums, personal communication).
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1.6. Phosphatidic Acid Phosphohydrolase: Functional Antagonist to 
Diacylglycerol Kinase Activity.
Phosphatidic acid phosphohydrolase (PPH) catalyses the dephosphorylation 
of phosphatidic acid (PtdOH) to sn- 1,2-diacyl glycerol and, as such, may participate 
in a futile cycle with DAG kinase. Additionally when receptor-stimulated PtdCho 
hydrolysis is catalysed by phospholipase D, PPH catalyses the dephosphorylation 
of the PtdOH product and thus may yield the 5W-l,2-diacylglycerol associated with 
receptor-stimulated PtdCho hydrolysis (see Section 1.4.1).
Both hydrolytic events are situated on the plasma membrane, the most likely 
site of DAG kinase-catalysed phosphorylation of the sn- 1,2-diacyl glycerol product 
of PtdIns(4 ,5)P2 hydrolysis (see Section 6.3). Alternatively, the sn-1,2- 
diacylglycerol produced by dephosphorylation of the PtdOH product of PLD- 
catalysed PtdCho hydrolysis accumulates in intracellular membranes (Martin et al., 
1990). Although the intracellular location of PPH active in the dephosphorylation 
of PtdCho-derived PtdOH has still to be identified, the accumulation of PtdCho- 
derived sn-1,2-diacylglycerol at an intracellular site may possibly indicate that it 
resides on such intracellular membranes. Indeed, the majority of cellular PPH 
activity has been localised to the endoplasmic reticulum (Jelsema & Morre, 1978; 
Brindley, 1984). However, such endoplasmic reticulum-associated PPH activity 
may represent an isoenzyme/s solely active in the de novo synthesis of 
phospholipid and triacyl glycerol and thus be distinct from the enzyme responsible 
for the dephosphorylation of PtdCho-derived PtdOH in agonist-stimulated cells. 
PPH activity, biochemically distinct from the cytosolic and microsomal-associated 
activity, has been identified in the plasma-membrane fraction of rat liver (Jamal et 
al., 1991) and may possibly localise the PtdOH dephosphorylation event to the 
plasma membrane with intracellular accumulation resulting from subsequent sn-1,2- 
diacyl glycerol translocation.
As discussed previously (Section 1.1.4), Ptdlns(4.,5)P2-derived sn- 1,2- 
diacyl glycerol is commited to the resynthesis of phosphoinositides initially by
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phosphorylation in a reaction catalysed by DAG kinase, whereas PtdCho-derived 
5A/-l,2-diacylglycerol is most likely committed to resynthesis of PtdCho via a 
reaction catalysed by sn- 1,2-diacyl glycerol choline phosphotransferase. In 
consideration of the direction of flux through these separate metabolic pathways of 
sn-1,2-diacylglycerol, PPH is apparently specific for the PtdOH produced from 
PLD-catalysed PtdCho hydrolysis and not the PtdOH product of the DAG kinase 
activity associated with PtdIns(4 ,5)P2 turnover. Therefore, the action of PPH may 
further indicate the metabolic compartmentalisation of the distinct sn- 1,2- 
diacyl glycerol products of receptor-stimulated Ptdlns-PLC and PLD hydrolysis (see 
Section 1.4.1).
The existence of DAG kinase:PPH futile cycles in both pathways of 
phospholipid resynthesis from the sn- 1,2-diacyl glycerol produced from PtdCho 
and PtdIns(4,5)P2 hydrolytic events cannot be overlooked. Both, DAG kinase and 
PPH isoenzymes are widely distributed throughout the cell and would seem 
suitably juxtaposed to operate futile cycling of the sn-l,2-diacylglycerol/PtdOH 
products of PtdCho and PtdIns(4,5)P2 hydrolysis. As yet, however, such futile 
cycling has yet to be reported and the reason for any such metabolically expensive 
processing within this physiological context is not clear.
In conclusion, although PPH functionally antagonises DAG kinase activity 
in broken cell prepartions (see Section 3.1.3), the situation within the cell is less 
clear. The cell possibly holds the potential to operate futile cycles to carefully 
regulate the flux of glycerolipid through the PtdCho and PtdIns(4,5)P2 resynthesis 
pathways but, as yet, there is little evidence of such. The cell would also seem, at 
first appearance, to possess the ability to reverse the direction of glycerolipid 
metabolism shortly after agonist-stimulation from phosphorylation of the sn- 1,2- 
diacyl glycerol produced on PtdIns(4,5)P2 hydrolysis to dephosphorylation of the 
PtdOH product of PtdCho hydrolysis. Yet, the evidence, although not conclusive, 
would suggest that both pathways operate, with the glycerolipid products of
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PtdIns(4 ,5)P2 and PtdCho hydrolysis remaining metabolically distinct if not 
spatially separated within the cell.
1.7. Does DAG Kinase Participate in the Production of lyso-PtdOH?
The mitogenic stimulation by PtdOH and its lyso-derivative, lyso-PtdOH, 
has recently received much attention (see Section 1.5). Potentially, PtdOH can be 
produced from the DAG kinase-catalysed phosphorylation of sn- 1,2-diacyl glycerol, 
PLD-catalysed hydrolysis of phospholipid or de novo synthesis via acylation of 
glycerol -3-phosphate in a reaction catalysed by glycerol-3-phosphate 
acyltransferase. Additionally, lyso-PtdOH may potentially be produced by 
phosphorylation of sn- 1-monoacyl glycerol, deacylation of PtdOH at the sn- 2 
position in a reaction catalysed by phospholipase A2 or by acylation of glycerol-3- 
phosphate.
The contribution of DAG kinase to the accumulation of PtdOH on cell- 
stimulation has been discussed previously (Section 1.1.1), its contribution to the 
accumulation of lyso-PtdOH has not. DAG kinase may function indirectly in the 
accumulation of lyso-PtdOH by catalysing the phosphorylation of 571- 1,2- 
diacyl glycerol, providing PtdOH that may be deacylated at the sn-2 position in a 
reaction catalysed by a phospholipase A2. Such a PtdOH-specific phospholipase 
A2 has been described in platelets (Billah et al., 1982), a cell that experiences an 
accumulation of PtdOH and lyso-PtdOH on thrombin-stimulation (Mauco et al., 
1978; Lapetina et al., 1981).
It is, however, unlikely that DAG kinase contributes directly to the 
accumulation of lyso-PtdOH by catalysing the phosphoryaltion of sn-1- 
monoacylglycerol. In addition to sn-1,2-diacylglycerol, the cytosolic 80kDa DAG 
kinase purified from pig brain was observed to catalyse the phosphorylation of 2- 
monoacylglycerol but only limited phosphorylation of sn-1 -monoacylglycerol was 
observed (Kanoh et al., 1986). Such shared identity between DAG kinase and 2- 
monoacylglycerol kinase activities has also been observed in both the particulate
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and soluble fractions prepared from rat brain (Bishop & Strickland, 1980). 
Furthermore, the rat brain acylglycerol kinase activity was observed to catalyse the 
phosphorylation of acyl glycerols with increasing reaction velocities: sn-1- 
monoacyl glycerol, 2-monoacyl glycerol, sn- 1,2-diacyl glycerol (Bishop & 
Strickland, 1980). This was not, however, found to be the case for the cytosolic 
72 kDa DAG kinase purified to near homogeneity from bovine brain (Lin et al., 
1986). This enzyme was found to be devoid of 2-monoacyl glycerol kinase activity 
with the ratio of DAG kinase/2-monoacylglycerol kinase activity increasing from 
4.6 in brain homogenate to 1381 in the 475-fold purified DAG kinase preparation 
(Lin et al., 1986). Subsequently, monoacyl glycerol kinase activity was found to 
copurify with bovine cytosolic DAG kinase. It was possible to partially resolve the 
monoacyl glycerol kinase and DAG kinase activities on hydroxy apatite 
chromatography (Shim et al., 1989). The partially purified 2-monoacylglycerol 
kinase activity reported by these workers was found to catalyse the phosphorylation 
of sn-1 -monoacylglycerol with a higher reaction velocity than measured for 2- 
monoacylglycerol (Shim et al., 1989).
Although the information is limited mainly to the mammalian brain enzyme, 
cytosolic DAG kinase is capable of phosphorylating 2-monoacylglycerol but not sn- 
1-monoacylglycerol. The activity observed to catalyse the phosphorylation of sn-1- 
monoacylglycerol also catalyses the phosphorylation of 2-monoacylglycerol, 
although at slightly lower reaction velocities than the sn-1 isomer and would thus 
appear to be distinct from cytosolic DAG kinase. In conclusion, if lyso-PtdOH is 
produced in the cell by phosphorylation of s«-l-monoacyl glycerol, it would appear 
that the sfl-l-monacylglycerol/2-monoacylglycerol kinase catalyses the reaction and 
not DAG kinase. However, the physiological route of lyso-PtdOH production still 
remains to be established.
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1.8. Properties of DAG Kinase.
1.8.1. Properties of the Diacylglycerol Kinase Involved in 
Stim ulated PtdIns(4,5)P2 Turnover.
The triple-faceted importance of DAG kinase in the metabolism of receptor­
generated sn- 1,2-diacyl glycerol would seem to be clear. Firstly, it establishes the 
link between receptor-mediated phosphoinositide hydrolysis and the subsequent 
phospholipd resynthesis events by converting the lipid product of phosphoinositide 
hydrolysis to PtdOH, the substrate of the commited step in phosphoinositide 
resynthesis. Secondly, it rapidly phosphorylates PtdIns(4 ,5)P2-derived 1,2- 
diacyl glycerol, contributing to the tight coupling of PKC activation to the receptor 
occupation event. Finally, the product of the reaction catalysed by DAG kinase, 
phosphatidic acid, has been identified as having putative signalling activity itself 
(Section 1.5).
Given that DAG kinase is active in the above roles, what are the properties 
of such an activity? As discussed previously, PtdIns(4,5)P2-derived sn-1,2- 
diacylglycerol is present only transiently, with a longevity similar to the time-course 
of PtdIns(4,5)P2 hydrolysis (Section 1.4.1). Therefore, the DAG kinase 
responsible must catalyse the phosphorylation of PtdIns(4,5)P2-derived sn-1,2- 
diacylglycerol with a reaction velocity that would result in the transience of sn-1,2- 
diacylglycerol in agonist-stimulated cells.
The DAG kinase active in the metabolism of PtdIns(4 ,5)P2-derived sn- 1,2- 
diacyl glycerol would most likely be associated with the plasma membrane, i.e. 
juxtaposed to the site of PtdIns(4,5)P2 hydrolysis. Direct access of DAG kinase to 
sn- 1,2-diacyl glycerol as it was produced would ensure tight coupling of PKC 
activation to receptor occupation. Rapid redistribution of sn-1,2-diacylglycerol 
from the plasma membrane to intracellular membranes, as demonstrated by Pagano 
& Longmuir (1985), might indicate such localisation of DAG kinase activity as a 
prerequisite for its role in defining the transient appearance of PtdIns(4 ,5)P2- 
derived sn-1,2-diacylglycerol.
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Finally, the DAG kinase responsible for catalysing the phosphorylation of 
PtdIns(4,5)P2-derived s«-l,2-diacylglycerol would seem to exhibit some selectivity 
amongst sn- 1,2-diacyl glycerol molecular species. MacDonald et al. (1988a) 
reported the presence of a membrane-associated DAG kinase activity in lysates 
prepared from PDGF-stimulated Swiss 3T3 fibroblast which catalysed the 
phosphorylation of endogenous 1,2-diacylglycerol. PDGF stimulation of Swiss 
3T3 fibroblasts in the presence of s«-l,2-didecanoylglycerol, a cell-permeable sn-
1,2-diacyl glycerol, resulted in the preferential phosphorylation of the endogenous 
lipid (MacDonald etal., 1988a). Furthermore, the membrane-associated DAG 
kinase of Swiss 3T3 cells exhibited selectivity amongst several endogenous sn- 1,2- 
diacyl glycerol s. It catalysed the phosphorylation of sw-l-stearoyl-2- 
arachidonylglycerol with a reaction rate 2- to 8-fold greater than other naturally 
occurringsw-l,2-diacylglycerols (MacDonald etal., 1988b).
1.8.2. D iacylglycerol Kinase: Subcellular Distribution.
Subcellular fractionation has demonstrated DAG kinase as an activity 
expressed ubiquitously throughout the cell. DAG kinase activity is located in the 
cytosol, non-synaptic plama membranes, synaptic plasma membranes, synaptic 
vesicles, mitochondria, microsomes and synaptosomes in rat cerebral cortex 
(Stubbs et al., 1988). Additionally, DAG kinase activity has been observed in the 
nuclear fraction of rat cerebral cortex (Lapetina & Hawthorne, 1971). Within this 
nuclear fraction, DAG kinase has further been localised both to rat liver nuclear 
envelope (Smith & Wells, 1983) and to the internal nuclear matrix of NIH 3T3 
mouse fibroblasts (Payrastre et al., 1992). In addition to the microsomal 
membrane-associated enzyme reported in rat cerebral cortex (Lapetina & 
Hawthorne, 1971; Stubbs et al., 1988) and rat lung (Ide & Weinhold, 1982), 
microsomal-associated DAG kinase activity from rabbit brain and liver has also 
been studied (Ford & Gross, 1990). As well as the plasma membrane activity 
identified in rat cerebral cortex by Stubbs et al. (1988), plasma membrane-
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associated DAG kinase has been demonstrated in human platelets (Chaffoy de 
Courcelles, 1985) and rat liver (Rider & Baquet, 1988). Freely soluble DAG 
kinase activity has been studied in the cytosolic fraction of rat liver (Kanoh &
Ohno, 1981), rat brain (Bishop & Strickland, 1980; Kato & Takenawa, 1990), rat 
lung (Ide & Weinhold, 1982), bovine brain (Lin et a l ,  1986), baboon brain 
(Lemaitre et al., 1990), pig brain (Kanoh et al., 1983; Kanoh & Ono, 1984), pig 
thymus (Sakane et al., 1989), human white blood cells (Schaap et al., 1990), 
human platelets (Yada et a l,  1990), Swiss 3T3 fibroblasts (McDonald et a l ,
1988b; Coco-Maroney & Macara, 1989) and NIH 3T3 fibroblasts (Strathoupoulos 
et a l,  1990).
Despite the ubiquitous distribution of DAG kinase activity throughout the 
cell, most of the activity within the cell is typically associated with the cytosol. 
Cytosolic DAG kinase is the predominant DAG kinase activity in rat brain, thymus, 
spleen, liver, lung, kidney and uterus (Kato & Takenawa, 1990), proving to have 
greater total and specific activity than the particulate-associated enzyme. However, 
Kato & Takenawa (1990) found an altered distribution in rat heart, with the 
particulate-associated DAG kinase predominating although it did possess reduced 
specific activity compared to the cytosolic enzyme. Coco-Maroney and Macara 
(1989) also observed partitioning of DAG kinase activty towards the cytosol of 
Swiss 3T3 fibroblasts when employing a deoxycholate-based assay similar to that 
utilised by Kato and Takenawa (1990). However, Coco-Maroney and Macara 
(1989) also observed that alteration of the detergent and phospholipid cofactor 
conditions of the assay could affect the measured specific activity of both the 
cytosolic and membrane fraction-associated DAG kinase activity. Replacing 
deoxycholate with 51 mM /i-octyl-(3,D-glucopyranoside indicated that the kinase 
was predominantly cytosolic, as previously observed. However, the measured 
specific activities of the membrane-associated and cytosolic enzymes were similar 
when PtdSer was introduced to the w-octyl-|3,D-glucopyranoside assay system to a 
Final concentration of 2 mM [7 mol%] (Coco-Maroney & Macara, 1989). PtdSer
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had previously been identified as a phospholipid cofactor for the membrane- 
associated DAG kinase of Swiss 3T3 fibroblasts (MacDonald et al., 1988b).
Finally, replacing the deoxycholate with 16 mM CHAPS resulted in membrane- 
associated DAG kinase displaying the greatest specific activity when the assay was 
performed in the presence of 2 mM (20 mol%) PtdSer (Coco-Maroney & Macara,
1989). Therefore, discussion of subcellular localisation and, indeed, the proportion 
of total cellular DAG kinase resident within each compartment must be carefully 
qualified with respect to the detergent and phospholipid requirements of the DAG 
kinase activity resident within each fraction.
1.8.3. M ultiple Isoenzymes of Diacylglycerol Kinase.
Rabbit antisera, raised against the 80 kDa cytosolic DAG kinase previously 
purified from pig brain (Kanoh et al., 1983), immunoprecipitated only 60 % of the 
DAG kinase activity from pig brain cytosol (Kanoh et al., 1986). Furthermore, it 
was possible to resolve the immunoreactive and non-immunoreactive activities by 
ion-exchange chromatography (Kanoh et al., 1986). Also, the antisera raised 
against the 80 kDa DAG kinase exhibited little or no cross-reactivity with the DAG 
kinase in cytosolic fractions prepared from chicken and rat brain and also from pig, 
chicken and rat liver (Kanoh et al., 1986). Further investigation of the distribution 
of the immunoreactive and non-immunoreactive DAG kinases in different pig 
tissues revealed the 80 kDa immunoreactive activity to be limited to brain, thymus 
and spleen (Yamada & Kanoh, 1988). In addition to the non-immunoreactive DAG 
kinase activity previously reported in pig liver, Yamada and Kanoh (1988) 
observed non-immunoreactive activity in pig platelet cytosol with further possible 
non-immunoreactive activity in pig heart and kidney. However, the low specific 
activity of the heart and kidney preparations indicate possible difficulty in 
quantifiying the expression of the 80 kDa immunoreactive DAG kinase by 
immunoblot analysis.
49
Gel filtration of cytosolic preparations from pig brain and thymus revealed 
the presence of a 280 kDa DAG kinase activity in addition to the immunoreactive 80 
kDa activity. In contrast, gel filtration of platelet cytosol identified the presence of a 
120 kDa non-immunoreactive DAG kinase in addition to the 80 kDa and 280 kDa 
activities observed in other pig tissues (Yamada & Kanoh, 1988). In an attempt to 
study the nature of this heterogeneity, Sakane etal. (1989) purified the soluble 
DAG kinases from porcine thymus cytosol. Consistent with the earlier findings of 
Yamada and Kanoh (1988) they were able to purify an 80 kDa DAG kinase from 
pig thymus that displayed cross-reactivity to the antisera raised against the pig brain 
80 kDa cytosolic activity. Additionally, they purified the non-immunoreactive DAG 
kinase activity which displayed an apparent native molecular weight of 150 kDa on 
gel filtration analysis of partially purified enzyme and 2 polypeptide bands of 50 
and 75 kDa after SDS-PAGE analysis of the purified preparation (Sakane et al.,
1989). These workers were further able to distinguish these isoenzymes on the 
basis of their heat-lability, action of anionic activators, inhibition by sphingosine 
and inhibition by the DAG kinase inhibitor; R59022. In pig there would thus 
appear to be three resolvable cytosolic DAG kinases, two of which have been 
purified to homogeneity.
Further proof of the existence of isoenzymes has been provided by the 
identification of individual DAG kinase activities in homogeneous cell populations 
rather than in tissue homogenates. Yada et al. (1990) have purified three distinct 
isoenzymes from human platelets. The 152 kDa and 58 kDa isoenzymes were both 
purified to homogeneity from this source, while an additional activity with apparent 
molecular mass of 75 kDa was identified and partially purified (Yada et al., 1990). 
These isoenzymes were further distinguishable by the different effects of 
detergents, phospholipids, and R59022 on their reaction velocity.
Similarly, two isoenzymes with different substrate, phospholipid cofactor, 
and detergent dependencies have been identified in the cytosol of rat brain and were 
successfully separated by heparin-agarose chromatography (Strathopoulos et al.,
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1990). These workers were also able to identify two isoenzymes in the cytosol of 
NIH 3T3 fibroblast which could be separated by heparin-agarose chromatography 
(Strathopoulos et al., 1990). Although the substrate, detergent and phospholipid 
cofactor dependencies of the NIH 3T3 isoenzymes were not further characterised, 
their separation on heparin-agarose was similar to that of the two DAG kinases 
identified in rat brain rat brain (Strathopoulos et al., 1990). Thus, there is strong 
evidence to suggest that isoenzymes of DAG kinase co-exist within a single cell 
type.
1.8.4. Regulation of Diacylglycerol Kinase by 'Translocation'.
Vasopressin-treatment of rat liver for 5 min resulted in both an elevation of 
apparent Km for sw-l,2-dioleoylglycerol and Vjnax of the plasma membrane- 
associated DAG kinase activity (Rider & Baquet, 1988). Total DAG kinase activity 
resident in homogenates of treated and untreated livers displayed no alteration in 
DAG kinase activity, although the activity recovered with the plasma membrane 
was found to have doubled.
Besterman et al. (1986b) demonstrated the redistribution of DAG kinase 
activity from the cytosol to the particulate fraction on incubation of rat brain 
homogenate with either sn-l, 2-diacyl glycerol or phospholipase C. After partial 
purification of DAG kinase from phospholipase C-treated rat brain homogenate, 
these workers were able to demonstrate binding of the purified kinase to 
phospholipase C-treated inside-out vesicles prepared from human red blood cells 
(Besterman et al., 1986b). The translocation event is wholly dependent on prior 
incubation of the vesicles with phospholipase C, presumably indicating the 
requirement for elevation of sn- 1,2-diacyl glycerol levels in the membranes for DAG 
kinase binding to occur. Similarly, incubation of PMA-down regulated Swiss 3T3 
fibroblasts with 5w-l,2-dioctanoylglycerol results in translocation of soluble DAG 
kinase to the cell membranes (Coco-Maroney & Macara, 1989). Short-term (2 min) 
treatment of Swiss 3T3 fibroblasts with PMA also affected a translocation of DAG
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kinase to the membrane (Coco-Maroney & Macara, 1989). The accumulation of 
DAG kinase activity on the cell membranes coincided with the PMA-stimulated 
elevation of sn-1,2-diacylglycerol within these cells. Also, PMA was found not to 
alter the total cellular DAG kinase activity, nor did it exert any direct effect on 
cytosolic or membrane-bound DAG kinase activity. Thus, the redistribution of 
DAG kinase towards the membranes was attributable solely to the PMA-stimulated 
production of sn- 1,2-diacyl glycerol within these cells (see also Cook et al., 1991).
It is not clear if this translocation event does indeed represent an up- 
regulation of the DAG kinase activity, functioning to remove PtdIns(4,5)P2-derived 
sn- 1,2-diacyl glycerol. PMA-stimulated elevation of cellular sn-1,2-diacylglycerol 
levels has been correlated with the stimulated hydrolysis of PtdCho, but not 
PtdIns(4,5)P2 (Muir & Murray, 1987). Therefore, hydrolysis of a phospholipid 
other than PtdIns(4,5)P2 could stimulate the redistribution of cytosolic DAG kinase 
observed on PMA treatment. Once resident on the membrane, it is not apparent if 
the DAG kinase is active in phosphorylating the sn-1,2-diacylglycerol that elicited 
its translocation. This is pertinent, as the sn- 1,2-diacyl glycerol accumulating in 
response to PMA-stimulated PtdCho hydrolysis would presumably be metabolised 
by a pathway other than DAG kinase-catalysed phosphorylation (see Section 
1.4.7). The subcellular localisation of the DAG kinase recruited to the membrane 
compartment by PMA treatment has yet to be identified. This prevents definition of 
the translocation as an increased association of the cytosolic activity with either the 
plasma or intracellular membranes. The importance of such a finding is under­
scored by the observed sustained accumulation of sn- 1,2-diacyl glycerol in 
intracellular membranes compared to its transient appearance in the plasma 
membrane (Martin et al., 1990).
The very nature of the translocation event is also called into doubt. Antisera 
specific for the cytosolic 80 kDa DAG kinase of pig brain have been employed in 
immunoblotting techniques to additionally further localise the 80 kDa DAG kinase 
to both the microsomal and synaptosomal fractions prepared from pig brain
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homogenate (Kanoh et al., 1986). Although originally purified from pig brain 
cytosol, the 80 kDa DAG kinase would seem to co-exist both in the soluble and 
membrane fractions of pig brain. Immunohistochemistry with anti-80 kDa DAG 
kinase antisera demonstrated intense staining of neuronal nuclei in pig brain, in 
addition to more diffuse staining of the cytosolic compartment in general (Kanoh et 
al., 1986). The 80 kDa DAG kinase has also been demonstrated to phosphorylate 
the sn-1,2-diacylglycerol present in phospholipase C-treated microsomes prepared 
from rat liver (Kanoh & Ono, 1984). Therefore, it would seem that rigid definition 
of soluble DAG kinases as cytosolic proteins may be premature. However, it may 
be possible to redefine them as non-integral membrane-associated proteins which 
rapidly redistribute to the cytosolic fraction on cell disruption. Such redistribution 
can be prevented by increased levels of sn-1,2-diacylglycerol within the cellular 
membranes, e.g. on agonist stimulation. However, distinction of this process from 
the previously discussed sn- 1,2-diacyl glycerol-stimulated translocation of soluble 
DAG kinase activity cannot be made at this time.
1.8.5. Regulation of Diacylglycerol Kinase Activity by Covalent 
M odification.
Alteration of DAG kinase activity by covalent modification, in particular 
phosphorylation, has been suggested by many workers. Rigorous examination of 
the alteration of activity by such modification has yet to be performed.
Phosphorylation of the 80 kDa cytosolic DAG kinase of pig brain by an 
endogenous protein kinase was demonstrated in vitro by Kanoh & Ono (1986). 
Despite considerable purification of the DAG kinase (equivalent to 50- and 1050- 
fold, see Kanoh et al., 1983), phosphorylation of the kinase was still observed on 
incubation of the heterogenous protein preparation with Mg2+ and [y-32P]ATP. 
Phosphorylation of the DAG kinase was not, however, observed after further 
purification of the protein to a homogeneous preparation (Kanoh & Ono, 1986). 
These workers reported the responsible kinase/s to be independent of Ca2+,
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Ca2+/calmodulin and cyclic nucleotides, and only capable of limited 
phosphorylation of the DAG kinase (maximally, phosphate was incorporated with a 
stoichiometry of 0.25 mol ^/m ol DAG kinase). It has also been demonstrated that 
PKC prepared from rat brain phosphorylates purified 80 kDa DAG kinase in vitro 
(Kanoh et al., 1989). Under the conditions employed, the 80 kDa DAG kinase 
proved to be only a poor substrate for cAMP-dependent protein kinase, compared 
with protein kinase C which achieves 1:1 stoichiometries of Pi incorporation per 
mol of enzyme. Clear alteration of either the apparent Km for sn- 1,2-diacyl glycerol 
or the enzyme's Vmax by protein kinase C-catalysed phosphorylation was not 
reported. The phosphorylated 80 kDa DAG kinase did display increased affinity 
for PtdSer vesicles and phosphorylation was postulated to stimulate partitioning of 
the soluble enzyme to a membrane-bound compartment (Kanoh et al., 1989). 
Moreover, the PKC-treated DAG kinase that remained soluble after incubation with 
PtdSer vesicles was found to be entirely non-phosphorylated. This may identify a 
mechanism for activation of DAG kinase by partitioning to a potentially sn-1,2- 
diacylglycerol-rich enviroment rather than by alteration of the Vmax and reduction of 
its apparent Km for sn-1,2-diacylglycerol.
In vitro the cAMP-dependent protein kinase phosphorylated the porcine 80 
kDa DAG kinase with lower stoichiometry than protein kinase C (Kanoh et al.,
1989). In parotid cells cAMP-dependent protein kinase has been implicated in the 
activation of DAG kinase (Soling et al., 1989). Activation of parotid gland DAG 
kinase activity has been demonstrated to be mediated by Ca2+/calmodulin dependent 
protein kinase activity on muscarinic stimulation (Soling et al., 1989). Yet, Kanoh 
& Ono (1986) reported that both Ca2+ and calmodulin were without effect on the 
rate of phosphorylation of the 80 kDa DAG kinase by an endogenous protein 
kinase. In conclusion, although the modulation of DAG kinase activity by protein 
phosphorylation events have, to date, been poorly examined, it is probably safe to 
conclude that such modulation will become evident with both a tissue- and agonist- 
specific pattern.
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1.8.6. Regulation of Diacylglycerol Kinase Activity by Calcium.
Alteration of DAG kinase reaction rates by Ca2+ has received little attention. 
Modulation of DAG kinase reaction rates was originally observed for both the 
soluble 110 kDa, and membrane-associated 150 kDa DAG kinases purified from rat 
brain (Kato & Takenawa, 1990). Both activities displayed maximal rates of 
reaction at 1 mM Ca2+, with rates rapidly decreasing as the Ca2+ concentration 
increased or decreased about the optimal. Isolation and sequencing of cDNA 
coding for the 80 kDa DAG kinase of porcine brain and thymus has revealed that 
the primary sequence of this protein possesses two E-F hand motifs (Sakane et al.,
1990). E-F hands are a-helix-loop-a-helix motifs which are highly conserved 
amongst the Ca2+-binding sites of calmodulin, troponin C and parvalbumin 
(reviewed Moncrief et al., 1990). Concomitant with the identification of these 
putative Ca2+-binding domains was the Finding that purified porcine thymus 80 kDa 
DAG kinase activity was enhanced by the presence of 10~7 - 10-4 M Ca2+, higher 
concentrations resulted in the return to basal levels of activity (Sakane et al., 1990). 
Sakane et al. (1991a) observed Ca2+ to bind the 80 kDa DAG kinase with both high 
affinity and a stoichiometry of 2 mol Ca2+ per mol. of enzyme. Furthermore, the 
Ca2+-dependent activation of the 80 kDa DAG kinase was found to require the 
presence of phosphatidyl serine for full stimulation of activity (Sakane et al.,
1991a). Physiologically, the requirement for phospholipid was found to represent 
a translocation event within the cell, from soluble to membrane-bound environment, 
in response to elevation of free Ca2+ concentrations (Sakane et al., 1991a). 
Expression of truncation and deletion mutants of the 80 kDa DAG kinase identified 
the requirement of the E-F hand motifs for Ca2+ binding of the resulting DAG 
kinase mutant (Sakane et al., 1991b), confirming Ca2+ does bind to the 80 kDa 
DAG kinase at a site equivalent to the E-F hands. Expression of a truncated mutant 
lacking E-F hand motifs in COS-7 cells resulted in greater Ca2+-independent DAG 
kinase activity than that observed for the native enzyme expressed in the same
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system. In the presence of 100 f.iM Ca2+, however, the truncated mutant displayed 
similar rates of reaction to the native enzyme. Additionally, deletion of the E-F 
hand was found to alter the subcellular distribution towards the membrane- 
associated compartment, compared to the soluble native kinase. Sakane et al. 
(1991b) concluded that binding of Ca2+ to the E-F hand domain induces 
conformational change, dis-inhibiting the binding of the soluble enzyme to cellular 
membranes.
Similarly, the deduced amino-acid sequence of the human 80 kDa DAG 
kinase purified from white blood cells revealed a high level of homology between 
the cloned human and porcine DAG kinases (Schaap et al., 1990). The sequences 
of these two proteins were found to differ by only 51 amino acid substitions and a 
single amino acid insertion in the human enzyme. The existence of two E-F hand 
motifs in the human enzyme with similar organisation to those observed in the 
porcine kinase would immediately identify the human DAG kinase a putative Ca2+- 
binding enzyme. Alignment of the tandemly repeated E-F hand motifs of the 
human and porcine enzymes revealed a high level of identity between the repeated 
motifs (27/29 and 27/29 residues, respectively). However, this enzyme, whether 
expressed in COS-7 cells from cloned cDNA or purified from human white blood 
cells, was unresponsive to alteration of free Ca2+ concentrations (Schaap et al.,
1990). This anomaly could simply represent problems in achieving Ca2+ 
modulation of DAG kinase activity in the absence of phospholipid (Sakane et al., 
1991b).
1.8.7. Further Structure/Function Analysis of Porcine 80 kDa 
Diacylglycerol Kinase.
Definitive structure/function relationships for DAG kinase as a family of 
related enzyme activities cannot, as yet, be undertaken, since only limited sequence 
data is available to date. Sakane et al. (1990) isolated and sequenced a full-length 
cDNA coding for the 80 kDa DAG kinase of porcine thymus. Subsequent to this,
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Schaap et al. (1990) sequenced a full-length cDNA coding for a soluble 80 kDa 
DAG kinase previously purified from human white blood cells. Comparison of the 
deduced amino-acid sequences revealed the human kinase to be a direct homologue 
of the porcine 80 kDa DAG kinase. A high degree of conservation between the 
aligned sequences was observed with 55 amino acid substitutions and only one 
insertion in the human sequence (Schaap et al., 1990). Furthermore, all the 
structural motifs deduced from the primary structure of the porcine enzyme were 
observed in the deduced human sequence, i.e. two E-F hand motifs localised 
towards the amino terminal, two cysteine-rich regions with homology to the 
cysteine-rich zinc finger sequences associated with sn-1,2-diacylglycerol/phorbol 
ester binding in the Cl region of PKC-a (Parker et al., 1989), and two putative 
ATP-binding sites. The high degree of homology between pig and human 
sequences does not aid interpretation of the structural requirements of a given DAG 
kinase. For clearer definition of the structural requirements for DAG kinase 
activity, comparison of the primary sequence of further, more divergent enzymes 
must be undertaken. Location of highly conserved sequences among polypeptides 
of little overall homology will allow functional motifs to be assigned with greater 
confidence.
Recently, a Drosophila melangoster DAG kinase homologue was isolated 
after screening of a Drosophila genomic library with the porcine DAG kinase cDNA 
under conditions of low stringency (Masai et al., 1992). Masai and co-workers 
then employed the isolated genomic DNA fragment to screen a Drosophila cDNA 
library to identify and isolate a full-length cDNA corresponding to the Drosophila 
DAG kinase homologue. Comparison of the Drosophila DAG kinase homologue's 
deduced primary structure to the porcine sequence reveals only limited homology. 
The carboxy-terminal half of the porcine protein holds 50 % identity with the 
homologous sequence in Drosophila, although the homologous region in the insect 
sequence is bissected by an insert of some 288 amino acids. However, these 
separated domains of Drosophila do have 76 and 72 % conserved homology with
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the correponding sequence of the porcine protein (Masai et al., 1992). This would 
suggest that the catalytic region of porcine DAG kinase to be resident within the 
carboxy terminus of the porcine kinase. Except for a single putative ATP-binding 
domain, the other putative structural/functional motifs are resident in the amino- 
terminal half of the porcine sequence and are, thus, absent from the Drosophila 
sequence (Sakane et al., 1990). This may suggest that these amino-terminal motifs 
are not involved in the catalytic site of DAG kinase and are restricted to the 
regulatory apparatus of the porcine/human 80 kDa DAG kinase isoenzyme. 
However, as yet, the Drosophila DAG kinase homologue has still to be expressed 
in an active form and despite its homology with the porcine protein may not actually 
possess any catalytic properties. This is pertinent, as the catalytic site of porcine 
diacylgycerol kinase has recently been located to the combined putative ATP- 
binding site/cysteine-rich zinc finger domain located between residues 218-252 of 
the porcine sequence (F. Sakane, personal communication), a structural motif that 
is lacking in the Drosophila homologue.
The cysteine-rich domain (CRD) of porcine 80kDa DAG kinase shares the 
motif H X n /i2CX2CXrtCX2CX4HX2CX6/7C (n varies between 12 and 14) with 
human 80 kDa DAG kinase (Schaap et al, 1990), human neuronal chimaerin (Hall 
et al., 1990), PKC-a, -|3, -y, -6, -e and PKC-£ (Parker et al., 1989, 1992). 
Additionally, the DAG kinases and PKC-a, -p, -y, -6 and -e possess two copies of 
the cysteine-rich motif expressed in tandem. Human neuronal chimaerin and PKC- 
however, only possess a single CRD. Such cysteine-rich domains are indicative 
of metal binding-domains where coordination between the metal, usually zinc, and 
the cysteinyl residues results in the stabilisalion of the characteristic structural motif 
(Berg, 1986). The requirement for a CRD to confer Zn2+-binding properties was 
demonstrated for neuronal chimaerin, human 80 kDa DAG kinase and human PKC- 
y (Ahmed et al., 1991). Ahmed and co-workers employed truncation mutants of 
neuronal chimaerin and PKC-y to demonstrate the requirement for an intact CRD 
for 65Zn2+-binding to the recombinant protein. These workers also demonstrated
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that human DAG kinase also bound 65Zn2+, presumably through its CRD (Ahmed 
et al., 1991). Furthermore, identification of the CRD as the structural motif 
responsible for high-affinity phospholipid-dependent binding of phorbol esters to 
neuronal chimaerin and PKC (Ono et al., 1989; Ahmed et al., 1990) strongly 
implicates the coordination of Zn2+ in the phorbol ester binding and membrane 
localisation activity of PKC. Although the possession of a CRD and the ability to 
bind Zn2+ correlates with phorbol ester binding in neuronal chimaerin and PKC-y, 
human DAG kinase was able to bind Zn2+ but not phorbol ester, despite the 
possession of two tandemly arranged cysteine-rich motifs (Ahmed et al., 1991). 
Therefore, although the secondary structure formed by a CRD in the presence of 
Zn2+ would confer phorbol ester binding and, thus, membrane association for 
neuronal chimaerin and PKC-y, it does not exclusively dictate phorbol ester and sn-
1,2-diacyl glycerol binding.
1.9. Aim of Project.
Receptor-stimulated hydrolysis and resynthesis of PtdIns(4 ,5)P2 is a 
response common to many agonists. Within such, DAG kinase activity can be 
identified and is essential in initiating the reincorporation of the sn- 1,2- 
diacyl glycerol glycerolipid backbone to the phosphoinositides and ultimately 
PtdIns(4,5)P2. Specifically, the DAG kinase involved in receptor-accelerated 
PtdIns(4,5)P2 turnover can be identified as catalysing the phosphorylation of sn-1- 
acyl-2-arachidonylglycerol with reaction velocities greater than those observed with 
non-arachidonyl SH-l,2-diacylglycerols (see Sections 6.1 & 6.2). This catalytic 
selectivity towards 572-1-acyl-2-arachidonylglycerol is not shared with all the DAG 
kinase activities that can be monitored in cell and tissue homogenates (MacDonald et 
al., 1988b; Lemaitre et al., 1990). In consequence, sw-l-acyl-2- 
arachidonylglycerol-selectivity has been employed as a diagnostic test for such 
DAG kinase activities dedicated to catalysing the phosphorylation of sn-1,2-
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diacylglycerol generated by receptor-stimulated PtdIns(4 ,5)P2 hydrolysis 
(MacDonald et al., 1988b).
The aim of the work towards this thesis was to purify from rat brain the 
DAG kinase involved in receptor-stimulated PtdIns(4,5)P2 turnover. From the 
information gained on the location of the s«-l-acyl-2-arachidonyl glycerol-selective 
DAG kinase in Swiss 3T3 mouse fibroblasts (MacDonald et al., 1988a, b) and the 
apparent inability of the previously purified cytosolic DAG kinases to catalyse the 
phosphorylation of s«-l-acyl-2-arachidonylglycerol with reaction velocities greater 
than those observed with other sn- 1,2-diacyl glycerols (Kanoh & Ohno, 1981; 
Kanoh et al., 1983; Lin et al., 1986), the particulate fraction of rat brain was 
selected as a suitable tissue source for the purification of the s«-l-acyl-2- 
arachidonylglycerol-selective enzyme.
sn- 1 -Stearoyl-2-arachidony 1 glycerol would also be employed as a substrate 
throughout the development of the purification so that the sw-l-acyl-2- 
arachidonylglycerol-selective enzyme may be resolved from other non-selective 
DAG kinase enzymes. Such, sw-l-acyl-2-arachidonylglycerol selectivity of the 
purified enzyme would be confirmed by comparison of the reaction velocities 
measured when incubated with non-arachidonyl sn-1,2-diacylglycerols and sn-1- 
acyl-2-arachidonylglycerol under reaction conditions identical to those developed 
for the assessment of the Swiss 3T3 fibroblast membrane-associated enzyme 
(MacDonald etal., 1988a, b).
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Chapter 2
Materials and Methods.
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2.1. M aterials.
All reagents were of analytical or similar grade. They were purchased from 
the following suppliers as follows.
Amersham International p.I.c. Aylesbury, U.K.
[y-32p]ATP (3 mmol/Ci), and [14C]sw-l-stearoyl-2-arachidonylglycerol.
Amicon Ltd. Stonehouse, U.K.
Centriprep 30 concentrators.
B.D.H. Ltd. Poole, U.K.
EDTA, ethanediol, formaldehyde, glutaraldehyde, imidazole, and |3- 
mercaptoethanol.
Bachem Feinchemikalien AG, Bubendorf, Switzerland.
sn-1,2-dilauryl glycerol.
B . D . H .
10 x 20 cm silica SG60 t.l.c. plates, and 20 x 20 cm silica SG 60 t.l.c. plates (Both 
are Merck products.
BioRad Laboratories Ltd. Hemel Hempstead, U.K.
Affigel Blue, BioGel HTP (hydroxyapatite), and Protein Assay Dye Reagent 
Concentrate.
Boehringer Manheim. Lewes, U.K.
ATP (high purity, from horse muscle), DTT, and Tris.
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Calbiochem Novabiochem . Leicester, U.K.
Diacylglycerol kinase (E. coli), w-octyl-|3,D-glucopyranoside, and Zwitteregent 3- 
14.
Fisons Scientific Equipment. Loughborough, U.K.
Absolute alcohol, acetic acid (glacial), acrylamide, chloroform, citric acid, CUSO4, 
Folin-Coicalteau solution, glycerol, glycine, hydrochloric acid, KC1, K2HPO4, 
KH2PO4, KOH, methanol, A,W-methylenebisacrylamide, MgCl2.6(H2 0 ), MES, 
MOPS, Na2CC>3, perchloric acid, polyethyleneglycol 6000,and iso-propyl alcohol.
Lipid Products. Redhill, U.K.
Phosphatidylserine (bovine brain).
May and Baker Ltd. Dagenham, U.K.
Ammonium persulphate.
Pharmacia. Milton Keynes, U.K.
Butyl-Sepharose 4B, phenyl-Sepharose CL-4B, octyl-Sepharose CL-4B, 
Sephacryl S-300 SF, QAE-Sephadex A-50, and SP-Sephadex C-50.
Scientific Instrument Centre Ltd. Eastleigh, U.K.
Dialysis tubing (Visking).
Scientific M arketing Associates. Barnet, U.K.
E64 [L-?ra«5-epoxysuccinyl-leucylamide-(4-guanidino)-butane], and leupeptin.
Sigma. Poole, U.K.
ATP-agarose (immobilised via A^-amino group), butyl-agarose, methyl-agarose, 
bovine serum albumin (fraction V), cardiolipin, Coomassie Brilliant Blue R-250,
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DETAPAC, heparin agarose (Type I), Lubrol PX, Nonidet P40, pepstatin A, 
phospholipase C (Type XIII, B. cereus), PMSF, sodium cholate, sodium 
deoxycholate, sodium fluoride, s«-l,2-dioleoylglycerol, sw-l-stearoyl-2- 
arachidonyl glycerol, TEMED, andTriton X-100.
Whatman LabSales Ltd. Maidstone, U.K.
DE 52 (DEAE-cellulose), P l l  (phosphocellulose), and PEI-cellulose.
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2.2. Determination of Protein Concentration.
2.2.1. Copper/Tartrate Method.
The copper/tartrate method of Lowry et al. (1951) was employed as 
follows. Protein samples (5.0 - 50 pg protein) were corrected to a volume of 100 
pi with buffer solution identical to that employed in the preparation of the sample. 
900 pi of copper/tartrate solution was added with mixing and the mixture incubated 
at room temperature for 10 min [copper/tartrate solution was prepared by mixing
2.0 % (w/v) Na2CC>3 in 100 mM NaOH, 2.0 % (w/v) sodium potassium tartrate 
and 1.0 % (w/v) CUSO4 in the ratio 100:1:1, (v/v) respectively]. 100 pi of 20 % 
(v/v) Folin-Ciocalteu solution was added with mixing and the absorbance of the 
solution measured at 750 nm after 10 min incubation at room temperature. The 
concentration of the sample protein solution was determined from a standard curve 
(5.0 - 50 pg protein) constructed from 1.0 mg/ml bovine serum albumin (fraction 
V) and treated identically to the protein samples of unknown concentration. The 
buffer/salt conditions of the protein sample were duplicated in the standard curve.
2.2.2. Trichloroacetic Acid Precipitation Method.
A method adapted from Peterson et al. (1977) was employed to determine 
the protein concentrations of solutions with compositions known to interfere with 
the Coomassie Dye or copper/tartrate methods..
The volume of the protein sample (5.0 - 50 pg protein) was corrected to 100 
pi with buffer solution identical to that employed in the preparation of the protein 
sample and brought to a final volume of 1.0 ml with H2O. 100 pi of 0.15 % (w/v) 
sodium deoxycholate was added to the solution with brief mixing and followed by 
the addition of 100 pi of 72 % (w/v) trichloroacetic acid. The resulting suspension 
was vortexed thoroughly and incubated at room temperature for 10 min before 
centrifugation (18,000 xg, 15 min, 4°C). The supernatant was carefully aspirated 
and 400 pi of water added to each pellet followed by the addition of 500 pi 
copper/SDS reagent with vigorous mixing [Copper/SDS reagent was prepared
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immediately before assay as follows: 1.0 % (w/v) C11SO4, 2.0 % (w/v) sodium 
potassium tartrate and 2 % (w/v) Na2CC>3 in 100 mM NaOH were mixed in the 
ratio of 1:1:100, (v/v) respectively. This copper/tartrate/carbonate solution was 
mixed with H2O, 0.8 M NaOH and 10 % (w/v) SDS at a ratio of 1:1:1:1, (v/v) 
respectively]. The mixture was incubated at room temperature for 10 min before 
addition of 100 pi of 50 % (v/v) Folin-Ciocalteu solution. The absorbance of the 
solution was measured at 750 nm after incubation at room temperature for 30 min. 
The protein concentration of the sample soution was determined by comparison to a 
standard curve (5.0 - 50 pg protein) constructed from 1.0 mg/ml bovine serum 
albumin (fraction V) and treated in an identical manner to the protein solution of 
unknown concentration. Prior to the TCA precipitation step, care was taken to 
duplicate the salt/buffer conditions of the protein samples in the standard curve.
2.2.3. Coomassie Dye Method.
A method adapted from Bradford et al. (1976) was employed to determine 
the protein concentration of pooled chromatography eluants. This method employs 
Protein Assay Dye Reagent Concentrate (BioRad) as described in the 
manufacturer's Micro assay protocol.
In brief, the volume of the protein sample (1.0 - 30 pg protein) was made to 
a volume of 100 pi with buffer solution identical to that employed in the preparation 
of the protein sample and the volume corrected to 800 pi with H2O. 200 pi of the 
Assay Dye Reagent Concentrate was added with mixing and the optical density of 
the solution measured at 595 nm after incubation at room temperature for 5 min.
The concentration of the protein sample was determined from a standard curve (0.5 
- 30 pg protein) constructed from 1.0 mg/ml bovine serum albumin (fraction V) and 
treated identically to the protein samples of unknown concentration. Care was 
taken to duplicate the salt/buffer conditions of the sample protein solutions in the 
standard curve.
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2.2.4. U.V. Absorbance Method.
The protein concentration of chromatography column eluants was 
determined by an 'on-line' Uvicord S spectrophotometer (LKB) connected in series 
with the column outlet. The absorbance of the eluant solution was monitored at 280 
nm in a 3 mm quartz flow cell and recorded by a 2210 pen recorder (LKB).
2.3. SDS-PAGE Analysis of Proteins.
Discontinuous buffer SDS-PAGE analysis of protein solutions was 
performed according to the method of Laemmli et al. (1970) in 1.5 mm thick 
polyacrylamide gels employing a vertical 100 mm x 140 mm slab gel apparatus 
(BioRad) as described by the manufacturers. The protein samples to be analysed 
and the SDS-PAGE gels prepared as follows.
2.3.1. Sample Preparation.
The protein sample solution was corrected to 1.0 ml in an eppendorf tube 
with H2O and 100 pi of 0.15 % (w/v) sodium deoxycholate added with mixing.
The protein was precipitated by addition of 100 pi of 72 % (w/v) trichloroacetic 
acid and the suspension incubated at room temperature for 10 min after vigorous 
vortexing. The suspension was pelleted by centrifugation (18,000 xg, 15 min,
4°C) and the supernatant removed by aspiration. 20 pi of 1.0 M Tris base and 20 
pi of Laemmli buffer were added to the pellet which was solubilised by incubation 
in a boiling water bath for 3 min [Laemmli buffer: 30 % (w/v) urea, 5 % (w/v)
SDS, 6 % (w/v) DTT, 20 mM Tris/HCl pH 8.0, 0.2 % bromophenol blue].
2.3.2. SDS-PAGE Stock Gel Solutions.
The following solutions were prepared and stored at 4°C.
Acrylamide solution: 30 % (w/v) acrylamide, 0.8%(w/v) N,N'~methylene-
bisacrylamide.
Resolving gel buffer: 0.4 % (w/v) SDS, 1.5 M Tris/HCl pH 8.8.
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Stacking gel buffer: 0.4 % (w/v) SDS, 0.5 M Tris/HCl pH 6.8.
Glycerol solution: 50 % (v/v) glycerol.
SDS solution: 0.1 % (w/v) SDS.
2.3.3. SDS-PAGE Resolving Gel Preparation.
SDS-PAGE analysis of proteins was performed on 10 % acrylamide 
resolving gels prepared by mixing the stock gel solutions as follows:
8.0 ml Acrylamide stock.
6.0 ml Resolving gel buffer stock.
1.6 ml Glycerol solution.
8.2 ml h 2o
8 pi TEMED.
90 pi 10 % (w/v) ammonium persulphate, freshly prepared.
Directly after preparation, the resolving gel solution solution was poured into the 
assembled electrophoresis apparatus and overlaid with a few ml of 0.1 % SDS 
solution and left at room temperature for 3 h to polymerise.
2.3.4. SDS-PAGE Stacking Gel Preparation.
3.0 % acrylamide stacking gels were prepared from the stock gel solutions 
by mixing the solutions as follows:
1.5 ml Acrylamide stock.
3.75 ml Stacking gel buffer stock.
9.75 ml H20 .
8 pi TEMED.
150 pi 10 % (w/v) ammonium persulphate, freshly prepared.
Immediately after preparation, the 0.1% (w/v) SDS overlay was removed from the 
polymerised resolving gel and the gel surface washed with a few ml of stacking gel 
solution. The stacking gel solution was then poured into the electrophoresis
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apparatus and the well comb positioned according to the manufacturer's instructions 
and the solution left at room temperature to polymerise.
2.3.5. SDS-PAGE Electrophoresis.
The polymerised gels were assembled into the buffer reservoir as described 
by the manufacturer's instructions, the well comb removed and the reservoirs filled 
with running buffer [25 mM Tris base, 125 mM glycine, 0.1 % (w/v) SDS].
Protein samples, prepared in Laemmli sample buffer (Section 2.3.1), were placed 
directly into the wells of the stacking gel with a Hamilton syringe. Electrophoresis 
was performed in the direction of the cathode at 110 v, 25 mA until the dye front 
reached the end of the resolving gel.
2.3.6. Fixing and Coomassie R-250 Staining of SDS-PAGE Gels.
After the completion of electrophoresis, the apparatus was disassembled and 
the polyacrylamide resolving gel removed to a dish for staining. The gel was fixed 
and stained by immersion in staining solution [10 % (v/v) glacial acetic acid, 20 % 
(v/v)/s<?-propylalcohol, 0.1 % (w/v) Coomassie Brilliant Blue R-250] for 2 h. The 
staining solution was removed to a bottle for re-use and the gel destained in 40 % 
(v/v) methanol, 10 % (v/v) glacial acetic acid until the desired level of destaining 
was achieved. The destained gel was transfered to 10 % (v/v) glacial acetic acid for 
storage at 4°C.
2.3.7. Silver Staining of SDS-PAGE Gels.
Gels were silver stained after the method of Morrissey (1981) either directly 
after electrophoresis or after staining with Coomassie Brilliant Blue R-250 (Section 
2.3.6).
Gels were placed in a clean dish and fixed by washing for 30 min with 50 
% (v/v) methanol, 10% (v/v) glacial acetic acid solution followed by washing in 5 
% (v/v) methanol, 7.5% (v/v) glacial acetic acid solution for 30 min. The washed
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gels were placed in 10 % (v/v) glutaraldehyde and incubated for 30 min. The 
glutaraldehyde was removed by washing the gels with repeated changing in distilled 
H2O over 3 h. After washing, the gels were placed in an aqueous solution of 5 
pg/ml DTT for 30 min followed by immersion in 0.1 % (w/v) silver nitrate for 30 
min. The excess silver nitrate solution was removed by aspiration and the gels 
washed briefly in a small volume of distilled H2O. The distilled H2O was rapidly 
removed by aspiration and the gels washed briefly in a small volume of developer 
solution (3 % (w/v) Na2CC>3, 0.019 % (v/v) formaldehyde). The developer 
solution was removed rapidly by aspiration and development continued by 
immersion of the gel in 100 ml of developer solution. When the desired level of 
staining was achieved the development reaction was stopped by the addition of 12 
ml of 2.3 M citric acid to the developer solution and agitation of the gel in this 
solution for 10 min. The developed gels were placed in 10 % (v/v) glacial acetic 
acid and stored in the dark at 4°C.
2.4. DAG Kinase Assays.
2.4.1. n-O ctyl-p,D-gIucopyranoside/CardioIipin M ixed M icellar  
M ethod.
The reaction velocity of rat brain DAG kinase was measured by adaptation 
of the w-octyl-p,D-glucopyranoside/cardiolipin mixed micellar assay employed by 
Preiss et al. (1986) and Walsh & Bell (1986) to measure the reaction velocity of E. 
coli DAG kinase.
The rat brain DAG kinase was incubated in the following reaction mixture:
1.5 % (w/v) «-octyl-p,D-glucopyranoside, 3.6 mol% (1.0 mM) cardiolipin, 0.36 
mol % (100 pM) sn- 1 -stearoyl-2-arachidony 1 glycerol, 60 mM imidazole/HCl pH
6.6 , 50 mM NaCl, 10 mM DTT, 12.5 mM MgCl2, 1.0 mM EGTA, 0.1 mM 
DETAPAC, 0.5 mM ATP (20 pCi/pmol [y-32P]ATP). These components were 
supplied to the final reaction mixture from concentrated stock solutions as follows: 
10 nmol of srt-l-stearoyl-2-arachidonylglycerol in chloroform stock solution (5
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mM) was dried under vacuum in each reaction tube. The dried sft-l-stearoyl-2- 
arachidonylglycerol was solubilised by sonication for 30 min at 4°C in 20 |xl of n- 
octyl-|3,D-glucopyranoside/cardiolipin solution [prepared immediately prior to use 
by sonication of 100 nmol cardiolipin, previously dried down under vacuum from 
chloroform/methanol stock solution, in 1.0 ml 7.5 % (w/v) w-octyl-p,D- 
glucopyranoside, 1.0 mM DETAPAC at 4°C until the solution was optically clear]. 
50 pi of 2x incubation buffer (100 mM imidazole/HCl pH 6.6 , 100 mM NaCl, 25 
mM MgCh, 2.0 mM EGTA) and 10 pi of 100 mM DTT were added to the 
solubilised sn- 1 -stearoyl-2-arachidonylglycerol solution. The DAG kinase reaction 
was initiated by the addition of 10 pi of rat brain DAG kinase preparation followed 
by 10 pi of 0.5 mM ATP (20 pCi/pmol [y-32P]ATP) in 100 mM imidazole/HCl pH
6.6, 1 mM DETAPAC and the reaction mixture vortexed briefly. The reaction 
mixture was incubated for 30 min at 30°C and the reaction terminated by the 
addition of 470 pi of CHCb/MeOH/l % (v/v) perchloric acid (15:30:2, v/v). The 
mixture were incubated at room temperature for 15 min and the phases split by 
addition of 150 pi of CHCI3 and 150 pi of H2O. The aqueous phase was removed 
and the lower phase washed twice with 1.0 ml H2O. The [32P]phosphatidic acid 
present in the final organic phase was quantitated directly by Cerenkov counting 
and the [32P]phosphatidic acid quantitated from the specific activity of [y-32P]ATP 
employed in the reaction mixture. The integrity of the [32P]-labelled products 
present in the final organic phase were routinely assessed by t.l.c. The final 
organic phase was dried down under vacuum, solubilised in 20 pi of CHC^/MeOH 
(19:1) and spotted onto 10 cm x 20 cm silica SG 60 plates (the silica t.l.c. plates 
were preactivated prior to use by heating to 100°C in an oven for 1 h and allowed to 
cool to room temperature). The t.l.c. plates were developed in 
CHCb/MeOH/glacial acetic acid (65:15:5, v/v). The radiolabelled products were 
visualised by autoradiography and [32P]phosphatidic acid was identified by the 
position of authentic non-radiolabel led phosphatidic acid on staining with iodine
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vapour. The silica corresponding to p 2P]phosphatidic acid was scraped and 
scintillation counted in 4 ml HiSafe II scintillation fluid.
2.4.2. Deoxycholate/Phosphatidylserine Dispersion Assay.
The dispersed diacylglycerol assay method of Coco-Maroney & Macara 
(1989) was routinely employed to monitor the DAG kinase activity present in 
column chromatography eluants.
The DAG kinase activity was measured by incubation in a reaction mixture 
of 1.0 mM sodium deoxycholate, 130 pM PtdSer, 200 pM sw-l-stearoyl-2- 
arachidonylglycerol, 50 mM Tris/HCl pH 7.4, 10 mM MgCl2, 20 mM NaF, 0.5 
mM DTT, 1.0 mM ATP (10 pCi/pmol [y-32P]ATP). These components were 
delivered to the reaction mixture as follows. Each reaction vial received 20 nmol 
sw-l-stearoyl-2-arachidonylglycerol from 5.0 mM stock solution in CHCI3 and the 
solvent removed under vacuum. The dried sw-l-stearoyl-2-arachidonylglycerol 
was dispersed by sonication in 40 pi of PtdSer/deoxycholate solution for 30 min at 
4°C [the PtdSer/deoxycholate solution had been prepared prior to use by 
solubilisation of 650 nmol PtdSer, dried down from chloroform stock solution, in
2.0 ml of 112.5 mM Tris/HCl pH 7.4, 50 mM NaF, 2.5 mM sodium 
deoxycholate, 1.25 mM DTT and the mixture sonicated at 4°C in a glass vial until 
the solution became optically clear]. 50 pi of DAG kinase preparation was 
introduced to the dispersed sn-1 -stearoyl-2-arachidonylglycerol mixture and the 
reaction initiated by addition of 10 pi of 10 mM ATP (10 pCi/pmol [y-32P]ATP) in 
100 mM MgCl2, 50 mM Tris/HCl pH 7.4. The reaction mixture was incubated at 
30°C for 30 min and the reaction terminated by the addition of 470 pi of 
CHCl3/MeOH/10 mM HC1 (15:30:2, v/v) and the mixture allowed to extract for 15 
min. Phases were split by the addition of 150 pi of CHCI3 and 1.0 ml of H2O.
The aqueous phase was removed by aspiration and the organic phase washed with a 
further 1.0 ml of H2O. The resulting lower phase was removed to a 2 ml polytube. 
The residue remaining in the glass vial was removed by extraction of the reaction
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vial with 470 pi of CHCl3/MeOH/10 mM HC1 (15:30:2, v/v) and this residue 
pooled with the original organic phase in the polytube. Phases were split by the 
addition of 150 pi of CHCI3 and 1.0 ml of H2O and the upper phase removed by 
aspiration. The [32P]-labelled products remaining in the final organic phase were 
quantitated by Cerenkov counting.
Routinely greater than 95 % of the p 2P]-labelled reaction products present 
in the final organic phase co-migrated with authentic phosphatidic acid when 
analysed by t.l.c. as described in Section 2.4.1 (data not shown).
This assay method was capable of measuring DAG kinase activity of 
between 10 and 90 pmol PtdOH formed/min. The relationship between measured 
enzyme activity and enzyme present in the incubation mixture was hyperbolic and 
found to saturate above 80 pmol/min. However, a linear relationship was obtained 
with enzyme activities below 50 pmol/min. DAG kinase activity measured by this 
method was found not to follow Michaelis-Menten kinetics with respect to its s/2- 
1,2-diacyl glycerol substrate.
2.4.3. /i>O ctyl-p,D -glucopyranoside/Phosphatidylserine M ixed  
M icellar Assay.
An w-octyl-p,D-glucopyranoside/PtdSer mixed micellar assay adapted from 
MacDonald et al. (1988a) was routinely employed in the kinetic analysis of the 
KCl-soluble enzyme.
Unless otherwise stated, the reaction velocity of DAG kinase was measured 
by incubation in a reaction mixture containing 73 mM «-octyl-p,D- 
glucopyranoside, 8.0 mol% (4.38 mM) PtdSer, 3.7 mol% (2.0 mM) sw-l-stearoyl- 
2-arachidonylglycerol, 50 mM MOPS/NaOH pH 7.2, 18 mM MgCl2, 20 mM NaF,
1.0 mM DTT, 2.0 mM ATP (10 pCi/pmol [y-32P]ATP). The assay was performed 
as follows: 16.05 mg (21.9 pmol) PtdSer (18 mg/ml CHCl3/MeOH stock solution) 
was dried down under a stream of N2 in a 2 ml glass vial. The dried PtdSer was 
solubilised in 2.0 ml of 182.5 mM w-octyl-p,D-glucopyranoside, 112.5 mM
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MOPS/NaOH pH 7.2, 50 mM NaF, 2.5 mM DTT by vortexing, followed by 
sonication at 4°C until the solution was optically clear. In each reaction vial 40 pi 
of the «-octyl-p,D-glucopyranoside/PtdSer solution was employed to solubilise 200 
nmol of sti- 1 -stearoyl-2-arachidonylglycerol, previously dried down under vacuum 
from 5.0 mM CHCb/MeOH stock solution. Solubilisation was completed by 
sonication of the reaction vials for 30 min at 4°C. Immediately before initiation of 
the DAG kinase reaction, 50 pi of diluted DAG kinase preparation was added to 
each vial and the reaction initiated by addition of 10 pi of 20 mM ATP (10 
(iCi/nmol [y-32P] ATP) in 180 mM MgCl2, 50 mM MOPS/NaOH pH 7.2. The 
reaction mixture was incubated for 3-15 min at 30°C and terminated by the addition 
of 940 pi of CHCl3/MeOH/10 mM HC1 (15:30:2, v/v) and the products allowed to 
extract for 15 min at room temperature. Phases were split by the addition of 300 pi 
of CHCI3 and 400 pi of H2O and the upper aqueous phase removed. The organic 
phase was washed twice with 1.0 ml of synthetic upper phase [produced as the 
upper phase when CHCI3, MeOH and H2O were mixed in the ratio 1:1:0.9, v/v]. 
The final organic phase was dried under vacuum and the p 2P]-labelled products 
separated by t.l.c. on 10 cm x 20 cm silica SG 60 plates [the t.l.c. plates were 
preactivated prior to use by heating to 100°C for 1 h and allowed to cool].
Routinely, half the organic [32P]-labelled reaction products were spotted in 20 pi of 
CHC^/MeOH (2:1, v/v) and the t.l.c. plates developed over 10 cm in 
CHCb/MeOH/glacial acetic acid (26:6:3, v/v). The p 2P]-labelled products were 
visualised by autoradiography and the p 2P]phosphatidic acid identified by the 
migration of authentic non-radiolabelled phosphatidic acid after staining in iodine 
vapour. The silica corresponding to p 2P]phosphatidic acid was scraped and the 
[32P]phosphatidic acid quantitated by scintillation counting in 4 ml HiSafe II 
scintillation fluid.
This assay of DAG kinase activity was found to be linear with increasing 
amounts of enzyme activity (0 -8 0  pmol/min), protein (0 - 3.0 pg of the post HIC 
preparation) and time (0 - 15 min). Furthermore, the KCl-soluble DAG kinase was
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observed to follow Michaelis-Menten kinetics with respect both to sn- 1,2- 
diacyl glycerol and ATP substrate.
The mean assay time for this method was 2 to 3 days. It has the advantage 
of measuring DAG kinase with first order rate kinetics for either substrate, time, 
and enzyme concentration. However, it is time consuming and was unsuitable for 
use in the assay of column fractions for DAG kinase activity. The 
deoxycholate/PtdSer method described above (Section 2.4.2) was employed for 
measuring the DAG kinase activity present in column fractions. Although it cannot 
be employed for kinetic analysis of the KCl-soluble enzyme, it is rapid (6 - 8 h) and 
provides a qualitative estimate of DAG kinase activity.
2.5. Preparation of the KCl-Soluble DAG Kinase.
2.5.1. Phospholipase C-Mediated Enrichment of Rat Brain 
Particulate Fraction in DAG Kinase Activity.
The particulate fraction of rat brain was enriched in DAG kinase activity by 
affecting a redistribution of DAG kinase activity within rat brain homogenate from 
the soluble to the membrane-associated compartment. This was achieved by 
incubation of rat brain homogenate with bacterial phospholipase C in a method 
adapted from that described previously by Besterman et al. (1986b).
Sprague-Dawley rats (250 g - 300 g) were killed by cervical fracture and the 
cerebral cortices removed to ice-cold buffer A (118 mM KC1, 20 mM Tris/HCl pH 
7.0, 5.0 mM DTT, 1.0 mM CaCl2, 0.5 mM EDTA). The cortices were 
homogenised in 5 vol. of buffer A supplemented with 0.1 mg/ml leupeptin and 6 
U/ml phospholipase C (Type XIII, B. cereus) with six strokes in a teflon/glass 
homogeniser at full speed (1100 r.p.m.) and the homogenate incubated for 15 min 
at 37°C. The phospholipase C-catalysed reaction was teminated by addition of ice- 
cold buffer A supplemented with 10 mM EGTA until a final concentration of 5.0 
mM was achieved and the mixture incubated on ice for 10 min. The enriched 
particulate fraction was pelleted by centrifugation (31,400 xgaV, 25 min, 4°C). The
75
supernatant (SNi) was collected as a crude cytosolic preparation and the pellet 
resuspended in 10 vol. of buffer B (78 mM KC1, 20 mM Tris/HCl pH 7.0, 2.0 mM 
EDTA, 2.0 mM DTT, 20 % (v/v) glycerol, 0.2 mM PMSF, 1.0 p,M E-64) and the 
suspension centrifuged (31,400 xgav, 25 min, 4°C), the supernatant discarded and 
the DAG kinase-enriched particulate fraction resuspended in 10 vol. of buffer B.
2.5.2. Solubilisation of Membrane-Associated DAG Kinase Activity  
from the Particulate Fraction of Rat Brain.
DAG kinase-enriched particulate fraction resuspended in 9 vol. of buffer C 
(buffer B supplemented with 0.5 M KC1) and incubated at 4°C with slow stirring 
for 30 min before pelleting by centifugation (31,400 xgav, 25 min, 4°C). The 
supernatant containing the KCl-extracted DAG kinase activity was removed and 
used for further purification of the membrane-associated DAG kinase.
2.5.3. Preparation of the KCl-Soluble DAG Kinase Activity o f Rat 
Brain Particulate Fraction.
The KCl-solubilised protein preparation was dialysed extensively against 20 
mM Tris/HCl pH 6.5, 2.0 mM EDTA, 2.0 mM p-mercaptoethanol, 20 % (v/v) 
glycerol, 0.2 mM PMSF, 1.0 pM E64, 1 pM pepstatin A. Dialysis was typically 
performed overnight at 4°C against 3 x 5 1  volumes of the above buffer solution. 
The precipitate that formed on dialysis was pelleted by centrifugation (100,000 
xgav, 1 h, 4°C) and the supernatant discarded. The KCl-soluble DAG kinase was 
solubilised from the pellet by resuspension of the pellet in 2.0 ml buffer E/g of rat 
brain used to prepare the DAG kinase-enriched particulate fraction (see Section
2.5.1) [buffer E: 20 mM Tris/HCl pH 6.5,300 mM KC1, 2.0 mM EDTA, 2.0 mM 
P-mercaptoethanol, 20 % (v/v) glycerol, 0.2 mM PMSF, 1.0 pM E64, 1.0 p,M 
pepstatin A]. The insoluble material was removed by centrifugation (100,000 xgav, 
1 h, 4°C) and the supernatant collected as the KCl-soluble protein preparation and 
further employed for purification of the KCl-soluble DAG kinase.
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N.B. Despite thae in appropriate use of Tris/HCl at pH 6.5, the dialysis 
buffer was found remain at pH 6.5 during dialysis. Similarly, the pH of the KCl- 
soluble protein preparation was measured as 6.5.
2.6. Preparation of Chromatography Media.
All the following procedures employed in the preparation of 
chromatography media were performed at 4°C. Despite the inappropriate use of 
Tris/HCl at pH 6.5 in the preparation of AffiGel blue and Hydrophobic Interaction 
Media, these matrices were found to be equilibrated at pH 6.5. Once prepared 
media was packed into columns, the pH of effluent buffer was found to have 
remained at 6.5.
2.6.1. AffiGel Blue.
Both new and previously used AffiGel blue were prepared for use by the 
following method. Settled AffiGel blue was suspended gently in 10 vol. of 20 % 
(v/v) ethanol and allowed to settle for 30 min. The supernatant and the gel finings 
were decanted and the process repeated. The settled gel was washed by suspension 
in 20 vol. of distilled H2O and the gel allowed to settle. This process was repeated 
twice with fresh distilled H2O. The washed gel was suspended in 20 vol. of 0.5 M 
NaOH and incubated for 30 min before the supernatant was decanted and the gel 
resuspended in a further 20 vol. of 0.5 M NaOH. After 30 min the supernatant was 
decanted and the gel washed with distilled H2O as described above. The final 
distilled H2O wash was decanted and the gel equilibrated to pH 6.5 at 4°C by 
incubation in 10 vol. of 200 mM Tris/HCl pH 6.5, 1.0 M KC1, 2.0 mM p- 
mercaptoethanol, 2.0 mM EDTA, 20 % (v/v) glycerol. After 30 min the solution 
was removed and the gel incubated in fresh 200 mM Tris/HCl pH 6.5, 1.0 M KC1,
2.0 mM p-mercaptoethanol, 2.0 mM EDTA , 20 % (v/v) glycerol as above. After 
30 min the gel was resuspended and the column packed and equilibrated with the 
initial chromatography buffer [20 mM Tris/HCl pH 6.5,300 mM KC1, 10 mM
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MgCl2, 2.0 mM P-mercaptoethanol, 2.0 mM EDTA, 20 % (v/v) glycerol]. Prior to 
use, the column was washed with at least 20 column vol. of initial chromatography 
buffer or until a steady baseline was observed when the column eluant was 
monitored at 280 nm.
2.6.2. Hydrophobic Interaction Chromatography Media.
Butyl-Sepharose 4B, phenyl-Sepharose CL-4B, octyl-Sepharose CL-4B, 
butyl-agarose and methyl-agarose were all prepared for column chromatography by 
the following method. An appropriate volume of gel suspension was placed in a 
small beaker and the gel allowed to settle. The solution was decanted and the gel 
suspended for column packing in an equal volume of equilibration buffer [20 mM 
Tris/HCl pH 6.5, 1.0 M KC1, 2.0 mM P-mercaptoethanol, 2.0 mM EDTA, 20 % 
(v/v) glycerol ]. The column was packed with the above equilibration buffer and 
the packed column washed with at least 50 column vol. of the same buffer until the 
a steady baseline was observed when the column eluant was monitored at 280 nm.
2.6.3. Sephacryl S-300 SF Gel Filtration Media.
An appropriate volume of Sephacryl S-300 SF suspension was measured 
into a beaker and the gel allowed to settle. The solution was decanted and the 
settled gel resuspended in an equal volume of 20 mM Mes/KOH pH 6.5,300 mM 
KC1, 10 mM MgCl2, 2.0 mM EDTA, 2.0 mM p-mercaptoethanol, 20 % (v/v) 
glycerol, 0.02 % (w/v) Triton X-100. This suspension was degassed and used to 
pack the gel filtration column (1.6 cm x 90 cm) by the method described in the 
manufacturer's instructions. The above buffer was employed during column 
packing and subsequent washing of the packed column.
2.6.4. H eparin-Agarose.
The heparin-agarose suspension supplied by the manufacturers was allowed 
to settle and the solution decanted. 10 vol. of 200 mM Mes/KOH pH 6.5, 1.0 M
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KC1 were employed to resuspend the gel and the suspension incubated overnight. 
The supernatant was removed and the settled gel resuspended in 10 vol. of 200 mM 
Mes/KOH pH 6.5, 1.0 M KC1 and the suspension incubated for 1 h and the gel 
allowed to settle. The settled gel was equilibrated by resuspension in the initial 
chromatography buffer [20 mM Mes/KOH pH 6.5, 300 mM KC1, 10 mM MgCl2,
2.0 mM EDTA, 2.0 mM p-mercaptoethanol, 20 % (v/v) glycerol, 0.02 % (w/v) 
Triton X-100] and the suspension incubated for 1 h. The process was repeated 
with fresh buffer. After 1 h the solution was decanted and the settled gel was 
resuspended in an equal volume of initial chromatography buffer and the column 
packed.
2.6.5. Hydroxyapatite (BioGel HTP).
An appropriate amount of BioGel HTP was weighed into a beaker and the 
powder suspended in H2O by gentle stirring. The BioGel HTP was 'fined' by 
allowing the hydroxyapatite to settle and the cloudy solution remaining decanted. 
The settled hydroxyapatite was resuspended in H2O and the fining procedure 
repeated until a clear solution was obtained on settling of the hydroxyapatite. The 
fined BioGel HTP was equilibrated by resuspension in 20 vol. of 200 mM 
Mes/KOH pH 6.5, 1.0 M KC1, the mixture incubated for 1 h and the solution 
decanted from the settled hydroxyapatite. The settled hydroxyapatite was 
resuspended in a further 20 vol. of 200 mM Mes/KOH pH 6.5, 1.0 M KC1 and the 
mixture incubated for 1 h. The hydroxyapatite was allowed to settle, the solution 
removed and the settled hydroxyapatite prepared for chromatography by 
resuspension in 20 vol. of initial chromatography buffer [20 mM Mes/KOH pH 
6.5,300 mM KC1, 2.0 mM p-mercaptoethanol, 20 % (v/v) glycerol, 0.02 % (w/v) 
Triton X-100]. After 1 h, the hydroxyapatite allowed to settle and the settled 
hydroxyapatite resuspended in a further 20 vol. of fresh initial chromatography 
buffer. The mixture was incubated for 1 h and the settled hydroxyapatite
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resuspended in an equal volume of initial chromatography buffer and used for 
column packing.
2.7. M easurem ent of s/i-l,2 -D iradylg!ycero l M ass: The T rito n  X-100 
M eth o d .
sn- 1,2-Diradylglycerol mass was determined by the Triton X-100/PtdSer 
method of Thompson et al. (1990), as adapted by Paterson et al. (1991).
The final reaction mixture contained 0.3% (w/v) Triton X-100, 144 pM 
PtdSer, 50 mM imidazole/HCl pH 6.6, 50 mM NaCl, 12.5 mM M gC h.l mM 
EGTA, 10 mM DTT, 0.5 mM ATP (20 nCi/nmol [y-32P]ATP) and 5 mU DAG 
kinase (E.coli) in a volume of 100 pi. DRG/lipid extract was dried under vacuum 
in a 2 ml glass tube and solubilised in 50 pi of 0.6 %(w/v) Triton X -100/288 pM 
PtdSer by brief vortexing followed by sonication (30 min, 4°C). To this was 
added 10 pi of 100 mM DTT and 20 pi of 5x incubation buffer (225 mM 
imidazole/HCl ph 6.6,250 mM NaCl, 62.5 mM MgCl2, 5.0 mM EGTA). Prior to 
incubation, 10 pi (5 mU) DAG kinase was added and the reaction initiated by the 
addition of 10 pi 5.0 mM ATP (20 pCi/pmol [y-32P]ATP). The mixture was 
incubated at 30°C for 30 min and the reaction terminated by the addition of 470 pi 
CHCl3:MeOH: 10 mM HC1 (15:30:2) and the tubes left to stand for 10 min at room 
temperature and the phases split by addition of 150 pi CHCI3 and 1.0 ml H2O. The 
resulting organic phase was washed twice with 1.0 ml H2O before drying under 
vacuum and the radiolabelled products are separated by tl.c  on silica SG60 plates 
developed in CHCl3:MeOH: Acetic Acid (130:30:15). The p 2P] phosphatidic acid 
was identified by autoradiography and comparison to unlabelled phosphatidic acid 
stained with iodine vapour. Silica corresponding to phosphatidic acid was scraped 
and quantitated by liquid scintillation counting.
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2.8. M iscallaneous Procedures.
2.8.1. Preparation of Dialysis Tubing.
Dialysis tubing was immersed in 20 % (v/v) ethanol and incubated at room 
temperature for 1 h. The swollen dialysis tubing was removed from the ethanol 
solution and boiled in 10 mM EDTA for 30 min. The boiled dialysis tubing was 
removed to distilled H2O and boiled for a further 30 min. The tubing was allowed 
to cool and either used immediately or stored in 20 % (v/v) ethanol.
2.8.2. Concentration of Protein Solutions.
Pooled chromatography eluants were concentrated by dialysis against 
polyethyleneglycol 6000 at 500 g/1 in 20 mM Mes/KOH pH 6.5, 300 mM KC1, 2.0 
mM (3-mercaptoethanol, 2.0 mM EDTA, 20 % (v/v) glycerol, 0.02 % (w/v) Triton 
X-100, 200 pM PMSF, 1.0 pM E64, 1.0 pM pepstatin A.
Concentration was also performed with Centriprep 30 concentrators. The 
protein solution (1 -1 5  ml) was placed in a Centriprep 30 concentrators and 
centrifuged (2000 xg, 4°C) until the appropriate volume obtained.
2.8.3. Critical Micelle Concentrations.
The critical micelle concentration (c.m.c.) values employed in this thesis 
were obtained from Neugebauer (1990).
2.8.4. Statistical Analysis.
Unless otherwise stated, the results presented within this thesis are 
representative of at least three experiments.
The DAG kinase reaction velocities measured in the fractions collected from 
chromatography columns are single determinations. Otherwise, the values stated 
within this thesis are expressed as the mean of a triplicate determination and the 
error expressed as ± 1 SD.
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2.9. Buffer Solutions Employed in the Purification o f the KC1- 
Soluble DAG Kinase.
Dialysis buffer
Buffer B:
Buffer C:
Buffer D:
Buffer E:
Buffer F:
20 mM Tris/HCl pH 7.0, 2.0 mM EDTA, 2.0 mM DDT, 1.0 
mM KC1, 20 %(v/v) glycerol, 200 pM PMSF, 1.0 pM E64, 1.0 
pM pepstatin A
20 mM Tris/HCl pH 7.0, 2.0 mM EDTA, 2.0 mM DTT, 78 mM 
KC1, 20 % (v/v) glycerol, 200 pM PMSF, 1.0 pM E64, 1.0 pM 
pepstatin A
20 mM Tris/HCl pH 7.0,2.0 mM EDTA, 2.0 mM DTT, 578 
mM KC1,20 % (v/v) glycerol, 200 pM PMSF, 1.0 pM E64,
1.0 pM pepstatin A
20 mM Tris/HCl pH 6.5, 2.0 mM EDTA, 2.0 mM DTT, 1.0 
mM KC1, 20%(v/v) glycerol, 200 pM PMSF, 1.0 pM E64, 1.0 
pM pepstatin A
20 mM Tris/HCl pH 6.5,2.0 mM EDTA, 2.0 mM DTT, 300 
mM KC1, 20%(v/v) glycerol, 200 pM PMSF, 1.0 pM E64, 1.0 
pM pepstatin A
20mM Tris/HCl pH 6.5, 2.0 mM EDTA, 2.0 mM 0- 
mercaptoethanol, 300 mM KC1, 10 mM MgCl2, 20 % (v/v) 
glycerol, 0.02 % (w/v) Triton X-100, 200 pM PMSF, 1.0 pM 
E64, 1.0 pM pepstatin A
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Buffer G:
Buffer H:
Buffer I:
Buffer J:
20 mM Tris/HCl pH 6.5, 2.0 mM EDTA, 2.0 mM 
P-mercaptoethanol, 1.0 M KC1, 10 mM MgCl2, 20 %( v/v) 
glycerol, 0.02 % (w/v) Triton X-100, 200 pM PMSF, 1.0 pM 
E64, 1.0 pM pepstatin A
20 mM Mes/KOH pH 6.5,300 mM KC1, 10 mM MgCl2, 2.0 
mM EDTA, 2.0 mM p-mercaptoethanol, 20 % (v/v) glycerol, 
0.02 % (w/v) Triton X-100, 200 pM PMSF, 1.0 pM E64,
1.0 pM pepstatin A .
20mM Mes/KOH pH 6.5, 300 mM KC1, 2.0 mM 
p-mercaptoethanol, 20 % (v/v) glycerol, 0.02 % (w/v)
Triton X-100, 200 pM PMSF, 1.0 pM E64, 1.0 pM 
pepstatin A.
20 mM potassium phosphate pH 6.5, 300 mM KC1, 2.0 mM p- 
mercaptoethanol, 20 % (v/v) glycerol, 0.02 % (w/v)
Triton X-100, 200 pM PMSF, 1.0 pM E64, 1.0 pM 
pepstatin A.
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Chapter 3
Purification of Membrane-Associated DAG Kinase From Rat Brain.
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3.1. Preparation of DAG Kinase-Enriched Particulate Fraction from  
Rat Brain Homogenate.
The proportion of cellular DAG kinase activity which is resident within the 
membrane-associated compartment of rat brain remains a point of contention. 
Lapetina & Hawthorne (1971) reported that 77.7 % of rat cerebral cortex activity is 
located on the particulate fraction of the tissue homogenate. Subsequent to this, 
Besterman et al. (1986b) reported that the membrane-associated enzyme of rat brain 
represents only 25 % of the total homogenate activity. It is most likely that these 
observed differences are the result of the different assay methodologies employed in 
the above two studies. Nevertheless, it is clear that a considerable proportion of rat 
brain DAG kinase is associated with the particulate fraction. Furthermore it is 
possible to enrich the membranes of rat brain homogenate with DAG kinase by 
facilitating the translocation of soluble activity to the particulate fraction. This is 
achieved by incubating rat brain homogenate with phospholipase C from a bacterial 
source. Besterman et al. (1986b) reported that incubation of rat brain homogenate 
with phospholipase C from Bacillus cereus increased the DAG kinase activity 
recovered with the particulate fraction by nearly 3-fold, such that the percentage of 
the total homogenate associated enzyme recovered in the particulate fraction 
increased from 25 to 73 %. The use of bacterial phospholipase C to affect a 
redistribution of soluble DAG kinase activity towards the membrane associated 
component within the homogenate has been succesfully demonstrated within this 
laboraotory. In this case, however, the magnitude of redistribution was of lower 
magnitude than that reported previously, i.e. membrane-associated DAG kinase 
activity increased from 37 to 65 % on treatment (S. Palmer and S.J. Cook, personal 
communication).
It has now been demonstrated in several laboratories that incubation of a 
tissue homogenate with phospholipase C increases the proportion of DAG kinase 
activity which is recovered with the membrane-associated component. For 
example, incubation of inside-out vesicle prepared from human red blood cells with
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phospholipase C (B. cereus) has been reported to increase the amount of rat brain 
DAG kinase which will bind to these membranes (Besterman et al., 1986b). 
Similarly, 80 % of the DAG kinase activity within a crude cytosolic preparation of 
rat brain has been reported to bind to phospholipase C-treated membranes prepared 
from human red blood cells (Coco-Maroney & Macara, 1989). Clearly, incubation 
of rat brain homogenate with phospholipase C has an application to the preparation 
of an enriched source of membrane-associated DAG kinase which would prove a 
suitable source for purification of the enzyme. Indeed, this approach has been 
successfully employed. A membrane-associated DAG kinase has been 500- to 750- 
fold purified from phospholipase C-treated rat brain membranes (Besterman et al., 
1986b). Therefore, the procedure of Besterman et al. (1986b) was adopted to 
prepare a particulate fraction enriched in DAG kinase activity. This DAG kinase- 
enriched particulate fraction would then be employed as a source of enzyme for 
purification of the membrane-associated DAG kinase. Typically, the particulate 
fraction prepared from phospholipase C-treated rat brain homogenate (see Section
2.5.1) possessed a specific activity of 1210 ± 160 pmol/30 min/mg of protein 
(DAG kinase activity measured in the presence of 5.0 mM NaF by the method 
described in Section 2.4.1).
3.2.1. Solubilisation of M em brane-Associated Diacylglycerol 
K in ase.
The exact nature of the interaction between DAG kinase and the membranes 
of the phospholipase C-treated homogenate is not clear. The enzyme could exist as 
an integral membrane protein with transmembrane hydrophobic domains or as a 
non-integral membrane protein associated with the surface of the phospholipid 
bilayer. In addition, it remains possible that DAG kinase exists as a cytoskeleton- 
associated protein, with its localisation depending on the cytoskeletal proteins . 
anchored to the membrane. In the absence of further information, solubilisation of
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the membrane-associated DAG kinase both by detergent and hypertonic KC1 
extraction were examined.
Hypertonic KC1 extraction was performed by resuspending the DAG 
kinase-enriched particulate fraction in buffer B supplemented with either 0.2 or 0.5 
M KC1. Solubilisation by non-ionic, anionic and zwitterionic detergents was 
examined by resuspension of the DAG kinase-enriched particulate fraction in buffer 
B (Section 2.9) supplemented with detergent of appropriate concentration. The 
non-ionic detergents Triton X-100, Nonidet P40, Lubrol PX and Saponin were 
examined at final concentrations of both 0.1 and 0.01 % (w/v). Solubilisation by 
the zwitterionic detergent Zwittergent 3-14 was examined at final concentrations of 
both 0.1 and 0.01 % (w/v), whilst the anionic detergent sodium deoxycholate was 
employed at final concentrations of both 0.2 and 0.02 % (w/v).
Solubilisation of the membrane-associated enzyme by these treatments was 
assessed by their ability to release DAG kinase activity to the supernatant after 
centrifugation of the KC1- or detergent-treated particulate fraction (Fig 3 .1A). At 
the above concentrations Zwittergent 3-14, Saponin and sodium deoxycholate 
reproducibly gave no significant decrease in the specific activity of the detergent- 
treated particulate fraction. Nor did they elicit a significant increase in the specific 
activity of the soluble fraction (Fig 3. IB). This indicated that these detergents were 
unsuitable for further use in the solubilisation of membrane-associated DAG kinase. 
However, 0.1 % (w/v) Nonidet P40, 0.1 % (w/v) Lubrol PX and 0.1 % (w/v) 
Triton X-100 did solubilise the membrane-associated DAG kinase. At a final 
concentration of 0.1 % (v/v) the above detergents affected a clear increase in the 
specific activity of the resulting soluble fractions. This increase was not observed 
at the lower concentration of 0.01 % (w/v) (Fig.3.1A). Incubation of the DAG 
kinase-enriched particulate fraction with 0.1 % (w/v) Nonidet P40 ,0.1 % (w/v) 
Lubrol PX and 0.1 % (w/v) Triton X-100 also elicited a lowering of the specific 
activity of the post solubilisation particulate fraction, consistent with solubilisation 
of membrane-associated DAG kinase (Fig 3. IB). In the experiment represented in
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Fig 3.1. Solubilisation of Membrane-Associated DAG Kinase from  
the DAG Kinase-Enriched Particulate Fraction of Rat Brain 
H om ogenate.
A. DAG kinase activity released to the soluble fraction after incubation of DAG 
kinase-enriched particulate fraction with various detergents and hypertonic KCI.
B. DAG kinase activity remaining associated with the particulate fraction after 
incubation of DAG kinase-enriched particulate fraction with various detergents and 
hypertonic KCI.
DAG kinase-enriched particulate fraction was prepared as described in Section
2.5.1 and suspended to 15.0 ml with buffer B. 1.0 ml aliquots (13.65mg protein) 
of the suspension were pelleted by centrifugation (18,000 xg,15min, 4°C) and the 
supernatants discarded. The pellets were resuspended in 1.0 ml of buffer B 
(Control) or buffer B supplemented with detergent/KCl, as appropriate, and 
incubated on ice for 30 min. The suspensions were centrifuged (18,000 xg, 15 
min, 4°C) and the solubilised DAG kinase collected in the supernatant. The pellet 
was resuspended in 1.0 ml of buffer B (no added detergent or KCI). 10 pi of post­
solubilisation supernatants and suspended particulates were assayed for DAG 
kinase activity by the w-octyl-|3,D-glucopyranoside method (Section 2.4.1).
Protein concentrations were determined by the copper/tartrate method (Section 
2 .2 . 1).
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Fig 3.1 both 0.1 and 0.01 % (w/v) Saponin would appear to have increased the 
specific activity of the DAG kinase recovered in the soluble fraction recovered after 
incubation of the DAG kinase-enriched particulate with detergent. However, this 
was not observed in two other experiments and Saponin was not observed to elicit a 
reduction in the specific activity of the DAG kinase activity remaining associated 
with the particulate fraction. It was concluded that Saponin at the concentrations 
employed was unsuitable for the solubilisation of the membrane-associated enzyme.
The membane-associated DAG kinase activity was also solubilised with 
hypertonic concentrations of KCI. Resuspension of the enriched particulate fraction 
in KCI resulted in the release of DAG kinase activity to the soluble fraction (Fig 
3 .1A). This release was concomitant with a reduction in the specific activity of the 
particulate-associated enzyme (Fig 3. IB). Supplementing buffer B (Section 2.9) 
with 0.5 M KCI reproducibly resulted in a solubilised DAG kinase preparation of 
greater specific activity than detergent-solubilised enzyme (Fig 3.1 A).
The yield of DAG kinase activity solubilised from the phospholipase C- 
treated membranes cannot be calculated. The enzyme solubilised from the 
membranes on incubation with either detergents or hypertonic concentrations of 
KCI was assayed for DAG kinase activity in the absence of NaF, a general 
phosphatase inhibitor. The presence of phosphatidic acid phosphohydrolase (PPH) 
activity in both the crude cytosolic and membrane fraction prepared from 
phospholipase C-treated rat brain has been confirmed (data not shown).
Additionally this enzyme activity has been shown to be inhibited by the presence of
5.0 mM or greater NaF (data not shown). This is relevant to the measurement of 
DAG kinase activity in enzyme preparations which also contain PPH activity as the 
product of the DAG kinase-catalysed reaction is also a substrate of PPH, i.e 
[32P]phosphatidic acid. Thus, the presence of an uninhibited PPH activity will lead 
to the underestimation of of the DAG kinase activity present. It is therefore not 
possible to calculate the yield of DAG kinase solubilised from phospholipase C- 
treated membranes as the extent of co-solubilisation of PPH was not determined.
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Similarly it is not possible to accurately detemine the fold-purification of the DAG 
kinase activity on solubilisation. However, subsequent to the completion of the 
above initial survey of solubilisation conditions, DAG kinase activity was measured 
in the presence of 10 mM NaF. Under these conditions it was found that 55.3 -
87.1 % (mean 69.5 %, n =4) of the DAG kinase activity associated with the 
phospholipase-treated particulate fraction was solubilised on suspension in buffer B 
supplemented with 0.5 M KCI (0.578 M KCI final concentration).
Suspension of the phospholipase C-treated particulate fraction in buffer B 
supplemented with 0.5 M KCI was selected as the preferred method of solubilising 
membrane-associated DAG kinase. As this investigation of detergent and KCI 
solubilisation was performed in the absence of NaF the results cannot be considered 
to be more than a qualitative indication of the extent of enzyme solubilisation by 
these treatments. It can only be concluded that 0.5 M KCI apparently solubilised 
the DAG kinase with greater selectivity than the detergents under these conditions. 
Subsequent to the completion of this work the yield of DAG kinase solubilised 
from the phospholipase C-treated membranes was determined in the presence of 10 
mM NaF, a PPH inhibitor. Under these conditions it was found incubation of the 
phospholipase C-treated membranes with 0.5 M KCI in buffer B results in 69.5 % 
of the membrane-associated DAG kinase being solubilised (data not shown). 
Therefore, KCI at a final concentration of 578 mM was chosen as the method for 
the solubilisation of the membrane-associated DAG kinase. The use of KCI also 
had the advantage of avoiding any possible interference with the mixed-micellar 
assay which may have arisen with a detergent-solubilised enzyme preparation. 
Moreover, the elevated levels of KCI would be more easily removed from the 
enzyme preparation than detergent, should the need arise.
The use of hypertonic concentrations of salt is a common approach to the 
solubilisation of membane-associated DAG kinase. Besterman e t a l. (1986b) 
employed 1.0 M KCI to solubilise DAG kinase from the enriched particulate 
fraction prepared from phospholipase C-treated rat brain homogenate. Kato and
90
Takenawa (1990) solubilised a membrane-associated DAG kinase from rat brain by 
incubation with 2.0 M NaCl. Coco-Maroney and Macara (1989) reported that 0.5 
M NaCl removed 70 % of the rat brain cytosolic DAG kinase activity that had 
previously been reconstituted with phospholipase C-treated human red blood cell 
membranes. Additionally, these workers also reported that 78 % of the DAG 
kinase activity associated with rat brain membranes could be extracted by a single 
0.5 M NaCl wash (Coco-Maroney & Macara, 1989). Therefore, it was with some 
confidence that solubilisation of the membrane-associated DAG kinase by 
incubation with 578 mM KCI was adopted for continued use in the purification 
procedure.
For the purposes of this thesis, the protein solubilised from the DAG 
kinase-enriched particulate fraction by incubation with 578 mM KCI is defined as 
the 'KCl-extracted protein1. Apropos of this, the DAG kinase activity within this 
protein preparation is defined as the KCl-extracted DAG kinase'.
3.2.2. Purification of the KCl-Extracted DAG Kinase of Rat Brain: 
Overall Strategy.
As discussed in Section 3.1, the ability to solubilise a considerable 
proportion of the DAG kinase activity associated with the phospholipase C-treated 
particulate fraction is in agreement with the work of Besterman et al. (1986b). In 
addition to the solubilisation of membrane-associated DAG kinase by incubation of 
the phospholipase C-treated membranes with 1.0 M KCI they also reported the 
ability to further purify the solubilised enzyme by affinity chromatography on a 
column of immobilised sn- 1,2-diacyl glycerol and phosphatidylserine (Besterman et 
al., 1986b). This procedure was reported to yield a protein preparation of DAG 
kinase which was purified 500- to 750-fold relative to the enzyme in the tissue 
homogenate and possessing only 4 - 5  proteins on analysis by SDS-PAGE. 
However, this procedure was not adopted in the work towards this thesis. Despite 
an obvious application of such affinity chromatography to the purification of DAG
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kinases, workers within this laboratory have been unable to reproduce these results. 
It was found that DAG kinase prepared from rat brain did not bind a 
polyacrylamide-immobilised column of sn-l, 2-diacyl glycerol/PtdSer which had 
been prepared by the method described in Besterman et al. (1986b) [S. Palmer & 
M.J.O. Wakelam, personal communication]. It was considered more prudent to 
progress with more conventional chromatographic methods, e.g. ion-exchange 
chromatography, gel filtration and ATP-agarose chromatography. This may 
possibly avoid the stability problems experienced with the DAG kinase preparation 
recovered from the acrylamide-immobilised sti-1,2-diacyl glycerol/PtdSer column 
(Besterman et al., 1986b). This strongly suggests that it would be preferable to at 
least partially purify the KCl-extracted enzyme by more conventional 
chromatographic methods before introduction of the sn-1,2-diacylgycerol affinity 
column, should this affinity column become applicable in our hands. Additionally, 
characterisation of a purification strategy using more conventional methods may be 
succesful in the purification of the KCl-extracted DAG kinase to homogenity 
without recourse to chromatography on immobilised sn-l,2-diacylglycerol/PtdSer. 
Since the initiation of this project Kato and Takenawa (1990) reported the 
purification of a membrane-associated DAG kinase from rat brain to homogeneity 
by a strategy which did not employ polyacrylamide-immobilised sn-1,2- 
diacylglycerol/PtdSer. Rather, these workers purified the 2.0 M NaCl-solubilised 
enzyme by chromatography on Q-Sepharose (anion-exchange), phenyl-Superose, 
hydroxyapatite, and ATP-agarose.
3.3. A Proportion of the KCl-Extracted DAG Kinase Activity is 
Insoluble in The Absence of KCI.
Initially, the use of anion-exchange chromatography was considered for 
purification of the KCl-extracted DAG kinase. In preparation for this, the activity 
of the KCl-extracted DAG kinase was not found to alter significantly on exposure 
to pH ranging from 4.5 to 9.0 (data not shown). The pH of the KCl-extracted
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protein preparation was altered to various pH values ranging from 4.5 to 9.0, 
maintained at this for 1 h and returned to the assay pH of 6.6 without significant 
alteration of the DAG kinase activity (data not shown). Therefore, investigation of 
the appropriate pH for ion-exchange chromatography can proceed as the KCl- 
extracted DAG kinase has proven stable to incubation for 1 h in buffer of pH 
ranging from 4.5 to 9.0 without detectable loss of activty.
In preparation for ion-exchange chromatography the KCl-extracted protein 
preparation was dialysed against buffer of reduced KCI concentration. Extensive 
dialysis of the KCl-extracted protein preparation against buffer containing 1.0 mM 
KCI (buffer D) resulted in considerable loss of DAG kinase activity from solution. 
Measurement of the DAG kinase activity remaining soluble after centrifugation 
(20,000 x g ,, 30 min, 4°C) of the dialysate revealed that only 13.4 ± 7.0 % of the 
KCl-extracted enzyme remained in solution. The possibility that a proportion of the 
KCl-extracted DAG kinase had precipitated during dialysis was indicated by the 
recovery of 38.1 ± 16.2 % of the KCl-extracted activity in the insoluble material 
collected by centrifugation of the dialysate. Although this did not represent a 
quantitative recovery of the DAG kinase activity lost from solution, it did indicate 
that a significant proportion of the KCl-extracted enzyme was rendered insoluble by 
reduction of the KCI concentration from 578 to 1.0 mM. It is felt likely that greater 
than 38.1 % of the KCl-extracted DAG kinase is present within the soluble material 
but cannot be accurately quantitated when present within a resuspended precipitate. 
Nevertheless, even in the absence of further information on the accuracy of 
determining DAG kinase activity within this insoluble material it is still clear that a 
significant proportion of the KCl-extracted DAG kinase is rendered insoluble by 
reduction of the KCI concentration.
3.4. KCI Maintains the KCl-Extracted DAG Kinase in Solution: KCI 
Concentration Dependence.
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The KCl-extracted protein preparation was dialysed against a range of KCI 
concentrations (1.0 mM - 0.6 M) and the DAG kinase activity remaining in solution 
measured. This range was selected as it would mimic the fall in KCI concentration 
experienced by the KCl-extracted protein in preparation for ion-exchange 
chromatography. Dialysis against 0.6 - 0.3 M KCI resulted in no KCl-dependent 
loss of DAG kinase activity from solution, although a KCl-independent loss was 
observed (Fig 3.2). Only 54.9 - 70.0 % of the KCl-extracted activity was 
recovered over the range 0.6 - 0.3 M KCI. Reduction of the KCI concentration 
below 0.3 M did, however, result in further loss of DAG kinase activity from 
solution in a KCl-dependent manner. Recovery of the KCl-extracted DAG kinase 
activity from dialysis decreased from 60.4 % at 0.3 M to 11.4 % at 1.0 mM KCI. 
Associated with this loss of activity from solution is an increase in the DAG kinase 
activity which can be measured in the insoluble material which forms on dialysis 
(Fig 3.2). It is therefore apparent that the KCl-extracted DAG kinase requires at 
least 300 mM KCI for continued solubility.
The nature of the KCl-independent loss of KCl-extracted DAG kinase 
activity during dialysis is unknown. This loss could possibly be due to the 
presence of proteolytic activity in the KCl-extracted protein preparation. 
Alternatively, this could indicate that a proportion of the KCl-extracted enzyme is 
insoluble on prolonged incubation in aqueous solution and cannot be maintained in 
solution by 0.3 - 0.6 M KCI. Indeed, DAG kinase activity is associated with the 
insoluble material recovered from dialysis of the KCl-extracted protein preparation 
against concentrations of KCI which maintain the KCl-dependent activity in 
solution, i.e. 0.3 M or greater (Fig 3.2). This insoluble activity does not represent 
a quantitative recovery of the enzyme activity lost from solution in a KCl- 
independent manner during dialysis. However, as discussed in Section 3.3, the 
DAG kinase activity present in the insoluble fraction may be underestimated. This 
possibility was not investigated further.
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Fig 3.2. KCI Concentration Dependence of the KCI-Extracted DAG 
K inase's Solubility.
KCl-extracted DAG kinase was prepared and centrifuged as described in Fig 3.6.
2.0 ml aliquots of the supernatant (2.0 mg protein) were dialysed against a range of 
KCI concentrations in dialysis buffer, as indicated. Dialysis was performed 
overnight against 2 x 500 ml volumes of buffer D supplemented with KCI as 
appropriate. The dialysates were clarified by centrifugation (100,000 xg, 1 h,
4°C). The supernatants were collected and the precipitates resuspended in 1.0 ml 
of dialysis buffer. DAG kinase activity and protein concentration were determined 
as described in Fig 3.1. DAG kinase activities are quoted as a percentage of the 
DAG kinase activity extracted from phospholipase C-treated membranes. This 
result is similar to an identical experiment, [open bars, soluble enzyme; hatched 
bars, insoluble enzyme]
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The non-ionic detergents Triton X-100, Nonidet P40 and Lubrol PX at final 
concentrations of both 0.1 and 0.01 % (w/v) did not resolubilise the KCl-extracted 
DAG kinase which precipitated on reductiuon of the KCI concentration below 300 
mM (data not shown). This was also found to be the case for the zwitterionic 
detergent Zwittergent 3-14 at 0.1% (w/v) and the anionic detergent sodium 
deoxycholate at final concentrations of 0.5, 0.2 and 0.02 % (w/v) (data not 
shown). At these concentration none of the above detergents significantly increased 
the DAG kinase activity in solution nor apparently decreased the enzyme present in 
the insoluble material on reduction of the KCI concentration below 300 mM. This 
range of detergents under similar conditions was also unable to prevent the KC1- 
soluble enzyme from precipitating on reduction of the KCI concentration below 300 
mM by dialysis (data not shown). Therefore, in conclusion, the membrane- 
associated DAG kinase solubilised from phospholipase C-treated rat brain 
membranes by incubation with 578 mM KCI must be maintained in the presence of 
0.3 M or greater KCI for continued solubility of the enzyme and this requirement 
for 300 mM KCI cannot be replaced by detergent.
3.5. Purification of the KCl-Extracted DAG Kinase by Precipitation.
The ability to precipitate the KCl-extracted DAG kinase in an active state 
identified the possibility of exploiting the enzyme's solubility in increasing 
concentrations of KCI as a purification method. The enzyme could be precipitated 
by dialysis against KCl-free buffer and then selectively resolubilised from the 
insoluble material by increasing concentrations of KCI.
Extensive dialysis against 1.0 mM KCI (buffer D) resulted in the loss of
85.0 - 94.1 % of the KCl-extracted DAG kinase activity from solution (six 
determinations). Resuspending the insoluble material which formed in buffer of 
increasing concentrations of KCI resulted in a KCl-dependent increase in the 
soluble DAG kinase activity which was recovered (Fig 3.3A). Incubation of the 
insoluble material in 1.0 - 300 mM KCI resulted in an increase in the amount of
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A. Recovery of DAG kinase Activity From Insoluble Material Formed on Dialysis.
B. Fold-Purification of DAG kinase Activity Resolubilised From Hypotonic
Precipitate.
KCl-extracted DAG kinase was prepared and centrifuged as described in Fig. 3.6. 
The KCl-extracted protein (14.4 mg, 41 ml) was dialysed against 2 x 5 1  volumes 
of buffer D and the dialysate clarified by centrifugation (100,000 xg, 1 h, 4°C). 
The precipitate was resuspended in 9.0 ml of buffer D. 1.0 ml aliquots of the 
suspension were corrected to 5.0 ml KCI in buffer D to form a concentration range
1.0 mM - 0.4 M, as indicated. The insoluble material pelleted by centrifugation 
(100,000, 1 h, 4°C) after the suspensions had been incubated on ice for 1 h with 
frequent mixing. The supernatant was collected and the pellet resuspended in 1.0 
ml of buffer D supplemented with KCI, as appropriate. DAG kinase activity was 
determined as described in Fig 3.1 and protein concentration measured by the 
Coomassie dye method (Section 2.2.3). Fold-purification was calculated as the 
increase in DAG kinase specific activity relative to the KCl-extracted protein 
preparation.
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DAG kinase resolubilised. The activity resolubilised increased from 4.3 ± 0.2 % to 
59.6 ± 6.7 % (relative to the KCl-extracted enzyme preparation) as the KCI 
concentration increased from 1.0 to 300 mM (Fig 3.3A). Incubation of the 
precipitated protein with greater than 300 mM KCI resulted in no further significant 
increase in DAG kinase activity recovered from the insoluble material (data not 
shown).
Purification of the KCl-extracted DAG kinase by this 
precipitation/resolubilisation procedure required resuspension of the precipitated 
protein in buffer containing 200 mM or greater KCI (Fig 3.3B). Incubation of the 
precipitated protein in solutions with lower than 200 mM KCI produced a 
resolubilised enzyme preparation with lower specific activity than the KCl-extracted 
protein. Thus, resolubilisation of the precipitated enzyme in buffer containing less 
than 200 mM KCI does not result in a net purification of the KCl-extracted DAG 
kinase (Fig 3.3B). However, elevation of the KCI concentration to 200 mM or 
greater did result in purification of the KCl-extracted enzyme (Fig 3.3B). The 
purification was greatest at 300 mM. Further increasing the KCI concentration 
from 300 mM to 600 mM did not result in any further increase in purification of the 
KCl-extracted activity (data not shown). In summary, dialysing the KCl-extracted 
protein preparation against 1.0 mM and resuspending the insoluble material which 
formed in 300 mM KCI resulted in a 1.76- to 2.54-fold purification of DAG kinase. 
The yield of enzyme activity recovered from this procedure was equivalent to 
between 48.5 and 59.6 % of that solubilised from the phospholipase C-treated 
membranes (n = 3).
It should be noted that 5.9 - 15.0 % of the KCl-extracted DAG kinase 
activity could not be removed from solution by extensive dialysis against 1.0 mM 
KCI. It would appear that the KCl-extracted enzyme preparation also contains a 
DAG kinase activity which remains soluble in the absence of 300 mM KCI, i.e. a 
KCl-independent DAG kinase. Exploitation of their different solubilities in reduced 
concentrations of KCI allows separation of the KCl-independent DAG kinase from
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DAG Kinase-Enriched Particulate Fraction
Incubate in 578 mM KCI
Centrifuge
Collect Supernatant
▼
KCl-Extracted DAG Kinase
Dialyse Against KCl-Free Buffer 
Centrifuge
Collect Pellet
Supernatant Resuspend in Buffer 
Containing 300 mM KCI
KCl-independent DAG Kinase KCl-Soluble DAG Kinase
Fig 3.4. Separation of the KCI-Soluble and KCI-Independent DAG Kinases of 
Rat Brain Membranes: A Schematic Diagram.
the enzyme that does require KCI for solubility, i.e. the KCl-soluble DAG kinase. 
Therefore, in addition to providing a modest purification of the KCl-extracted DAG 
kinase the precipitation/resolubilisation procedure also allows fractionation of the 
KCl-extracted DAG kinase activity into KCl-independent and KCl-soluble 
enzymes.
3.6. KCI Maintains the KCl-Extracted DAG Kinase in Solution: 
D iscu ss io n .
It is clear that incubation of a phospholipase C-treated particulate fraction 
prepared from rat brain in buffer containing 578 mM KCI affects solubilisation of a 
considerable proportion of the membrane-associated DAG kinase. It is now also 
apparent that the solubilised DAG kinase activity is composed of two components; 
1) a DAG kinase activity which remains freely soluble in the absence of greater than
1.0 mM KCI and 2) a DAG kinase activity which requires greater than 1.0 mM KCI 
to remain soluble with its KCl-dependent solubility being maximal in the presence 
of 300 mM or greater KCI. For the purposes of this thesis these enzymes have 
been refered to as the KCl-independent and the KCl-soluble DAG kinases 
respectively. It has also been possible to exploit these differential solubilities in 
solutions of reduced KCI concentration to separate the KCl-independent DAG 
kinase from the KCl-soluble enzyme (Fig 3.4). This has led to the development of 
a precipitation/resolubilisation procedure which apart from fractionating these 
enzymes also allows a modest purification of the KCl-soluble DAG kinase (Section 
3.3).
The observation of a requirement for the continued presence of KCI (or salt 
in general) to maintain a DAG kinase in solution is novel and unique to the work 
reported in this thesis. Subsequent to preparing salt-solubilised fractions from rat 
brain, both Besterman et al. (1986b) and Kato and Takenawa (1990) purified 
membrane-associated DAG kinase by strategies which include dialysis against salt- 
free buffer. In both these reports the solubility of the membrane-associated DAG
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kinases does not require the presence of greater than 1.0 mM concentrations of salt 
for continued solubility. Therefore, it can be concluded that both these reports are 
concerned with the KC1-independent DAG kinase and not the KCl-soluble enzyme 
which is described in Sections 3.3 & 3.4.
It may be possible that other workers have experienced a loss of a KCl- 
soluble DAG kinase. Prior to chromatography of the membrane-associated enzyme 
on AffiGel Blue, Kato and Takenawa (1990) determined the yield of DAG kinase 
activity solubilised from rat brain membranes by incubation with 2.0 M NaCl as 
only 39.3 %. Yet Coco Maroney and Macara (1989) reported that 78 % of the 
membrane-asssociated DAG kinase was solubilised from rat brain membranes by 
incubation with 0.5 M NaCl. This could indicate that Kato & Takenawa (1990) 
experienced a substantial loss of NaCl-extracted DAG kinase during dialysis against 
NaCl-free buffer in preparation for AffiGel blue chromatography? This would be 
analagous to the loss of KC1-extracted DAG kinase activity on dialysis against 
buffer containing 1 mM KC1 (Section 3.1 & 3.3) as only 5.9 - 15 % of the 
solubilised enzyme remains in solution on dialysis, yet 55.3 - 87.1% of the 
membrane-associated enzyme is solubilised on incubation with 578 mM KC1. 
Regardless of this possibility, the data in Sections 3.3. & 3.4 is the first report of a 
membrane-associated DAG kinase from rat brain which retains a requirement for at 
least 300 mM KC1 for continued solubility.
Further purification of the rat brain membrane-associated DAG kinase 
concentrated on the KCl-soluble enzyme alone. Characterisation of its KC1 
dependence for continued solubility allowed the development of a KC1 dependent 
precipitation/resolubilisation purification procedure. Furthermore, the use of this 
precipitation step in the purification of DAG kinase was adopted in view of both its 
relative ease of use and also the defined environment of the resulting DAG kinase 
preparation. The KCl-soluble DAG kinase is thus present in 300mM KC1, the 
lowest KCl concentration that reproducibly conferred full solubility to the enzyme.
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This removed the need for further desalting of the preparation prior to 
chromatography.
3.7. AffiGel Blue Chromatography.
AffiGel Blue, a dye-ligand matrix, belongs to the family of immobilised 
triazine dyes that have been effectively employed in the purification of lipoproteins, 
serum albumin and nucleotide-requiring enzymes (for review see Lowe and 
Pearson, 1984). With a possible application to the purification of DAG kinases as a 
whole, the chromatographic behavior of the KCl-soluble DAG kinase on AffiGel 
Blue was investigated.
KCl-soluble DAG kinase activity was found to reproducibly bind AffiGel 
Blue in the presence of the 300 mM KC1 at pH 6.5. Once bound, the DAG kinase 
activity could be effectively eluted by increasing the KC1 concentration of the 
chromatography buffer. The KCl-soluble DAG kinase eluted throughout a 0.3 -
2.0 M KC1 gradient with the activity peaking between 0.9 - 1.2 M (data not 
shown). The inability of the linear KC1 gradient to resolve DAG kinase from the 
other proteins eluting from the column suggested no benefit in its use compared to a 
step gradient. Therefore, elution by a 0.3 to 1.0 M KC1 step-gradient was selected 
for routine purification of the KCl-soluble DAG kinase (Fig 3.5). As the step 
gradient resulted in the elution of DAG kinase a a sharp peak of activity it facilitated 
the recovery of the enzyme in a far smaller volume than would be achieved by a 
linear gradient. Further increasing the KC1 concentration of the chromatography 
buffer from 1.0 to 2.0 M resulted in no further elution of DAG kinase activity (Fig 
3.5). Thus, the 0.3 to 1.0 M KC1 step gradient would appear to have efficiently 
removed all the bound DAG kinase activity from the AffiGel Blue column. Using 
this approach, the KCl-soluble DAG kinase was purified 1.29- to 1.94-fold across 
the column with a 50.6 - 94.2 % yield of activity (from four independent 
preparations, see Table 1).
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Fig 3.5. AffiGel Blue Chromatography of the KCl-SoIuble DAG 
K in ase.
The KCl-soluble DAG kinase (79.0 mg protein, equivalent to 104 rats) was 
prepared as described in Section 2.6.1. The KCl-soluble protein preparation was 
applied to a 60 ml (2.6 x 11.3 cm) column of AffiGel Blue prepared and 
equilibrated in buffer F. The column was washed with buffer F to remove loosely 
bound proteins and developed with step gradients of 0.3 - 1.0 M KC1 followed by
1.0 - 2.0 M KC1 in buffer F (— ). 6.4 ml fractions were collected and assayed for 
DAG kinase activity (-•-) as described in Section 2.4.2. The protein concentration 
of the column eluant was measured by absorption at 280 nm (solid line). Fractions 
containing DAG kinase activity (fractions 92-151) were pooled. (N.B. the pH of 
buffer F was found to remain at 6.5 during chromatography under the above 
conditions)
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Despite the reported use of immobilised triazine dyes in the purification of 
many nucleotide-requiring enzymes (see Stellwagon et al., 1990), purification of 
DAG kinases based on the exploitation of their requirement for ATP has mainly 
centred on the use of immobilised ATP in the form of ATP-agarose (Kanoh and 
Ohno, 1981; Kanoh et al., 1983; Lin et al., 1986; Sakane et al., 1989; Kato & 
Takenawa, 1990; Schaap et al., 1990; Yada et al., 1990). Although Kato and 
Takenawa (1990) did employ AffiGel Blue in the initial fractionation of rat brain 
cytosolic protein during purification DAG kinase I (their notation) to homogeneity, 
they did not further exploit the nature of the interaction between the nucleotide- 
requiring enzyme and the dye-matrix. Elution of DAG kinase by washing the 
AffiGel Blue column with adenosine nucleotides, e.g. ATP, may possibly have 
resulted in greater fold-purification of the enzyme than was achieved by NaCl 
elution. Indeed, if the KCl-soluble DAG kinase binds AffiGel Blue via its 
nucleotide binding site, elution of the enzyme by ATP and other nucleotides could 
possibly result in increased purification of the enzyme across this column. To date, 
this possibility has not been investigated.
3.8. Hydrophobic Interaction Chromatography.
The need to include 300 mM KC1 in all chromatography buffers prevented 
the use of ion-exchange at pH 6.5, whereas the binding of the KCl-extracted DAG 
kinases to hydrophobic interaction chromatography (HIC) media would be 
enhanced by its inclusion. Therefore, the feasibility of employing a HIC separation 
step in the purification protocol was investigated.
Phenyl-Sepharose CL-4B, octyl-Sepharose CL-4B, methyl-agarose, butyl - 
agarose and butyl-Sepharose 4B were screened for the ability to bind KCl-extracted 
DAG kinase activity in the presence of 1.0 M KC1 at pH 6.5. Of these, the KCl- 
extracted activity was only observed to bind phenyl-Sepharose CL-4B and octyl- 
Sepharose CL-4B (data not shown). Reduction of the KC1 concentration from 1.0 
to 0.3 M did not elicit the elution of the KCl-extracted DAG kinases activity from
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either of these matrices. Elution from either phenyl- or octyl-Sepharose CL-4B 
was found to require both reduction of the KC1 concentration to 0.3 M and 
inclusion of 30 - 60 % (v/v) ethanediol in the chromatography buffer (data not 
shown).
The inclusion of 0.02 % (w/v) Triton X-100 in buffers employed during 
phenyl-Sepharose CL-4B chromatography resulted in an altered elution pattern of 
DAG kinase activity from the HIC matrix. Previously, DAG kinase was found to 
reproducibly elute from phenyl-Sepharose CL-4B with concentrations of between 
30 and 50 % (v/v) ethanediol in the presence of 0.3 M KC1 (data not shown). The 
incorporation of 0.02 % (v/v) Triton X-100 in the buffers employed during phenyl- 
Sepharose CL-4B chromatography resulted in the elution of DAG kinase from the 
HIC matrix on reduction of the KC1 concentration from 1.0 to 0.3 M alone, without 
the inclusion of ethanediol. Therefore, an optimised procedure for the use of 
phenyl-Sepharose CL-4B in the presence of Triton X-100 was employed in the 
purification protocol. KCl-soluble DAG kinase was applied to the phenyl- 
Sepharose CL-4B in the presence of 1.0 M KC1, 0.02 % (w/v) Triton X-100 in 
buffer E and the DAG kinase was eluted in a single peak of activity by introducing 
ethanediol to the chromatography buffer at a final concentration of 40 % (v/v) 
whilst reducing the KC1 concentration to 0.3 M (Fig 3.6). No further DAG kinase 
could be eluted from the phenyl-Sepharose CL-4B on raising the ethanediol 
concentration of the elution buffer to 50 % (v/v).
The fold-purification achieved by this optimised elution procedure was 
increased to some extent by the use of a butyl-Sepharose 4B pre-column in series 
with the the phenyl-Sepharose CL-4B (Fig 3.6). In the presence of 1.0 M KC1, the 
butyl-Sepharose 4B column bound up to 25 % of the protein present in the post- 
AffiGel blue enzyme preparation without binding any DAG kinase activity. On 
disconnection of the butyl-Sepharose 4B pre-column, DAG kinase could be eluted 
from the phenyl-Sepharose CL-4B column with higher specific activity than that 
observed without the use of the pre-column.
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Fig 3.6. Hydrophobic Interaction Chromatography of the KCI- 
Soluble DAG Kinase: Chromatography on a Butyl-Sepharose 
4B/Phenyl-Sepharose CL-4B Column Combination Run in Series.
A 7.5 ml (1.3 x 5.7 cm) column of butyl-Sepharose 4B was connected upstream of 
a 15 ml (1.6 x 7.5 cm) column of phenyl-Sepharose CL-4B, both columns had 
been prepared and equilibrated in buffer G as described in Section 2.6.2. The 
pooled DAG kinase preparation from AffiGel Blue chromatography (43.2 mg 
protein, 360 ml) was applied to the column combination and the columns washed 
with buffer G to remove loosely bound protein (fractions 117-131). The butyl- 
Sepharose 4B column was disconnected and the phenyl-Sepharose CL-4B 
developed with 20mM Tris/HCl pH 6 .5 ,300mM KC1, lOmM MgCl2, 2mM 
EDTA, 2mM p-mercaptoethanol, 40% (v/v) ethanediol, 20% (v/v) glycerol,
0.2mM PMSF, lpM  E64, lpM  pepstatin A (N.B. The pH of this buffer was found 
to remain at 6.5 during chromatography). 4.0 ml fractions were collected and 
assayed for DAG kinase activity (-•-) by the deoxycholate/phosphatidylserine 
dispersion assay (Section 2.4.2). The protein concentration of the column eluant 
was monitored at 280 nm (solid line). Fractions containing DAG kinase activity 
(fractions 136-156) were pooled. [---- , KC1 concentration].
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In summary, after characterisation of HIC, it proved extremely difficult to 
effect further significant purification of membrane-associated DAG kinase by this 
method. Recovery of DAG kinase after combined butyl-Sepharose 4B/phenyl- 
Sepharose CL-4B chromatography was measured to be only 29.6 % , with 0.7-fold 
purification of the enzyme over these columns. Therefore, at best, HIC 
chromatography could be employed in the purification protocol as a concentration 
step.
3.9. Gel Filtration Chromatography.
The ability to further purify the KCl-soluble DAG kinase by gel filtration 
chromatography of the post phenyl-Sepharose CL-4B preparation on Sephacryl S- 
300 SF was investigated.
The pooled post phenyl-Sepharose CL-4B DAG kinase preparation was 
concentrated by dialysis against polyethyleneglycol 6000 and subjected to gel 
filtration chromatography on a 1.6 x 90 cm column of Sephacryl S-300 SF (Fig 
3.7). DAG kinase activity eluted from the Sephacryl S-300 SF column as a single 
peak of activity. The peak typically eluted in a volume of 94.0 to 97.0 ml of buffer 
(from four determinations). After determination of the column's v0 value from the 
elution of blue dextran 2000, the DAG kinase's elution volume was calculated to 
correspond to v j \ 0 values ranging between 1.41 and 1.46. Comparison of DAG 
kinase's elution volume to those of standard proteins of known molecular weight 
allowed calculation of the native molecular weight of DAG kinase (Fig 3.8). The 
native molecular weight of the KCl-soluble DAG kinase was calculated to be 160 ± 
10 kDa (mean ± 1 SD, n = 4), with determined values ranging from 175 kDa to 150 
kDa.
Sephacryl S-300 SF gel filtration chromatography typically resulted in 0.50- 
to 2.26-fold purification of the post AffiGel Blue preparation with only 13.2 to 
38.5 % yield of activity (n = 4). However, SDS-PAGE analysis of the protein
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Fig 3.7. Sephacryl S-300 SF Gel Filtration Chromatography of the 
KCl-Soluble DAG Kinase.
The DAG kinase preparation (13.2 mg protein) pooled from hydrophobic 
interaction chromatography, as described in Fig 3.6, was concentrated to 8.0 ml by 
dialysis against 50 % (w/v) polyethylene glycol 6000 in buffer F. The dialysate 
was applied to a 180 ml (1.6 x 90 cm) column of Sephacryl S-300 SF equilibrated 
buffer H as described in Section 2.6.3. The column was developed with buffer H 
and the protein concentration of the eluant monitored at 280 nm {solid line). 3.0 ml 
fractions were collected and assayed for DAG kinase activity (-•-) by the 
deoxycholate/phosphatidylserine dispersion assay (Section 2.4.2). The fractions 
containing DAG kinase activity (fractions 26-39) were pooled.
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Fig 3.8. Calibration Curve of the Sephacryl S-300 SF Gel Filtration  
Colum n.
The 180 ml (1.6 x 90 cm) column of Sephacryl S-300 SF employed in Fig 3.7 was 
equilibrated in buffer H. Protein standards (8 - 16 mg) or post HIC DAG kinase 
preparation were applied to the column in 8.0 ml and the column developed with 
buffer H at a flow rate of 8.0 ml/h. The void volume (vG) of the column was 
determined from the elution of blue dextran 2000 monitored at 280 nm. The elution 
of ferritin (440 kDa), aldolase (158 kDa), bovine serum albumin (67 kDa), 
chymotrypsinogen (25 kDa), soybean trypsin inhibitor (20.1 kDa) and cytochrome 
(16.5 kDa) from the column were also monitored at 280nm and their elution volume 
(ve) determined. The ve of the KCl-soluble DAG kinase was determined for the 
elution of DAG kinase activity from the column (see Fig 3.7). The apparent 
molecular weight of the KCl-soluble DAG kinase was calculated from the 
calibration curve of logMW against ve/vD.
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populations before and after Sephacryl S-300 SF chromatography revealed them to 
be quite different (Fig 3.11). Thus, the low fold-purifications across the gel 
filtration column may result from the enzyme's lability rather than the inability of 
Sephacryl S-300 SF to fractionate protein. Despite the poor yield and low level of 
purification across this column, it was retained in the purification protocol because 
of its additional ability to remove the ethanediol and Triton X-100 present in the 
post HIC DAG kinase preparation. DAG kinase activity had previously been 
observed to be inhibited by the presence of either Triton X -100 or ethanediol at 
concentrations greater than 0.01 % (v/v) and 5 % (v/v), respectively (data not 
shown). Therefore, it was advantageous that the KCl-soluble DAG kinase to be 
exchanged into ethanediol-free buffer of defined Triton X-100 concentration.
Fold-purification could be improved by reducing the volume of the post 
HIC DAG kinase preparation applied to the gel filtration column. In the present 
purification protocol the pooled protein preparation from the HIC step is loaded in a 
volume equivalent to 4.4 % of the column bed volume (8.0 ml). Further 
concentration of the DAG kinase preparation towards a volume equivalent to 1.0 % 
of the column bed volume could have increased the resolution of the individual 
proteins in the DAG kinase preparation. This was not undertaken due to concern 
about the recovery of protein and DAG kinase activity on concentration to volumes 
of less than 8.0 ml by dialysis against polyethyleneglycol 6000 (Section 2.8.2).
The possibility of increasing the fold-purification across the Sephacryl S-300 SF 
column by further reducing the volume of protein applied to it is attractive. 
Examination of the protein preparation pooled from the Sephacryl S-300 SF column 
by SDS-PAGE reveals that it consists of polypeptides with widely variant 
molecular masses (ranging from 100 kDa to less than 29 kDa, see Fig 3.11). As 
the KCl-soluble DAG kinase elutes from Sephacryl S-300 SF with an apparent 
molecular mass of 160 kDa (see above) it would appear that increasing the 
resolution of the column by reduction of its load volume could increase the fold- 
purification across the column. However, examination of the post HIC and post
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gel filtration DAG kinase preparations by SDS-PAGE reveals that the protein 
molecular mass distribution does not markedly alter on gel filtration, although the 
composition does. This confirms that size fractionation is occurring, although 
many smaller polypeptides elute with an apparent molecular mass of 160 kDa. 
Therefore, it is unlikely that reduction of the gel-filtration load volume will 
significantly increase the fold-purification achieved on Sephacryl S-300 SF.
The native molecular weight of the KCl-soluble DAG kinase was 
determined by gel filtration on Sephacryl S-300 SF to be 160 kDa (see above).
This value is similar to the 150 kDa molecular weight reported for the membrane- 
associated DAG kinase previously purified from rat brain by Kato and Takenawa 
(1990). These workers estimated this value from SDS-PAGE analysis of the 
purified protein and did not determine a native molecular weight by gel filtration. 
However, as the purified protein resolved as a single band on SDS-PAGE it was 
possible to assume that the native molecular weight was 150 kDa, although, this 
does assume that the protein does not exist a multimeric complex consisting of 
similar subunits in the native state. This conclusion also assumes that the protein 
does not migrate anomalously with respect to molecular weight on SDS-PAGE. 
Despite the native molecular weight of the KCl-soluble DAG kinase being 
determined as 160 kDa, the subunit structure of the protein has still to be 
determined. Thus, the KCl-soluble DAG kinase may not resolve as a single 
polypeptide of molecular mass 160 kDa on SDS-PAGE. Additionally, within the 
error of the methods used, it cannot be concluded that the KCl-soluble DAG kinase 
is of identical molecular mass to the enzyme purified by Kato and Takenawa 
(1990).
High resolution gel filtration by HPLC could possibly be employed as a 
preparative step in the latter stages of the purification protocol where its increased 
resolution over low-pressure gel filtration may be beneficial. Preparations of the 
KCl-soluble DAG kinase from various stages of the purification protocol were 
subjected to gel-filtration chromatography on a TSK-G 3000SW (7.5 x 600 mm)
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column using a Pharmacia HPLC apparatus. DAG kinase activity from all stages of 
the purification protocol proved to be highly labile. No measurable amount of 
activity eluted from the column, despite its correct functioning as assessed by 
elution of protein standards (data not shown). The reason for the lability of the 
KCl-soluble DAG kinase activity on this column compared its stability on 
Sephacryl S-300 SF is unknown and prevented further use of this method as either 
an analytical or preparative step.
3.10. H eparin-Agarose Chromatography.
The nature of interaction of proteins with heparin-agarose is still a matter of 
some contention. Chromatography on heparin-substituted agaroses consists of 
both an ion-exchange process between protein and the immobilised polyanion and 
also an undefined binding process that is independent of such a cation-exchange 
process. Nevertheless, immobilised heparin has been successfully employed in the 
purification of DNA-binding proteins, kinases, lipases and phospholipases. These 
include a receptor and G-protein regulated polyphosphoinositide-specific 
phospholipase C from turkey erythrocytes (Morris et al., 1990), a 
phosphoinositide-specific phospholipase C from bovine liver membranes (Taylor et 
al., 1990) and an inositol (l,3,4,5)-tetrakisphosphate 3-phosphatase from rat liver 
(Nogimori et al., 1991). With reference to its application to DAG kinases, heparin- 
agarose has been employed in the purification of both the 150 kDa heat-stable DAG 
kinase of porcine thymus cytosol (Sakane et al., 1989) and the cytosolic DAG 
kinases of human platelets (Yada et al., 1990). Additionally, it has successfully 
resolved DAG kinase isoenzymes present in both rat brain and NIH 3T3 fibroblast 
cytosol (Strathopoulos et al., 1990).
The DAG kinase activity present in the post gel filtration preparation was 
found to bind to heparin-agarose in the presence of 0.3 M KC1 at pH 6.5 (Fig 
3.10). The KCl-soluble DAG kinase was routinely eluted as a single peak of 
activity from heparin-agarose by a linear gradient of 0.3 -1.3 M KC1. This peak
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Fig 3.9. Heparin-Agarose Chromatography of the KCl-Soluble DAG  
K inase.
The DAG kinase preparation pooled from Sephacryl S-300 SF chromatography 
(12.4 mg protein, 48.0 ml) was applied to a 7.0 ml (1.0 x 8.9cm) column of 
heparin-agarose (type 1) prepared and equilibrated in buffer H. The column was 
washed with buffer H and developed with an 182 ml linear gradient of 0.3 - 1.3 M 
KC1 prepared in the same buffer. The protein concentration and DAG kinase 
activity of the column eluant was determined as described in Fig 3.7. Fractions 
containing DAG kinase activity (fractions 36 - 46) were pooled.
(-•- , DAG kinase activity; — , KC1 concentration; solid line, A28o)-
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was typically found to elute at a position in the gradient equivalent to 0.4 - 0.5 M 
KC1. Routinely, heparin-agarose chromatography of the post gel filtration enzyme 
preparation resulted in the 2.22- to 4.69-fold purification (n = 4). Recovery of the 
activity applied to the heparin-agarose column varied between 40.0 and 97.5 % (n = 
4). Heparin-agarose was further employed in the purification of the KCl-soluble 
DAG kinase as its use had resulted in moderate fold-purification of the enzyme with 
reasonable recovery of activity.
Why the KCl-soluble DAG kinase should bind heparin-agarose in the 
presence of 0.3 M KC1 at pH 6.5 is unknown. It is doubtful if the interaction is of 
simple ionic nature as the KCl-dependent DAG kinase does not bind the cation- 
exchange media SP-Sephadex C-50 under similar conditions (data not shown). 
Despite this, a complex ionic interaction may be occurring with the polyanionic 
heparin. Alternatively, the multiple sulphonyl moieties of the immobilised heparin 
molecule may allow the kinase to bind in a manner similar to its interaction with the 
polyanionic triphosphate moiety of ATP. If kinases interact with immobilised 
heparin via their nucleotide binding sites in a manner similar to affinity 
chromatography, the high degree of purification often observed with such proteins 
on heparin-agarose may be explained.
3.11. Hydroxyapatite Chromatography.
The possibility of further purification of the post heparin-agarose DAG 
kinase preparation by hydroxyapatite chromatography was assessed. Proteins 
adsorbed to a hydroxyapatite chromatography matrix can be specifically eluted on 
the basis of their isoelectric point. Gorbunoff (1990) summarised procedures that 
allow specific elution of basic, acidic and neutral proteins. Systematic disruption of 
the complex electrostatic interaction between the proteins' amino and carboxyl 
groups and the charged calcium and phosphate of the hydroxyapatite crystal surface 
facilitates separation of proteins based on their isoelectric point. Moreover, 
chromatography on hydroxyapatite has been successfully employed in several DAG
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Fig 3.10. Hydroxyapatite Chromatography of the KCl-soluble DAG  
K in ase .
A 5.0 ml (1.0 x 6.4 ml) column of hydroxyapatite (BioGel HTP)prepared and 
equilibrated buffer I as described in Section 2.6.5. The DAG kinase preparation 
pooled from heparin-agarose (2.7 mg protein, 35 ml) was applied to the column 
and the column was washed with buffer I followed by 5 column volumes of 1.0 M 
KC1, 10 mM MgCl2 in buffer I {open bar). Finally, the column was washed with
12.0 ml of buffer I and developed with an 150 ml linear gradient of 0.0 to 0.5 M 
potassium phosphate, pH 6.5, in buffer I. The DAG kinase activity and the protein 
concentration of the column eluant were determined as described in Fig 3.7. 2.0 ml 
fractions were collected and fractions containing DAG kinase activity pooled
(fractions 45 - 58; 2.1 mg protein, 33.0 ml). DAG kinase activity; ,
potassium phosphate concentration; solid line, A280]
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kinase purifications (Kanoh and Ono, 1984; Kato & Takenawa, 1990; Yada et al., 
1990).
Partially purified DAG kinase activity, pooled after heparin-agarose 
chromatography, was found to bind hydroxyapatite (BioGel HTP) in the presence 
of 0.3 M KC1 at pH 6.5 (data not shown). Bound DAG kinase activity was 
retained on the column during washing with either 10 mM M gC ^or 1.0 M KC1 in 
buffer D. It did, however, elute during washing with 0.3 M potassium phosphate, 
pH 6.5 (data not shown). From this information, a protocol for the elution of KCl- 
soluble DAG kinase was constructed (Fig 3.10). The protocol employed washing 
the column with a combined 10 mM MgCl2, 1.0 M KC1 step gradient in buffer D, 
to selectively elute basic and neutral proteins from the hydroxyapatite, followed by 
a linear gradient of 0 - 0.5 M potassium phosphate in buffer D to displace the DAG 
kinase. Reproducibly, the KCl-soluble DAG kinase eluted as a single peak of 
activity at a position in the gradient equivalent to 50 - 75 mM potassium phosphate. 
Typically, hydroxyapatite chromatography of KCl-soluble DAG kinase obtained 
from heparin-agarose resulted in 0.49- to 0.72-fold purification with 48.0 to 55.6 
% recovery of activity across the column. The use of hydroxyapatite 
chromatography to further purify the post heparin-agarose preparation of the KCl- 
soluble DAG kinase is a matter for review. The inability of preparative scale 
columns to provide the purification previously recorded with pilot-scale 
experiments may require hydroxyapatite chromatography to be ommitted from the 
purification protocol in future.
3.12. Purification of the KCl-SoIuble DAG Kinase: A Summary.
At the completion of the work towards this thesis, the following rationalised 
protocol was employed in the routine partial purification of the KCl-soluble DAG 
kinase. The order of the individual steps are as follows: phospholipase C-catalysed 
enrichment of rat brain particulate fraction with DAG kinase activity, KC1-extraction 
of the membrane-associated DAG kinase from the phospholipase C-treated
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particulate fraction, fractionation of the KCl-soluble DAG kinase from the KC1- 
independent enzyme by KCl-dependent precipitation/resolubilisation, AffiGel Blue 
chromatography, combined butyl-Sepharose 4B and phenyl-Sepharose CL-4B 
hydrophobic interaction chromatography, Sephacryl S-300 SF gel filtration 
chromatography, heparin-agarose chromatography, and finally hydroxyapatite 
chromatography on BioGel HTP.
Partial purification of the KCl-soluble DAG kinase has been performed by 
the above protocol, as far as the heparin-agarose chromatography step, on four 
separate occaisions with similar results. The DAG kinase recovered from each step 
was pooled an analysed by SDS-PAGE (Fig 3.11). A typical purification summary 
is given in Table 1. The above purification protocol, employed as far as the 
heparin-agarose separation, results in 27.0- to 59.7-fold purification of the KCl- 
soluble DAG kinase relative to the total membrane-associated activity, with 0.6 to 
1.3 % yield of activity. The resulting post heparin-agarose preparations were 
measured to have specific activities ranging from 44.1 to 116.0 nmol PtdOH 
formed/min/mg. Further purification of the post heparin-agarose DAG kinase by 
hydroxyapatite chromatography has been achieved (Fig 3.11). However, the post 
heparin-agarose enzyme was measured to be 0.55- to 0.81-fold purified by 
hydroxyapatite chromatography. This decrease in fold-purification is most likely to 
result both from the lability of the partially purified protein and the problems 
associated with accurate quantitation of the protein.
The fractions obtained from hydroxyapatite chromatography which 
contained DAG kinase activity were analysed by SDS-PAGE (Fig 3.12). It is 
impossible to identify any single polypeptide which co-migrates with DAG kinase 
activity. There is also an absence of any polypeptide with molecular mass of 160 
kDa, the apparent native molecular mass of the KCl-soluble DAG kinase when 
determined by gel filtration chromatography (see Section 3.9).
In conclusion, the KCl-soluble DAG kinase is substantially purified, 
although not to homogeneity, by the above protocol. Several polypeptides obtained
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Fig 3.11. Purification of the KCl-soluble DAG kinase: SDS PAGE 
A n alysis .
The KCl-soluble DAG kinase was purified by the method summarised in Section
4.9. 20 pg of the DAG kinase preparation pooled from each step of the purification 
was analysed by SDS-PAGE on a 10 % gel, as described in Section 2.3, and silver 
stained by the method described in Section 2.3.7.
Lane 1: DAG kinase-enriched particulate fraction.
Lane 2: KCl-extracted protein preparation.
Lane 3: KCl-soluble protein preparation.
Lane 4: post AffiGel blue.
Lane 5: post hydrophobic interaction chromatography.
Lane 6: post gel filtration.
Lane 7: post heparin-agarose.
Lane 8: post hydroxyapatite
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Fig 3.12. SDS-PAGE of the Fractions Co-Purifying With DAG  
Kinase Activity During Hydroxyapatite Chromatography.
100 pi of each fraction co-eluting with DAG kinase activity from the hydroxyapatite 
column discussed in Fig 3.10 was analysed by SDS-PAGE. A 10 % gel was run 
as described in Section 2.3 and silver stained by the method described in Section
2.3.7. The DAG kinase activity contained in a 10 pi aliquot of each fraction is 
marked on each lane as appropriate. DAG kinase activity was measured as 
described in Fig 3.7.
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after heparin-agarose and hydroxyapatite chromatography are observed to be 
substantially purified from the phospholipase C-treated particulate fraction of rat 
brain by the above protocol (Fig 3.11) and the KCl-soluble DAG kinase remains to 
be identified. It is, however, notable that none of these polypeptides are observed 
to co-purify with DAG kinase activity on hydroxyapatite chromatography (Fig
3.12).
3.13. Purification of the KCl-Soluble DAG Kinase to Homogeneity:
A Discussion.
Despite considerable purification of the membrane-associated KCl-soluble 
DAG kinase, many polypeptides co-purified with the DAG kinase preparation 
recovered from heparin-agarose and hydroxyapatite chromatography (Fig 3.11). 
This indicates that further purification of the KCl-soluble DAG kinase is required. 
The KCl-soluble enzyme pooled after heparin-agarose chromatography possessed a 
specific activity of 103.4 nmol/min/mg (Table 1), a value 50-fold less than the Vmax 
(5.2 pmol/min/mg) of the membrane-associated DAG kinase previously purified to 
homogeneity from rat brain (Kato and Takenawa, 1990). Caution must be 
exercised when comparing DAG kinase reaction velocities determined by different 
assay methodologies. The above specific activity of the post heparin-agarose was 
determined by an «-octyl-p,D-glucopyranoside mixed micellar assay, whereas Kato 
and Takenawa (1990) employed a sodium deoxycholateAs?i-1,2-diacylglycerol 
dispersion method. It is now well documented that these methods support DAG 
kinase-catalysed phosphorylation of sn-1,2-diacylglycerol with widely different 
reaction velocities (Coco Maroney and Macara, 1989; Lemaitre et al., 1990). 
Similarly, the specific activity of the post heparin-agarose DAG kinase described in 
Table 1 was determined to be 794 nmol/min/mg when measured by the 
deoxycholate/PtdSer dispersion method described in Section 2.4.2. This value is 
over 7-fold greater than the 103.4 nmol/min/mg determined with the rc-octyl-p,D- 
glucopyranoside/PtdSer mixed micellar method (Section 2.4.3). This clearly
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indicates the problems associated with comparing DAG kinase specific activities 
when different assay methodology has been employed. Nevertheless, the protein 
preparation obtained after heparin-agarose chromatography represents a DAG 
kinase preparation purified 59.7-fold relative to the phospholipase C-treated 
membranes (Table 1). Yet Kato and Takenawa (1990) reported their homogeneous 
preparation of rat brain membrane-associated DAG kinase was 7410-fold purified 
compared to brain particulate fraction. Similarly, Besterman et al. (1986b) reported 
the 500- to 750-fold partial purification of the membrane-associated DAG kinase 
from phospholipase C-treated rat brain homogenate. From these reports it is clear 
that substantial further purification of the post heparin-agarose KCl-soluble DAG 
kinase is required if a homogeneous protein preparation is to be obtained. In order 
that the KCl-soluble DAG kinase could be purified to homogeneity, many 
purification strategies in addition to those discussed above could be employed.
The purification protocol, as summarised in Section 3.12, does not include 
a true ion-exchange separation. However, the existing purification protocol does 
employ heparin-agarose chromatography (see Section 3.10). In this case, ionic 
interaction may be occurring between the DAG kinase and the multiple sulphonyl 
groups of the immobilised heparin in the presence of 300 mM KC1 at pH 6.5. It is 
also possible that DAG kinase interacts with heparin by a mechanism still to be 
established, in a manner more similar to affinity than ion-exchange 
chromatography. This was found to be the case for the heat-stable 150 kDa DAG 
kinase of pig thymus (Sakane et al., 1989). During the purification of the 150 kDa 
DAG kinase Sakane and co-workers (1989) found the enzyme able to bind both 
anion-exchange media (DE 52) and heparin-Sepharose at pH 7.4. As the enzyme 
bound to both an anion-exchange and a heparin-Sepharose column at the same pH, 
it may be possible to conclude that the interaction of the enzyme with the 
immobilised heparin is by a process other than ion-exchange.
It would be highly desirable to include an ion-exchange separation in the 
purification of the KCl-soluble DAG kinase as it could add a further dimension to
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the purification of the enzyme. To date, the enzyme's requirement for 300 mM KC1 
has prevented the KCl-soluble DAG kinase from binding DEAE-cellulose (DE 52), 
QAE-Sephadex A-50 and SP-Sephadex C-50 at pH 6.5 (data not shown).
Reduction of the KC1 concentration below 300 mM would be required if an ion- 
exchange separation is to be successfully incorporated into the purification protocol. 
The exact nature of the KC1 requirement for solubility remains to be established. It 
is possible that the solubility of a protein with exposed hydrophobic surfaces may 
become more favourable in a solution of increased strength. Therefore, as the 
solvation of such a protein becomes more favourable it is less likely to aggregate 
with other amphiphilic proteins or precipitate. This may be especially pertinent to 
the proteins solubilised from rat brain particulate fraction by incubation with 578 
mM KC1. Such treatment solubilises non-integral membrane-associated proteins, 
i.e. proteins that are juxtaposed to the surface of the membrane. It would not be 
inconceivable that the protein surface normally associated with the phospholipid 
bilayer would possess some hydrophobic character. This is very likely to be the 
case for the KCl-soluble DAG kinase, whose function is to phosphorylate sn-1,2- 
diacylglycerol intercalated in the phospholipid bilayer. Although this may be a 
generalisation for all the proteins solubilised by KC1 treatment, it does seem that a 
considerable proportion of these proteins possess sufficient hydrophobic character 
to cause their precipitation in KCl-free buffer.
Detergents have proven unable to replace the 300 mM KC1 required to 
maintain the KCl-soluble DAG kinase in solution (Section 3.4.). It may be 
possible, however, to replace KC1 with another salt that would maintain the KCl- 
soluble DAG kinase in solution at concentrations below 300 mM. If successful, 
this could renew the possibility of ion-exchange chromatography. Consideration of 
the Hofmeister lyotrophic series of anions and cations would suggest that the use of 
a salt with an increased 'salting out' nature compared to KC1 may maintain DAG 
kinase in a fully soluble state at concentrations below 300 mM, e.g. (NH4)2SC>4, 
(NH4)3P 04 or ((CH3)4N)2S04.
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Additionally, if exposure of a hydrophobic surface is the cause of the 
protein's limited solubility in solution of low ionic strength, the addition of a co­
solvent to the protein solution could terminate the requirement for KC1. The 
introduction of polyhydric alcohols to the aqueous solution results in 'preferential 
hydration' of the protein molecule, a result of increased surface tension at the 
protein:solution interface (Gekko and Timasheff, 1981a, b; Lee and Lee, 1987). 
This elicits stabilisation of the protein's shell of hydration, resulting in maintenance 
of the protein in the soluble state. Therefore, the introduction of co-solvents such 
as ethanediol, propanediol, polyethyleneglycol, or sucrose may maintain the KCl- 
soluble DAG kinase in solution in the absence of KC1. Thus, the KCl-soluble 
DAG kinase could be applied to ion-exchange media under conditions that would 
not prevent the protein from binding.
Alteration of the pH that ion-exchange chromatography is performed at from 
pH 6.5 would enhance the possibility of the KCl-soluble DAG kinase binding an 
ion-exchange column in the presence of 300 mM. As discussed in Section , the 
activity of the KCl-extracted DAG kinase was stable on exposure to a pH ranging 
from 4.5 to 9.0 for 1 h. This indicates that this approach would not be impeded by 
instability of the KCl-soluble DAG kinase' activity in buffer of pH much altered 
from neutrality. It may therefore be possible to successfully apply an ion-exchange 
separation in the presence of 300 mM KC1, but only if the chromatography was 
undertaken at a pH much removed from the protein's pi value. Moreover, the 
possibility of the KCl-soluble DAG kinase binding ion-exchange media under such 
pH conditions would be further increased on reduction of the KC1 concentration at 
which chromatography was initiated. However, the success of this strategy again 
depends on the identification of a co-solvent that maintains the KCl-soluble DAG 
kinase's solubility in the presence of less than 300 mM KC1 (see above). The 
stability of the KCl-soluble enzyme on prolonged exposure to co-solvents and pH 
altered from 6.5 has still to be established.
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Cation-exchange chromatography on phosphocellulose P l l  could be re­
examined. The KCl-soluble DAG kinase had previously been found to bind 
phosphocellulose PI 1 in the presence of 300 mM KC1 at pH 6.5. This is notable as 
the KCl-soluble enzyme was unable to bind either QAE-Sephadex A-50 or SP- 
Sephadex C-50 under these conditions. However, phosphocellulose P l l  was not 
further employed in the purification protocol due to problems associated with its 
routine preparation and use in columns of 10 ml bed-volume or greater. These 
problems could be circumvented by employing a phospho-agarose cation-exchange 
medium. Alternatively, the phosphocellulose P l l  cation-exchange separation could 
be introduced at a later stage of the purification. During the latter stages of the 
purification a small bed-volume column of phosphocellulose P l l  would be 
sufficient, thus avoiding large bed-volume columns which had previously proven 
difficult to operate.
As reported in Section 3.7, AffiGel Blue binds the KCl-soluble DAG kinase 
in the presence of 300mM KC1 at pH 6.5. Once bound the DAG kinase activity 
was eluted from the dye-matrix by increasing concentrations of KC1 rather than by 
the use of ATP or other nucleotides. AffiGel Blue was initially considered for use 
in the purification of the KCl-soluble DAG kinase on the basis of dye-ligand 
matrices' ability to bind nucleotide-requiring enzymes. Thus, if the KCl-soluble 
DAG kinase binds via its nucleotide binding site, it would seem feasible to elute the 
bound enzyme by free nucleotides, especially ATP. Moreover, due to the selective 
nature of elution by free nucleotide compared to elution with increasing 
concentrations of KC1, greater purification of the kinase across AffiGel blue would 
result. However, ATP, ADP, AMP and adenosine were unable to displace the 
KCl-soluble DAG kinase from AffiGel Blue when employed at 2.0 mM (S. 
Gardner, personal communication). It would seem that the KCl-soluble enzyme 
does not bind the dye-matrix via a nucleotide binding site. Therefore, the resolution 
of the KCl-soluble DAG kinase gained on AffiGel Blue chromatography cannot be 
improved by the use of free nucleotide to displace the enzyme. This conclusion
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may be premature as the enzyme could elute on developing the column with 
concentrations of nucleotide and nucleoside greater than 2.0 mM.
Subsequent to the completion of the work conducted towards this thesis, a 
series of dye-matrices were examined for the ability to bind the KCl-soluble DAG 
kinase. In addition to the previously characterised AffiGel Blue (see Section 3.7), 
Matrex Orange A, Matrex Red A and Matrex Green A were screened for the ability 
to bind the enzyme in the presence of 300 mM KC1 at pH 6.5. The KCl-soluble 
DAG kinase bound to all these dye-matrices in the presence of 300 mM KC1, 
although binding to Matrex Orange A was only partial. Washing the dye-matrices 
with 600 mM KC1 elicited elution of DAG kinase activity from Matrex Orange A 
alone. Further increasing the KC1 concentration to 1.0 M initiated the elution of 
activity from Matrex Green A and AffiGel Blue. Finally, increasing the KC1 
concentration to 2.0 M resulted in elution of the DAG kinase from Matrex Red A, 
while also accomplishing further elution of activity from Matrex Green A and 
AffiGel Blue. (S. Gardener, personal communication). This ordered elution 
would indicate increasing affinity of the KCl-soluble DAG kinase for dye-matrices 
in the order: Matrex Orange A<AffiGel Blue<Matrex Green A<Matrex Red A 
(group 1, group 3, group 5 and group 3, respectively; as discussed by Stellwagen, 
1990). The arrangement of dye-affinity matrices into groups is based on the 
individual dye-matrix's ability to bind protein, with group 1 binding least and group 
5 most. Therefore, the KCl-soluble DAG kinase binds the above dye-matrices with 
a ranked order of increasing affinity that is a departure from that predicted by 
Stellwagen (1990). If a second dye-affinity column were to be incorporated into 
the purification protocol, the above departure would indicate that Matrex Red A is 
probably the best candidate for providing further purification. The increased 
affinity of the KCl-soluble DAG kinase for Matrex Red A allowing more selective 
elution of the enzyme than would be achieved with Matrex Green A. Furthermore, 
it would seem possible that the KCl-soluble DAG kinase could bind Matrex Red A 
in the presence of KC1 concentrations that would affect its elution from AffiGel
Blue. Thus, the KCl-soluble DAG kinase activity eluting from an AffiGel Blue 
column could be selectively collected on a Matrex Red A column. This illustrates 
the possibility of employing AffiGel Blue and Matrex Red A columns in tandem, 
whereas incorporation of a second dye-affinity column during the latter stages of 
the purification is equally possible. Altogether it would appear that the 
incorporation of a second dye-affinity column could further purify the KCl-soluble 
DAG kinase towards homogeneity. Indeed, the consecutive application of two 
different dye-matrix columns has been reported in the successful purification of 
lysophosphatidylcholine transacylase from bovine heart muscle (Sanjanwala et al.,
1989).
If a second dye-affinity column were to be incorporated into the 
purification, the possibility of more selective elution of the bound DAG kinase by 
free nucleotide compared to increasing concentrations of KC1 should be 
investigated. As reported above, the KCl-soluble DAG kinase binds Matrex Red A 
with greater affinity than predicted by the classification of dye-matrices discussed 
by Stellwagen (1990). It is possible that this may indicate the KCl-soluble DAG 
kinase binds Matrex Red A by a process different from that which it associates with 
the other dye-matrices. Although it would appear that the KCl-soluble DAG kinase 
does not interact with AffiGel Blue via its nucleotide binding site (see above), it 
may do so when binding Matrex Red A. Therefore, if Matrex Red A 
chromatography were to be included in the purification, it would be worth 
investigating the elution of the KCl-soluble DAG kinase by free nucleotide.
Chromatofocusing can not be applied to the purification of KCl-soluble 
DAG kinase for much the same reasons that ion-exchange chromatography cannot 
be employed. In essence, chromatofocusing is an adaptation of ion-exchange 
chromatography. Rather than eluting a bound protein with increasing 
concentrations of salt, a decreasing pH gradient is developed across the anion- 
exchange column and proteins elute as their net positive charge is lost. Thus, 
chromatofocusing involves the application of proteins to a strong anion-exchange
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medium a pH above their pi values in order that it may bind. However, this 
binding process will be prevented by the 300 mM KC1 required to maintain 
solubility of the KCl-soluble DAG kinase. As is the case for ion-exchange 
chromatography, development of conditions that would maintain the KCl-soluble 
DAG kinase in solution in salt-free buffer are required before this chromatography 
method can be considered further.
Affinity chromatography of DAG kinase has mainly revolved around the 
ATP substrate of the enzyme, e.g. rat liver cytosol (Kanoh & Ohno, 1981), pig 
brain cytosol (Kanoh et al., 1983), bovine brain cytosol (Lin et al., 1986), pig 
thymus cytosol (Sakane et al., 1989), human platelet cytosol (Yada et al., 1990), 
human white blood cell cytosol (Schaap et al., 1989), and rat brain cytosol and 
membranes (Kato and Takenawa, 1990). In all these cases the DAG kinase bound 
the ATP-agarose and requires more than 300 mM NaCl to displace the bound 
enzyme. The KCl-soluble DAG kinase, however, does not bind ATP-agarose in 
the presence of 300 mM KC1 at pH 6.5 (data not shown).
Affinity chromatography on immobilised sn-1,2-diacylglycerol or 
phospholipid would appear to be attractive alternatives. Uchida and Filbum (1984) 
successfully employed an affinity matrix of sn-1,2-diacylglycerol and PtdSer 
immobilised in a polyacrylamide gel to purify protein kinase C from rabbit renal 
cortex. It may be significant that Besterman et al. ( 1986b) have employed 
polyacrylamide-immobilised sn- 1,2-diacyl glycerol to purify the membrane- 
associated DAG kinase of rat brain to near homogeneity. However, work 
previously conducted in this laboratory has found rat brain DAG kinase unable to 
bind such polyacrylamide immobilised sn- 1,2-diacyl glycerol (S. Palmer & M.J.O. 
Wakelam, personal communication). Alternatively, the covalent attachment of sn-
1,2-diacyl glycerol to a chromatography support may provide a suitable affinity 
chromatography medium. PtdCho covalently immobilised via its acyl chains to an 
agarose support has been employed successfully in the purification of Crotalus 
adatnantens venom phospholipase A2 (Rock & Snyder, 1975). Unfortunately it is
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not known what effect the presence of 300 mM KC1 would have on the interaction 
of the KCl-soluble DAG kinase with immobilised sn- 1,2-diacyl glycerol affinity 
media. The affinity of KCl-soluble DAG kinase for the immobilised sn-1,2- 
diacylglycerol may be sufficiently great to overcome any displacing effect that 
results from the presence of 300 mM KC1. As a purification strategy, the use of 
immobilised sn- 1,2-diacyl glycerol could possibly result in substantial purification 
of the KCl-soluble DAG kinase. The greater relative selectivity of immobilised sn-
1,2-diacylglycerol for DAG kinases, compared to agarose-immobilised nucleotides, 
must indicate the former as most likely to lead to the final purification of the KCl- 
soluble enzyme.
Preparative-scale non-denaturing electrophoresis of the final KCl-soluble 
DAG kinase preparation obtained from the established purification protocol is 
unlikely to resolve the enzyme to homogeneity. The final preparation contains 
many polypeptides (Fig 3.11) and it is unlikely that they will separate sufficiently 
on non-denaturing electrophoresis. This will also prevent the final identification of 
the KCl-soluble DAG kinase. Those polypeptides that do not co-migrate with DAG 
kinase activity can, however, be eliminated from the identification process. Thus, 
the KCl-soluble DAG kinase could be identified as one of a small number of 
proteins. If this were the case, non-denaturing electrophoresis would at least allow 
further partial purification of the enzyme. Unfortunately, DAG kinase activity has 
never been recovered from non-denaturing electrophoresis of the KCl-soluble 
enzyme (data not shown). This inability to recover activity from a polyacrylamide 
gel has led to doubt about the KCl-soluble DAG kinase entering the gel and thus 
migrating through the gel during electrophoresis. Therefore, the use of preparative 
non-denaturing PAGE has not been considered further.
As yet, the KCl-soluble DAG kinase has still to be identified on SDS-PAGE 
analysis of the post hydroxyapatite protein preparation (see Section 3.11). This has 
prevented the purification of the KCl-soluble DAG kinase by preparative SDS- 
PAGE.
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Purification of the KCl-soluble DAG kinase of rat brain could proceed by 
several possible strategies. Employing affinity chromatography on immobilised s/2-
1,2-diacyl glycerol would seem to offer the best possibility of continued 
purification. Nevertheless, this conclusion remains speculative until the ability of 
immobilised sn- 1,2-diacyl glycerol to bind the KCl-soluble enzyme in the presence 
of 300 mM KC1 is established.
3.14. Identification of the KCl-Soluble DAG Kinase Polypeptide: A 
D iscu ss io n .
In the absence of a homogeneous preparation of the KCl-soluble DAG 
kinase, its identification within a mixture of other polypeptides could allow protein 
sequencing. Identification would allow direct electroblotting of the polypeptide 
from an SDS-PAGE gel to a PVDF membrane. Solid-phase N-terminal sequencing 
could then be undertaken. This does require that the polypeptide to be sequenced is 
sufficiently resolved from the other proteins on SDS-PAGE. If this is not the case 
further partial purification would be required prior to SDS-PAGE and 
electroblotting to the PVDF support.
As reported in Section 3.11, it is not possible to identify the KCl-soluble 
DAG kinase from the mixture of proteins pooled from hydroxyapatite 
chromatography. SDS-PAGE analysis of the fractions collected failed to identify 
any polypeptide(s) that co-migrate with DAG kinase activity on hydroxyapatite (Fig
3.12). Furthermore, no 160 kDa polypeptides were observed on SDS-PAGE of 
the post hydroxyapatite enzyme preparation (Figs 3.11,3.12), despite the apparent 
native molecular mass of the KCl-soluble DAG kinase being determined as 
approximately 160 kDa (Section 3.9). Identification of the KCl-soluble DAG 
kinase will thus require that further analytical methods be employed.
Identification of the KCl-soluble DAG kinase’s catalytic polypeptide may be 
possible upon covalent modification with a photo-affinity ATP analogue. If the 
photo-affinity analogue were radiolabelled, the modified polypeptide could then be
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subjected to SDS-PAGE and identified by autoradiography. The most likely 
candidate analogues are [a-32P]8-azido ATP and [a -32P]3'-0  -(4-benzoyl)benzoyl 
ATP. Both these photo-activated analogues competitively occupy ATP binding 
sites, irreversibly inhibiting the enzyme on exposure to UV lig h t. Indeed, [a- 
32P]3'-(9 -(4-benzoyl)benzoyl ATP has been successfully employed in identifying 
the P2Y-purinergic receptor of turkey erythrocyte plasma membranes by the above 
approach (Boyer et al., 1990). However, the application of such photo-affinity 
analogues to the identification of the KCl-soluble DAG kinase requires the prior 
characterisation of their suitability as substrates. They must be able to competitively 
inhibit the binding of ATP to the catalytic site of the enzyme. The possibility could 
still exist that several ATP-binding proteins have co-purified with the KCl-soluble 
DAG kinase on AffiGel Blue and heparin-agarose chromatography. As it likely that 
such proteins would also be labelled with ATP photo-affinity analogues, the 
modification of the the KCl-soluble DAG kinase by their use must be carefully 
characterised. Conditions would need to be developed to optimise the labelling of 
the KCl-soluble DAG kinase over the other ATP-binding proteins that may possibly 
be present.
The use of analytical non-denaturing PAGE to both resolve and identify the 
KCl-soluble DAG kinase cannot be considered as a likely method. As discussed in 
3.13, activity has yet to be recovered after non-denaturing PAGE of the KCl- 
soluble DAG kinase. The inability to recover DAG kinase activity from non­
denaturing gels may be the result of any one of several causes. It is not clear 
whether the KCl-soluble DAG kinase entered the gel at the initiation of 
electrophoresis. Equally, it was not clear if the proteins applied to the non­
denaturing gel migrated through the gel during electrophoresis. If the proteins did 
enter the gel and migrate on electrophoresis, problems may be associated with 
efficiently eluting the KCl-soluble DAG kinase from the non-denaturing gel prior to 
assay. Finally, it may also be possible that the KCl-soluble DAG kinase is unstable 
and denatures to an inactive form during non-denaturing electrophoresis.
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In conclusion, the KCl-soluble DAG kinase is most likely to be identified 
by covalent labelling with photo-affinity ATP analogues. This may not 
automatically allow N-terminal sequencing of the protein or the peptides derived 
from it as the protein may not be clearly resolved from the others present in the post 
hydroxyapatite preparation on SDS-PAGE. It would, however, allow further 
purification of the enzyme by a more informed protocol. Additionally, if the protein 
is identified or selectively labelled within a mixture of other proteins, purification 
could proceed by methods that are not associated with the preservation of enzyme 
activity, e.g. reverse phase chromatography.
3.15. Comparison of the KCl-Soluble Enzyme to Membrane- 
Associated DAG Kinases Previously Purified From Rat Brain.
The DAG kinase purified in the work towards this thesis is different from 
the enzymes purified from rat brain by Besterman et al. (1986b) and Kato and 
Takenawa (1990). The membrane-associated DAG kinase reported within this 
thesis possesses an absolute requirement for the presence of salt for continued 
solubility, specifically 300 mM or greater KC1 (see Section 3.4). Neither 
Besterman et al.{ 1986b) nor Kato and Takenawa (1990) reported DAG kinase 
activities which required the presence of salt for continued solubility. Indeed, both 
enzymes were substantially purified by protocols which required dialysis of the 
enzyme against salt-free buffer followed by clarification of the dialysate.
Therefore, this thesis represents the first report of a membrane-associated DAG 
kinase which requires the presence of elevated concentrations of salt alone to remain 
soluble.
Additionally, a membrane-associated DAG kinase activity which did not 
require the presence of KC1 for continued solubility was also observed in this KC1- 
extracted protein preparation employed in this thesis (see Sections 3.4,3.5). It is 
notable that the KC1-independent DAG kinase displayed different chromatographic 
behavior from the KCl-soluble enzyme on hydroxyapatite (data not shown).
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However, the KC1-independent enzyme eluted from hydroxyapatite under 
conditions similar to those employed in the purification of the 150 kDa DAG 
kinase. Both the KCl-independent DAG kinase reported within this thesis and the 
150 kDa enzyme purified to homogeneity by Kato and Takenawa (1990) are eluted 
from hydroxyapatite by increasing concentrations of salt, whereas the KCl-soluble 
DAG kinase remains bound and requires in excess of 50 mM potassium phosphate 
for elution (Section 3.11). This strongly indicates that the KCl-independent 
enzyme discussed in Section 3.14 is likely to be the 150 kDa activity purified to 
homogeneity by Kato and Takenawa (1990) while the KCl-soluble enzyme is novel 
and not previously reported.
The differences between the KCl-soluble DAG kinase and the enzyme 
purified by Kato and Takenawa (1990) are further accentuated if their respective 
purification protocols are further examined. The 150 kDa DAG kinase was purified 
from a 2.0 M NaCl extract by sequential chromatography on Q-Sepharose Fast 
Flow (anion-exchange), phenyl-Superose, hydroxyapatite, and ATP-agarose (Kato 
and Takenawa, 1990). All these chromatographic methods have been applied to the 
purification of the KCl-soluble enzyme and have been found to be unsuccessful. 
The differences in the functional group, the degree of their substitution in QAE- 
Sephadex A-50 and Q-Sepharose Fast Row and also the difference in pH employed 
(pH 6.5 and 7.4 respectively) prevent any comparison of the two enzymes' 
behavior on anion-exchange media. It is also difficult to compare the behavior of 
the two enzymes on phenyl-Superose. The 150 kDa elutes from phenyl-Superose 
as the NaCl concentration is dropped from 100 to 0 mM, whereas the KCl-Soluble 
enzyme cannot be purified by this method as it would precipitate on the phenyl- 
Superose column under these conditions of reduced salt concentration. It sholuld 
be noted that the KCl-soluble DAG kinase can be purified by phenyl-Superose 
chromatography. In the presence of 300 mM KC1 and 0.02 % (w/v) Triton X-100 
the KCl-soluble enzyme elutes from phenyl-Superose between 40 and 50 % (v/v) 
ethanediol. Apart from the unsuitability of the phenyl-Superose chromatography
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method of Kato and Takenawa (1990) to the KCl-soluble DAG kinase, it is 
impossible to further compare their behavior on phenyl-Superose. As discussed 
above, the KCl-soluble DAG kinase and the 150 kDa enzyme previously purified 
from rat brain behave quite differently on hydroxyapatite. Finally, the 150 kDa 
DAG kinase was substantially purified on ATP-agarose and eluted with between 
350 and 380 mM NaCl (Kato and Takenawa, 1990). The KCl-soluble DAG 
kinase, however, was found not to bind ATP-agarose in the presence of 300 mM 
KC1 at pH 6.5 (S.D. Gardner, personal communication). Therefore the purification 
protocol of Kato and Takenawa (1990) is inapplicable to the KCl-soluble DAG 
kinase reported within this thesis.
Rather than using the separation methods which were successful with the 
150 kDa DAG kinase, the KCl-soluble enzyme was purified by protocol which 
employed AffiGel blue, gel filtration, and heparin-agarose chromatography.
AffiGel blue, heparin-agarose and gel filtration chromatography are procedures 
which have been employed in purification of DAG kinases distinct from the 150 
kDa membrane-associated enzyme of rat brain. For example, AffiGel blue was 
employed as the initial chromatographic separation in the purification of the 110 
kDa cytoolic DAG kinase of rat brain (Kato and Takenawa, 1990). Additionally, 
heparin-agarose and gel filtration chromatography have been successfully applied to 
purification of the porcine cytosolic DAG kinases (Sakane et al., 1989). Therefore, 
the application of these separation procedures to the purification of a membrane- 
associated DAG kinase is novel and not previously reported.
As the KCl-soluble DAG kinase is only partially purified 59.7-fold by the 
protocol reported here, its in the pure state cannot be compared to that of the 
enzyme purified to homogeneity by Kato and Takenawa (1990). The impurity of 
the final preparation of the KCl-soluble activity prevents detemination of its 
molecular mass by SDS-PAGE. Although it possesses an apparent molecular mass 
of 160 kDa on gel filtration, it cannot be assumed to be of similar mass to the 150 
kDa enzyme of Kato and Takenawa (1990). Similarly, this value cannot be
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compared to the mass of the four polypeptides purified by sn-1,2- 
diacylglycerol/PtdSer affinity chromatography (Besterman et al., 1986b).
In summary, apart from the KC1 requirement for solubility, the KCl-soluble 
DAG kinase is purified by a protocol quite different from those previously 
employed for purification of membrane-associated DAG kinases. In the absence of 
a homogeneous preparation of the KCl-soluble enzyme, comparison of its 
chromatographic behavior to that of the 150 kDa DAG kinase previously purified 
from rat brain suggests that they are two different enzymes. Furthermore, this is 
the first report of a membrane-associated DAG kinase which is solubilised by 
hypertonic concentrations of salt and requires the continued presence of salt, 
specifically 300 mM or greater KC1, for solubility.
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Chapter 4
Characterisation of a Triton X-100 Based j/i-l,2 -D ira d y lg ly cero l 
Mass Measurement Assay and Kinetic Characterisation of the KC1
Soluble DAG Kinase.
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4.1. Characterisation of the Triton X-100 Method and Its Application 
to the Measurement of s/i-l,2-Diradylglycerol Mass in Cell Lipid 
E xtracts.
In order that the j/z-l-acyl-2-archidonylglycerol selectivity of the KCl- 
soluble DAG kinase of rat brain can be assessed, it is necessary to determine the 
kinetic constants, Km and Vmax, of the enzyme when different sn-1,2- 
diacylglycerol substrates are employed, e.g. s«-l,2-dilauroylglycerol, sn-1,2- 
dioleoylglycerol and sn- 1 -stearoyl-2-arachidonylglycerol. This permits the 
identification of catalytic selectivity of the enzyme towards a particular substrate by 
the enzyme exhibiting a reduced Km or elevated Vmax towards any one substrate 
compared to other sn- 1,2-diacyl glycerol species. Therefore, the concentrations of 
sn-1,2-diacylglycerol substrates within the assay tube must be determined 
accurately if true values for the above kinetic constants, especially Km, are to be 
determined. The sn- 1,2-diacyl glycerol concentrations employed in this study of the 
concentration dependence of the KCl-soluble DAG kinase's reaction velocity were 
normalised to that of 5W-1-stearoyl-2-arachidonylglycerol by means of a quantitative 
assay that employs the DAG kinase of Eschericia coli.
Such a quantitative assay relies on the solubilisation of sn-1,2- 
diacylglycerol in a detergent mixed micellar system with subsequent 
phosphorylation of the sn-1,2-diacylglycerol in a reaction catalysed by the DAG 
kinase (dgkA gene product) of E. coli. The inclusion of [y-32P]ATP of known 
specific activity in the DAG kinase reaction mixture allows quantitation of the 
P 2P]phosphatidic acid produced. Comparison to a standard curve constructed 
from sn-1,2-diacylglycerol of known concentration and treated in an identical 
manner further allows quantitation of the sn- 1,2-diacyl glycerol mass originally 
present. Furthermore, assay conditions were developed to provide complete 
phosphorylation of sn- 1,2-diacyl glycerol to phosphatidic acid, eliminating possible 
erroneous quantitation that might arise from altered efficiency of conversion 
between the standard and experimental s«-l,2-diacylglycerol samples. Originally,
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an «-octyl-p,D-glucopyranoside/cardiolipin mixkl micellar method was reported to 
quantitatively measure sn-1,2-dioleoylglycerol over the range 25 pmol to 25 nmol 
with greater than 95 % efficiency (Preiss et al., 1986, 1987). Complete conversion 
of sn-1,2-diacylglycerol to phosphatidic acid by this method was achieved by 
employing membranes from E. coli strain N4830/pJW10, a strain that 
overproduces 100-fold the membrane-associated DAG kinase of E. coli, to provide 
an initial reaction velocity of 43 nmol/min within the assay, and incubation of the 
reaction mixture for 30 min. Enzyme inactivation during this prolonged incubation 
period is reduced by inclusion of cardiolipin, DTT and DETAPAC in the reaction 
mixture and incubation at 30°C rather than 37°C (Walsh & Bell, 1986a).
The lipid/detergent mixed micellar system that could be provided by such 
use of w-octyl-p,D-glucopyranoside also allowed solubilisation of the lipid extracts 
from stimulated cells and quantitation of the sn-1,2-diacylglycerol within the extract 
(Preiss et al., 1986). These workers reported that conversion of sn-1,2- 
diacylglycerol to phosphatidic acid was not impared by the addition of cell lipid 
extract prepared from 0.5 x 109 to 2.0 x 109 platelets (Preiss et al., 1986). 
Therefore, the observed complete conversion of sn-1,2-diacylglycerol to 
phosphatidic acid in the presence of cell lipid confirmed that the E. coli DAG kinase 
assay could indeed be employed in the quantitation of sn- 1,2-diacyl glycerol mass 
contained within the cellular lipid extract prepared from cells. Workers in this, and 
other laboratories have, however, experienced difficulty in the adaptation of the 
assay methodology reported by Preiss et al. (1986). It has been the experience of 
the workers within this laboratory to observe incomplete conversion of the sn- 1,2- 
diacyl glycerol standard curve to phosphatidic acid. Typically, 57 ± 9.4 % of the 
sn-l-stearoyl-2-arachidonylglycerol over the range 100 pmol to 2 nmol is 
phosphorylated in the absence of cell lipid extract (Fig 4.1). Such inefficient 
conversion was not related to impurity of the w-octyl-p,D-glucopyranoside as 
recrystalised detergent was employed, as suggested by Preiss et al. (1987). 
Additionally, although reported as a possible source of inefficient
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Fig 4.1. Conversion of sn -l-S tearoyl-2-A rach idon yIglycerol to 
Phosphatidic Acid by /i-OctyI-p,D-GIucopyranoside and Triton X- 
100 M icellar Methods.
Conversion of 100 pmol - 2 nmol sw-l-stearoyl -2-arachidonylglycerol to 
[32P]phosphatidic acid by the n-octyl-(3,D-glucopyranoside ( • )  and Triton X-100 
(O) micellar systems was monitored in the absence of endogenous cell lipid. 
Quantitation by the Triton X-100 method was performed as described in Section 
2.7 and the w-octyl-p,D-glucopyranoside assay performed as described in Section
2.4.1.
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conversion by Preiss and co-workers (1986, 1987), the integrity of the [y-32P]ATP 
was established by PEI-cellulose t.l.c. (data not shown) and this possibility 
eliminated.
The possibility that, under the conditions reported by Preiss and co-workers 
(1986, 1987), n-octyl-p,D-glucopyranoside was unable to fully solubilise the sn-
1,2-diacyl glycerol substrate and, thus, prevented complete DAG kinase-catalysed 
phosphorylation was investigated. This was pertinent as the lipid extract prepared 
from Swiss 3T3 fibroblasts was visibly insoluble in the detergent conditions of the 
existing assay protocol (data not shown). Methodology adapted from Thompson et 
al. (1990), employing Triton X-100, was examined for its ability to provide 
increased conversion of sn-1,2-diacylglycerol to phosphatidic acid. This would 
indicate if 0.3 % (w/v) Triton X-100 (c.m.c. = 0.019 % (w/v)/4.8 mM) provides 
conditions within the assay mixture that are more favourable towards complete 
conversion of sw-l,2-diacylglycerol to phosphatidic acid than provided by the 52 
mM «-octyl-p,D-glucopyranoside (c.m.c = 25 mM) employed by Preiss et al. 
(1986).
More efficient phosphorylation of 5?z- l-stearoyl-2-archidonylglycerol over 
the range 100 pmol - 2 nmol was observed when 4.8 mM [0.3 % (w/v)] Triton X- 
100, rather than 52 mM «-octyl-p,D-glucopyranoside, was employed to establish 
mixed micellar enviroment within the assay mixtutre (Fig 4.1). Routinely, 
quantitative phosphorylation of sn-1 -stearoy 1-2-arachidonylglycerol is observed 
over the range 100 pmol - 2 nmol (113 ± 1.9 %, Fig 4.1), indicating the suitability 
of Triton X-100 as the detergent to be employed in such a sn-1,2-diacylglycerol 
mass determination assay. Greater than 100 % conversion of the sn-1,2- 
diacylglycerol present within the standard curve is observed, this is most likely 
attributable to inaccurate quantitation of the sn-1 -stearoyl-2-arachidonylglycerol 
stock solution employed in constructing the standard curve and also inaccurate 
determination of the specific activity of the [y-32P]ATP present in the DAG kinase 
incubation mixture. However, the degree of phosphorylation, although greater than
138
100 %, is similar at all points in the standard curve and confirms that the sn- 1,2- 
diacyl glycerol present is uniformly quantitated throughout the range 100 pmol - 2 
nmol.
The Triton X-100 mixed micellar assay system proved suitable for the 
quantitation of sn-1,2-diacylglycerol mass within cell lipid extracts. The efficiency 
of conversion of 330 pmol sw-l-stearoyl-2-arachidonylglycerol added to increasing 
amounts of cell lipid extract prepared from confluent, quiescent Swiss 3T3 
fibroblasts monolayers was determined for both the Triton X-100/PtdSer and n- 
octyl-|3,D-glucopyranoside/cardiolipin methods (Table 2). Maximally, in the 
presence of endogenous cell lipid equivalent to that prepared from 2.25 x 105 
fibroblasts, the «-octyl -13, D-glucopyranoside/cardiolipin method of Preiss et al. 
(1986) resulted in 80.4 % conversion of s/z-l-stearoyl-2-arachidonylglycerol to 
phosphatidic acid (Table 2). As the concentration of cell lipid within the incubation 
mixture increased to that equivalent to 2.25 x 106 fibroblasts, the measured 
efficiency of conversion fell to 0.4 % (Table 2). In comparison, the conversion of 
sw-l-stearoyl-2-arachidonylglycerol was complete in the Triton X-100/PtdSer assay 
method at lipid concentrations equivalent to 2.25 x 105 - 4.50 x 105 fibroblasts, 
falling to 38.8 % in the presence of lipid equivelent to 2.25 x 106 fibroblasts (Table 
2). Additionally, increased precision of sw-l-stearoyl-2-archidoylglycerol mass 
determination in the presence of cell lipid was observed with the Triton X- 
100/PtdSer method (Table 2).
In the presence of cell lipid equivalent to 2.25 x 106 Swiss 3T3 fibroblasts, 
quantitative recovery of p 2P] phosphatidic acid over the range 100 pmol - 1 nmol 
was recorded in a sham Triton X-100/PtdSer assay (data not shown). This 
indicated that the decreased efficiency of sn-1,2-diacylglycerol measurement in the 
presence of lipid equivalent to that produced from greater than 4.50 x 105 
fibroblasts was not a product of limited phosphatidic acid recovery in the presence 
of elevated lipid concentrations but, rather, the product of inhibited DAG kinase
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Table 2. Efficiency of s/i-l,2-Dirady!gIycerol Mass Q uantitation by 
the /i-Octyl-p,D-GIucopyranoside and Triton X-100 M icellar Methods
in the Presence of Increasing Endogenous Cell Lipid.
Efficiency of phosphorylation (%) 
«-octyl-p,D-glucopyranoside Triton X-100
Cell No.
2.25 x 105 80.4 ±52.1 101.2 ± 2.1
4.50 x 105 60.4 ± 9.6 97.3 ± 16.8
7.50 x 105 4.45 ± 10.1 80.8 ± 7.6
2.25 x 106 0.4 ± 14.0 38.8 ± 8.5
Conversion of 330 pmol sn-1 -stearoyl-2-arachidonylglycerol in the presence of four concentrations 
of endogenous cell lipid, prepared from confluent monolayers of Swiss 3T3 fibroblasts, was 
measured by the methods described in Fig 4.1.
reaction in the presence of such elevated lipid concentrations. Therefore, unlike the 
n-octyl-p,D-glucopyranoside method, the Triton X-100/PtdSer method is capable 
of supporting DAG kinase-catalysed phosphorylation of the sn- 1,2-diacyl glycerol 
present in cell lipid extracts with 100 % efficiency and, thus, complete quantitation 
of the sn-1,2-diacylglycerol present in cell lipid extracts. However, the capacity of 
the method for cell lipid is finite and the amount from which an sn-1,2- 
diacylglycerol mass determination is made must be carefully titrated to avoid lipid 
concentrations that are inhibitory to the DAG kinase reaction.
Without further characterisation, the Triton X-100/PtdSer method 
(Thompson et al., 1990; Paterson et al., 1991) would appear to quantitate the mass 
of sn-1,2-diacylglycerol over the range 100 pmol - 2 nmol, both, in the absence and 
presence of limited amounts of lipid derived from cell lipid extracts with a degree of
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precision not experienced with the H-octyl-p,D-glucopyranoside detergent method 
(Preiss et al., 1986). However, such a conclusion assumes the assay converts 
differing molecular species of sw-l,2-di acyl glycerol with an efficiency equal to sn-
l-stearoyl-2-arachidonylglycerol. This has not been investigated directly but,
Walsh and co-workers (1990) observed the Vmax of the E. coli DAG kinase to 
remain unaltered when incubated with 1,2-dihexanoy 1 glycerol, sn-1,2-
dioctanoylglycerol and SH-l,2-dioleoylglycerol in an «-octyl-p,D- 
glucopyranoside/phosphatidylglycerol mixed micellar system. The apparent Km for 
each substrate was observed to fall with increasing acyl-chain length (sn-1,2- 
dihexanoylglycerol = 2.4 mol%; 5«-l,2-dioctanoylglycerol = 1 .9  mol%; sn-1,2- 
dioleoylglycerol = 0.37 mol%). Although Vmax and Km were not determined, 
MacDonald et al. ( 1988b) reported the E. coli DAG kinase to catalyse the 
phosphorylation of srt-l-stearoyl-2-linoleoylglycerol, sn-1,2-dioleoylglycerol and 
s«-stearoyl-2-oleoyl glycerol in an w-octyl-|3,D-glucopyranoside mixed micellar 
system with greater reaction velocity than measured with sw-l-stearoyl-2- 
arachidonylglycerol. This information has been gathered for the reaction velocity of 
DAG kinase on solubilisation of the sn- 1,2-diacyl glycerol substrate in w-octyl-p,D- 
glucopyranoside but, it does indicate that sn- l-stearoyl-2-arachidonylglycerol is a 
less favourable jw-l,2-di acyl glycerol substrate than other molecular species, e.g. 
sn- l-stearoyl-2-oleoyolglycerol. Morever, how such initial reaction velocity 
information extrapolates to a situation of complete phosphorylation of sn- 1,2- 
diacyl glycerol, as encountered in the sn- 1,2-diacyl glycerol mass quantitation assay, 
is unknown. Although information has not been gathered for the substrate 
selectivity of the E. coli DAG kinase in a Triton X-100 assay system, the above 
data may indicate, however, that in a non-ionic detergent mixed micellar assay 
system the accuracy of quantitation of long-chain sn- 1,2-diacyl glycerols is assured 
if sw-l-stearoyl-2-arachidonylglycerol is observed to be converted to phosphatidic 
acid with 100 % efficiency under identical assay conditions.
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It should be noted in the discussion of the application of enzymatic 
determination of sn- 1,2-diacyl glycerol that the E. coli DAG kinase can catalyse the 
phosphorylation of 1-0-alky 1-2-acyl glycerol and 5«-l-0-alkenyl-2-acyl glycerol
in /z-octyl-p,D-glucopyranoside-based reaction mixtures with similar reaction 
velocities to those determined for sn- 1,2-diacyl glycerol substrates (Ford & Gross,
1990). Similarly, sw-l-O-alkyl-2-acylglycerol and sw-l-O-alkenyl-2-acyl glycerol 
together with sn-1,2-diacylglycerol are phosphorylated in the Triton X-100/PtdSer 
method (Thompson et al., 1990). As a result, all three sw-l,2-diradylglycerol 
classes, i.e. sn-1,2-diacylglycerol, s/z- 1-0-alkyl-2-acyl glycerol and 5«-l-0-alkenyl-
2-acylglycerol, are phosphorylated in these enzymatic methods without 
discrimination. In this context, without prior knowledge of the sn-1,2- 
diradylglycerol subclass population, the assay must be considered as quantitating 
the sn-1,2-diradylglycerol content of cell lipid extracts, sn-1,2- Diacyl glycerol mass 
can, however, be determined specifically if the 5«-l-0-alkyl-2-acylglycerol and sn- 
l-O-alkenyl-2-acylglycerol mass within the total sn-1,2-diradylglycerol population 
is determined by enzymatic analysis employing phospholipase Ai in combination 
with the DAG kinase enzymatic sn- 1,2-diacyl glycerol mass determination method 
(Thompson et al., 1990; Tyagi et al., 1989).
4.2. Kinetic Characterisation of the KCl-Soluble DAG Kinase: 
Introduction.
The aim of this project was to purify the DAG kinase involved in 
phosphorylating the sn-1,2-diacylgycerol produced on receptor-stimulated 
PtdIns(4,5)P2 hydrolysis. This specific DAG kinase isoenzyme would appear to 
be identified by its substrate selectivity (Section 1.8.1). It catalyses the 
phosphorylation of szz-l-acyl-2-arachdonylglycerols with greater reaction velocities 
than when non-arachidonyl sn- 1,2-diacyl glycerols are employed as substrate. This 
highlights a property of the enzyme that can be employed in assessing a DAG 
kinase isoenzyme's contribution to the metabolism of sn- 1,2-diacyl glycerol
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generated from PtdIns(4,5)P2 hydrolysis. In addition, the s«-l-acyl-2- 
arachidonylglycerol selectivity of the PtdIns(4,5)P2-linked DAG kinase was 
employed to facilitate the isolation of this isoenzyme from the non-selective 
enzymes encountered in tissue homogenates (Section 1.9).
The kinetic properties of the KCl-soluble DAG kinase shall now be 
investigated. This enzyme has been partially purified by the strategy proposed in 
Section 1.9. However, it remains to be determined if this enzyme is the DAG 
kinase involved in phosphorylating the PtdIns(4,5)P2-derived 1,2- 
diacyl glycerol. This chapter will compare some of the catalytic properties of the 
KCl-soluble enzyme of rat brain to those of the PtdIns(4,5)P2-linked DAG kinase 
of Swiss 3T3 fibroblasts. This will establish if the enzymes share any common 
propetics and, thus, verify if the KCl-soluble DAG kinase is involved in the 
metabolism of PtdIns(4,5)P2-derived sn- 1,2-diacyl glycerol. The activation of both 
these enzymes by PtdSer will also be investigated. When assayed in an w-octyl- 
P,D-glucopyranoside mixed micellar solution, the sw-l-acyl-2-arachidonylglycerol- 
selective enzyme of Swiss 3T3 fibroblasts is activated by PtdSer. Inclusion of 6 
mol% PtdSer results in an elevation of the enzyme's Vmax and also a reduction of 
its apparent Km for s«-l-stearoyl-2-arachidonylglycerol (MacDonald et al., 1988b). 
Therefore, activation of the KCl-soluble DAG kinase by PtdSer will be compared to 
that of the Swiss 3T3 fibroblast enzyme. Comparison of the sn-1,2-diacylglycerol 
substrate selectivity of the KCl-soluble and Swiss 3T3 DAG kinases and also the 
effects of PtdSer on their activity will provide some indication of the rat brain 
enzyme's ability to function as the DAG kinase involved in the phosphorylation of 
PtdIns(4,5)P2-derived sn- 1,2-diacyl glycerol.
This chapter will also examine the ATP, Mg2+, and Ca2+ concentration 
dependence of the KCl-soluble DAG kinase's reaction velocity.
The kinetic characterisation of the KCl-soluble DAG kinase has been 
performed with post gel filtration or post heparin-agarose preparations of the 
enzyme. These have been prepared by the existing purification protocol which is
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summarised in Section 3.12. In both cases, the DAG kinase is present as single 
species, which migrates on gel filtration and heparin-agarose chromatography as a 
single peak of activity.
4.3. s/i-l,2-D iacyIgIycerol Concentration Dependence.
4.3.1. Determination of Apparent K m and Vmax Values with s n - l -  
Stearoyl-2-Arachidonylglycerol as Substrate.
The KCl-soluble DAG kinase's rate of reaction increased as a hyperbolic 
function of sn -l-stearoyl-2-arachidonylglycerol concentration (Fig 4.2A). Over 
the range of s/z-l-stearoyl-2-aqrachidonyl glycerol concentrations employed, a 
maximal rate of reaction was not observed. The concentration of sn -l-stearoyl-2- 
arachidonylglycerol was expressed as a mol fraction of the «-octyl-p,D- 
glucopyranoside/PtdSer/DAG mixed micellar phase in the reaction mixture and the 
data fitted to the Michaelis-Menten kinetic model. Under these conditions, the post 
gel filtration enzyme was found to have a Vmax of 29.9 nmol/min/mg and an 
apparent Km of 1.7 mol%. These fitted values of Vmax and apparent Km 
correspond to those determined from Eadie-Hofstee analysis of the experimental 
data (Fig 4.2B).
The apparent Km of the KCl-soluble DAG kinase for stt-l-stearoyl-2- 
arachidonylglycerol is similar to that of the membrane-associated enzyme of Swiss 
3T3 fibroblasts (MacDonald et al., 1988b). Using a similar n -octyl-p,D- 
glucopyranoside mixed micellar assay system, MacDonald and co-workers (1988b) 
determined the apparent Km of the Swiss 3T3 enzyme, an s/z-l-acyl-2- 
arachidonylglycerol-selective enzyme, to be 1.2 mol%, when measured in the 
presence of 6 mol% PtdSer. This compares to the 1.7 mol% determined for the rat 
brain KCl-soluble DAG kinase when measured in the presence of 7.8 mol%
PtdSer. Under the detergent and phospholipid conditions employed, the apparent 
Km of 1.7 mol% is comparable to 890 pM when expressed as a bulk concentration. 
This value is nearly 10-fold greater than the apparent Km of 90 pM determined for
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Fig 4.2. DAG Kinase Reaction Velocity: Concentration Dependence 
on j/i-l-S tearoy l-2 -A rach id on y lg lycero l.
A. sn -l-stearoyl-2-arachidonylglycerol concentration dependence of the KCl- 
soluble DAG kinase's reaction velocity.
B. Eadie-Hofstee plot of data shown in A.
The DAG kinase rate of reaction was determined by the «-octyl-p,D- 
glucopyranoside/PtdSer assay method (Section 2.4.3) in the presence of the 
indicated concentrations of sw-l-stearoyl-2-arachidonylglycerol and 1.0 mM ATP. 
The reaction velocity was determined with 20 pi of the post gel filtration enzyme 
preparation diluted to 50 pi with buffer E. After 15 min, the reaction was 
terminated and the [32P]phosphatidic acid quantitated as described in Section 2.4.3. 
The protein concentration of the DAG kinase preparation was determined by the 
Coomassie dye method (Section 2.2.3).
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the 150 kDa DAG kinase of rat brain with the same sn- 1,2-diacyl glycerol substrate 
(see Table 3). However, as the sn- 1,2-diacyl glycerol concentration dependence of 
the 150 kDa DAG kinase's reaction velocity was examined with a deoxycholate 
dispersion assay, no true comparison can be made between this Km and the value 
determined for the KCl-soluble enzyme by a mixed micellar system (see Section 
5.5). Similarly, due to the differences in DAG kinase reaction velocities obtained 
by different methods of assay, no comparison can be made between the Vmax 
values obtained for the previously purified 150 kDa DAG kinase and the KCl- 
soluble DAG kinase. Although the Km values may be comparable between the 
KCl-soluble DAG kinase and the membrane-associated enzyme of Swiss 3T3 
fibroblasts, the Vmax values obtained for these activities cannot be compared. 
Despite reaction velocity being measured under near-identical conditions, the Swiss 
3T3 DAG kinase is prepared solely by fractionation of the total membrane 
component of a cell lysate, whereas the post gel filtration preparation of KCl- 
soluble enzyme has been purified 7-fold from the particulate fraction of rat brain 
(see Table 1). Therefore, their disparate levels of purity prevents a meaningful 
comparison of their Vmax values.
4.3.2. Determination of Vmax and Apparent K m Values with s /i-1 ,2 - 
Dilauroylglycerol and sn-l,2-D ioleoylglycerol as Substrates. Is the 
Kinase Selective for its Substrate?
As discussed in Section 1.8.1, the DAG kinase which phosphorylates the 
sn -1,2-diacylglycerol produced Swiss 3T3 fibroblasts on PDGF stimulation is 
membrane-associated and selective for s«- 1,2-diacylglycerols possessing 
arachidonate in the 2-acyl position (MacDonald et al., 1988a, b). Further DAG 
kinases which are selective for sn- l-acyl-2-arachidonylglycerol substrates have 
been identified in rat brain microvessels (Hee-Chong et al., 1985), rabbit aorta 
(Severson & Hee-Chong, 1986), and baboon brain (Lemaitre et al., 1990). To 
assess if the KCl-soluble DAG kinase is selective towards different sn-1,2-
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diacyl glycerol substrates, especially s/7-1-acyl-2-arachidonyl glycerol, the enzyme's 
Vmax and apparent Km were determined with s/7-l,2-dioleoylglycerol and sn-1,2- 
dilauroylglycerol and the values obtained compared to those calculated with sn-1- 
stearoyl-2-arachidonylglycerol.
The reaction velocity of the post gel filtration KCl-soluble DAG kinase 
increased with increasing concentrations of both sn- 1,2-dioleoylglycerol and sn-
1.2-dilauroylglycerol, the rates increasing as a hyperbolic function of sn- 1,2- 
diacyl glycerol concentration in both cases (Fig 4.3A). Expressing the 
concentrations of s/i-l,2-dioleoylglycerol and s/i-1,2-dilauroylglycerol as a mol 
fraction of the /7-octyl-|3,D-glucopyranoside/PtdSer/s/7-l,2-diacylglycerol mixed 
micellar phase in the assay mixture, the data was fitted to the Michaelis-Menten 
kinetic model. The enzyme possesses an apparent Km of 1.6 mol% for both sn-
1.2-dioleoylglycerol and 5/1-1,2-dilauroylglycerol. The fitted Vm ax values were 
calculated as 34.8 nmol/min/mg and 21.7 nmol/min/mg for s/7-l,2-dioleoylglycerol 
and s/7-l,2-dilauroylglycerol, respectively. These values agree with those 
determined by Eadie-Hofstee analysis of the same data (Fig 4.3B).
Comparison of these values to those obtained with s/z-l-stearoyl-2- 
arachidonylglycerol (apparent Km = 1.7 mol% and Vmax = 29.9 nmol/min/mg) 
suggests that the KCl-soluble DAG kinase does not exhibit any selectivity towards 
sn- l-acyl-2-arachidonylglycerols. The enzyme displayed similar apparent Km 
values for all three sn-1,2-diacylglycerol substrates with only small alteration in the 
V m ax between substrates. The specificity constant Vm ax was calculated as 
17.6, 21.8, and 13.6 nmol/min/mg/mol% for sn -l-stearoyl-2-arachidonylglycerol, 
sti- 1,2-dioleoyl glycerol and s//- 1,2-dilauroyl glycerol, respectively. Although these 
values would suggest that the KCl-soluble enzyme displays some specificity for s/7-
1.2-dioleoyl glycerol, this was not observed consistently. Routinely, similar Vm ax 
and apparent Km values were determined for the KCl-soluble DAG kinase with the 
above three s//-l,2-diacylglycerol substrates. Thus, the KCl-soluble enzyme of rat 
brain is not s/7-l-acyl-2-arachidonylglycerol-selective as it neither possesses a
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The DAG kinase reaction velocity was determined by the «-octyl-(3,D- 
glucopyranoside/PtdSer assay method (Section 2.4.3) in the presence of the 
indicated concentrations of sw-l,2-diacylglycerols, as appropriate, and 1.0 mM 
ATP. 20 pi of the post gel filtration preparation of the KCl-soluble DAG kinase 
(1.95 pg protein) was diluted to 50 pi with buffer E and employed to determine the 
reaction velocity. After 15 min, the reaction was terminated and the 
[32p]phosphatidic acid quantitated as described in Section 2.4.3. The protein 
concentration of the DAG kinase preparation was determined by the Coomassie dye 
method (Section 2.2.3). [□, sn- 1,2-dioleoyl glycerol; • ,  s«-l-stearoyl-2- 
arachidonylglycerol; O, sn-1,2-dilaurylglycerol]
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reduced Km for 5/j-l-stearoyl-2-arachidonyl glycerol compared to sn- 1,2- 
dioleoyl glycerol or 5/i-l,2-dilaurylglycerol, nor does it catalyse the phosphorylation 
of the sn- l-acyl-2-arachidonylglycerol with increased Vmax. This is different from 
the sn-l-acyl-2-arachidonylglycerol-selective DAG kinase of Swiss 3T3 fibroblasts 
(MacDonald et al., 1988b). This enzyme catalyses the phosphorylation of sn-1- 
stearoyl-2-arachidonylglycerol with a rate 2- to 8-fold higher than other sn- 1,2- 
diacyl glycerols, including sn- 1,2-dioleoyl glycerol. This is despite the fibroblast 
enzyme being incubated with sn- 1,2-diacyl glycerols concentrations capable of 
supporting maximal reaction velocities. Similarly, the sw-l-acyl-2- 
arachidonylglycerol-selective DAG kinase of baboon brain catalyses the 
phosphorylation of sn- 1-acyl-2-arachidonylglycerols with a reaction rate 3-fold 
higher than those measured with other 5//-l,2-diacylglycerols (Lemaitre et al.,
1990). Therefore, the KCl-soluble DAG kinase is not comparable to any 
previously characterised s«-l-acyl-2-arachidonylglycerol-selective enzyme and is 
unlikely to be the rat homologue of the selective enzymes identified in Swiss 3T3 
fibroblasts and baboon brain. It may be possible that the KCl-soluble DAG kinase 
loses its physiological selectivity for sn- 1,2-diacyl glycerol species when assayed in 
the w-octyl-p,D-glucopyranoside/PtdSer mixed micellar system. Possibly the KCl- 
soluble enzyme could catalyse the phosphorylation of sw-l-acyl-2- 
arachidonylglycerol with elevated velocity compared to non-arachidonyl sn-1,2- 
diacyl glycerols in the environment of the cell membrane, but loses this ability when 
incubated with substrate in a detergent mixed micelle. This is discussed further in 
Section 5.5. In addition, it must be acknowledged that the above investigation of 
sn-l,2-diacylglycerol selectivity of the KCl-soluble DAG kinase is made in the 
absence of a positive control. As discussed above, several groups have 
demonstrated 5«-l-acyl-2-arachidonylglycerol-selective DAG kinases using the n- 
octyl-p,D-glucopyranoside/PtdSer assay method. However, a positive control in 
the form a selective enzyme was not included in the study reported here. Such a 
control could be provided by the DAG kinase associated with the membranes of
Swiss 3T3 fibroblasts (MacDonald et al., 1988b). In the absence of such a control 
it is not apparent if the assay method would have allowed identification of an 
arachidonyl-selective enzyme.
Finally, it should be noted that the conclusions made about the substrate 
selectivity of the KCl-soluble DAG kinase assume that the sn-1,2-diacylglycerol 
concentrations were accurately determined. The enzymatic method described in 
Section 2.7 and in Paterson et al. (1991), which utilises the DAG kinase of E. coli, 
was employed to measure the concentrations of the sn-1,2-diacylglycerol stock 
solutions. This allowed the concentrations of sn- 1,2-dioleoyl glycerol and sn-1,2- 
dilaurylglycerol to be normalised to that of sn-1 -stearoyl-2-arachidonylglycerol. 
However, this does assume that the E. coli DAG kinase assay quantitates sn-1,2- 
diacylglycerols of different acyl-chain composition with equal identical efficiency. 
This is discussed further in Section 2.7.2.
4.4. ATP Concentration Dependence: Determination of Vmax and 
Apparent Values.
The reaction velocity of the KCl-soluble DAG kinase was measured over a 
range of ATP concentration (10 - 500 p M ), under conditions of near-saturating 
substrate concentrations with respect to sn -l-stearoyl-2-arachidonylglycerol (Fig 
4.4A).
Employing the «-octyl-p,D-glucopyranoside/PtdSer mixed micellar 
methodwith 3.7 mol% (2.0 mM) sn- 1 -stearoyl-2-arachidonylglycerol, the reaction 
velocity of the KCl-soluble DAG kinase increased as a hyperbolic function of ATP 
concentration (Fig 4.4A). Although maximal rates of reaction were not obtained 
over the above range of ATP concentrations, near maximal rates have been obtained 
with greater than 1.0 mM ATP (data not shown). The data was fitted to a 
Michaelis-Menten kinetic model and the Vmax and apparent Km of the KCl-soluble 
DAG kinase for ATP determined as 26.4 nmol/min/mg and 330 pM respectively. 
These values were found to correspond to those values determined graphically by
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an Eadie-Hofstee plot (Fig 4.4B). It is noticeable in the Eadie-Hofstee plot that the 
experimental values deviate from the fitted line. However, a Hill plot of the 
experimenta data was linear, with no deviation of the experimental values from the 
fitted line (Fig 4.4C). The Hill coefficient was determined as 0.93 and was taken to 
indicate that the enzyme was not allosterically regulated by increasing 
concentrations of ATP. The deviation of the experimental values from the fitted 
Eadie-Hofstee plot at low reaction velocities is most likely due to problems 
associated with accurate quantitation of the ATP concentrations within the assay 
incubation mixture. Eadie-Hofstee transformation of the experimental data served 
to emphasise this error and led to the deviation, whereas this did not occur with the 
Hill transformation.
The apparent ^ mof the KCl-soluble DAG kinase for ATP (330 pM) is 
similar to the Km values determined for several other DAG kinases. These values 
range from 125 to 300 pM (Table 3) and are all somewhat lower than the 
intracellular concentrations of ATP. This is illustrated in the example of rat brain 
where the steady-state concentration of ATP is 2.5 mM (Lehninger, 1982), yet the 
cytosolic and membrane-associated DAG kinases purified from this tissue by Kato 
and Takenawa (1990) have Km values of 125 pM and 250 pM, respectively, and 
the KCl-soluble enzyme has a Km for ATP of 330 pM. This would seem to 
indicate that all three rat brain activities discussed here, would operate at near 
maximal rates of reaction with respect to ATP concentration. This would indicate 
cellular DAG kinase activity is not modulated by intracellular ATP concentrations, 
but by another mechanism, e.g. by sw-l,2-diacylglycerol concentration or the 
enzyme's phosphorylation state. If cellular DAG kinase activity were to be 
regulated by intracellular ATP concentrations, the Km of the enzyme would require 
to be altered by a process independent of ATP concentration, e.g. alteration of the 
enzymes' Km for ATP in response to phosphorylation/dephosphorylation of the 
protein or Ca2+-binding to a regulatory domain, as is observed with the porcine 80 
kDa DAG kinase (Sakane et al., 1991) Until methods that would allow
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A. ATP concentration dependence of the KCl-soluble DAG kinase's reaction 
velocity.
B. Eadie-Hofstree plot of data shown in A.
C. Hill plot of the data shown in A.
DAG kinase reaction rate was determined as described in Fig 4.2. 20 pi of the post 
gel filtration preparation of the KCl-soluble DAG kinase (1.95 pg protein) was 
diluted to 50 pi with buffer Eand incubated with 2.0 mM (3.7 mol%) s n - 1- 
stearoyl-2-arachidonylglycerol and the indicated concentrations of ATP. The 
protein concentration of the KCl-soluble DAG kinase preparation was determined 
as decribed in Fig 4.2.
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the study of such changes in DAG kinase's kinetic parameters on cell activation are 
developed, this question remains open.
Further characterisation of the nucleotide requirements of KCl-soluble DAG 
kinase and, indeed, the concentration dependence of the enzyme on nucleotides as 
substrates or competitive inhibitors was not investigated. It should, however, be 
noted that the reaction rate of the DAG kinase partially purified from rat liver 
cytosol was reduced by 72.1% by the addition of 2.0 mM ADP (^fm = 170 pM) 
when present with 2.0 mM ATP substrate (Kanoh & Ohno, 1981). Subsequently, 
ADP was found to inhibit that rat liver enzyme with a of 50 pM (Kanoh &
Ohno, 1981). Moreover, both the cytosolic and membrane-associated DAG 
kinases of rat brain were inhibited 77 % and 66 %, respectively, by 500 pM ADP 
when assayed with 1.0 mM ATP (Kato & Takenawa, 1990). Thus, from this in 
vitro evidence, it would appear that the cellular DAG kinase activity may be 
regulated by alteration of the cell's energy charge. Is the physiological reaction 
velocity of DAG kinase tightly coupled to the energy charge of the cell? As 
discussed earlier, it would seem that under cellular ATP concentrations, the DAG 
kinases operate at maximal rates with respect to ATP. However, intracellular ADP 
concentrations in rat brain, for example, have been reported at 730 pM (Lehninger, 
1982). Thus, due to ADFs action as a competitive inhibitor of rat brain and liver 
DAG kinases (see above), intracellular concentrations of ADP would be expected to 
reduce the physiological reaction velocity of these enzymes from the values 
obtained in the presence of ATP alone. Therefore, acceleration of cell metabolism 
and alteration of the energy charge of the cell may result in modulation of the 
cellular DAG kinase reaction velocity. Nevertheless, it is more likely that the 
reaction velocity of PtdOH production within the cell is dependent on the rate of sn-
1,2-diacyl glycerol production within the cell and not inhibition of the DAG kinase 
activity responsible for its removal. However, inhibition of DAG kinase by cellular 
concentrations of ADP could dictate the longevity of sn- 1,2-diacyl glycerol within 
the cell and, thus, the signal modulated by this second messenger. This
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observation is tentative and very preliminary in nature as investigation of DAG 
kinase rates of reaction in the presence of ATP and ADP concentrations equivalent 
to those experienced in a resting cell and also those experienced during 
physiological fluctuations of cellular energy charge have still to be undertaken.
4.5. Dependence on Phosphatidylserine for Activity?
The DAG kinase activity in Swiss 3T3 fibroblasts identified by MacDonald 
et al. (1988a) as the cellular activity responsible for the phosphorylation of the sn-
1,2-diacylglycerol produced in response to PDGF was membrane-associated and 
apparently selective for s«-l-acyl-2-arachidonylglycerol. These workers also 
observed the DAG kinase reaction rate of Swiss 3T3 cell lysates to be increased by 
inclusion of PtdSer in the reaction mixture, with the effect being maximal at 6 mol% 
(MacDonald et al., 1988a). Similar activation was observed with the DAG kinase 
activity of membranes fractionated from Swiss 3T3 cell lysates (MacDonald et al., 
1988b). This activation was found to result both from an increase in the enzyme's 
V^ax and a lowering of its apparent Km for sn-1 -stearoy 1 -2-arachidonylglycerol. 
PtdSer has also been reported to enhance the Ca2+-dependent activation of the 
porcine cytosolic 80 kDa DAG kinase when the enzyme has been assayed in an n- 
octyl-p,D-glucopyranoside mixed micellar assay system (Sakane et al., 1991a). 
Although a small increase in the porcine DAG kinase's reaction rate could be 
measured in the presence of 10 pM Ca2+ alone, the presence of 10 pM Ca2+ and 20 
mol% PtdSer resulted in a 10-fold reduced Km for ATP and approximately 4-fold 
higher Vmax without any significant alteration in the apparent Km for sn-1,2- 
diacylglycerol (Sakane et al., 1991). However, this phospholipid-dependent 
activation of the 80 kDa DAG kinase, in the presence of 10 pM Ca2+, was only 
observed at concentrations above 10 mol% PtdSer and greater than 20 mol% PtdSer 
was required to provide maximal Ca2+-stimulated activity (Sakane et al., 1991a). 
These concentrations of PtdSer are somewhat higher than the 6 mol% found to 
produce maximal activation of the membrane-associated DAG kinase of Swiss 3T3
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fibroblast membranes (MacDonald et al., 1988b). This may reflect the difference in 
the two observed phenomena: a Ca2+/phospholipid dependency of the porcine 
cytosolic enzyme and a PtdSer dependency, alone, of the Swiss 3T3 membrane- 
associated activity. Activation of DAG kinase reaction velocity by PtdSer is not 
limited to these two enzymes; although less well characterised, PtdSer has been 
reported to increase the reaction rate of the 80 kDa enzyme of pig brain (Kanoh et 
al., 1983) and platelets (Yada etal., 1990).
To assess if the KCl-soluble DAG kinase was activated by PtdSer, the 
reaction velocity of the enzyme was measured in the w-octyl-p,D-glucopyranoside 
mixed micellar assay system with increasing concentrations of PtdSer. Increasing 
the PtdSer concentration of the detergent mixed micelle solution from 0 to 14 mol% 
resulted in no significant increase in the reaction velocity of the KCl-soluble enzyme 
(Fig 4.5). The reaction velocity of the enzyme was measured with near-saturating 
concentrations of ATP and s«-l,stearoyl-2-arachidonylglycerol, therefore it can be 
concluded that no significant alteration in the DAG kinase's Vmax was observed. 
However, the effect of PtdSer on the enzyme's apparent Km for either substrate 
was not assessed. Furthermore, direct comparison of the KCl-soluble DAG 
kinase's Vmax and Km values in the presence and absence of PtdSer was not made. 
In the absence of such information and from the information presented in Fig 4.5, it 
would appear that PtdSer does not activate the KCl-soluble DAG kinase by 
elevating the enzyme's Vmax. Thus, the KCl-soluble DAG kinase is unlike the 
membrane-associated enzyme of Swiss 3T3 fibroblasts as it is neither s«-l-acyl-2- 
arachidonylglycerol-selective in an «-octyl-p,D-glucopyranoside mixed micelle, nor 
is it activated by PtdSer.
4.6. M agnesium Concentration Dependence.
The effect of magnesium on the reaction rate of the KCl-soluble DAG 
kinase was assessed. The rate of PtdOH formation was determined over the range
6.0 x 10*7 M to 23.4 x 10*3 M Mg2+ (Fig 4.6A; personal communication, S.
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Fig 4.5. Effect of PtdSer on the Reaction Velocity of the KCl- 
soluble DAG Kinase.
10 id of the post heparin-agarose preparation of the KCl-soluble DAG kinase (0.8 
fig protein) was diluted to 50 pi with buffer E and assayed for DAG kinase activity 
in the presence of the indicated concentrations of PtdSer, 2.0 mM ATP and 2.0 mM 
(3.7 mol%, at 7.5 mol% phosphatidylserine) sn -l-stearoyl-2-arachidonylglyceol 
by the method described in Fig 4.2. The protein concentration of the DAG kinase 
preparation was determined by the Coomassie dye method (Section 2.2.3).
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Gardner). The enzyme's rate of reaction was found to increase as a hyperbolic 
function of Mg2+ concentration when measured in the «-octyl-|3,D- 
glucopyranoside/PtdSer mixed micellar assay system in the presence of 1.0 mM 
ATP and 3.7 mol% (2.0 mM) s«-l-stearoyl-2-arachidonylglycerol (Fig 4.6A). 
Although the rate of reaction was not determined at concentrations less than 600 
nM, it would appear that the KCl-soluble DAG kinase is dependent on the presence 
of magnesium for activity, regardless of whether the magnesium concentration is 
plotted as the sum of free Mg2+ and MgATP2- together, or as free Mg2+ alone (Fig 
4.6B). Maximal rates of reaction were obtained with 7.0 mM free Mg2+, with no 
further significant increase in the measured rate of reaction at greater concentrations 
of Mg2+ (Fig 4.6B).
The Mg2+-dependence of the KCl-soluble DAG kinase is comparable to that 
of the porcine 80 kDa enzyme (Kanoh et al., 1983) and the 150 kDa membrane- 
associated DAG kinase of rat brain.(Kato & Takenawa, 1990). The reaction 
velocities of both of these purified DAG kinases increase as a hyperbolic function 
of Mg2+ concentration when measured by a deoxycholate/s«-l,2-diaylglycerol 
dispersion assay method, reaching maximal values at 5.0 mM. However, when the 
deoxycholate in the reaction mixture is replaced by 0.5 mM PtdSer or 0.5 mM 
PtdCho, the porcine 80 kDa enzyme requires 8.0 and 24.0 mM Mg2+, respectively, 
for maximal reaction velocities. Not only does the porcine enzyme require greater 
concentrations of magnesium, in the presence of PtdSer and PtdCho, than the KCl- 
soluble DAG kinase for maximal reaction velocities, its rate of reaction increased as 
a sigmoidal rather than hyperbolic function of increasing Mg2+ concentration in the 
presence of these phospholipids (Kanoh et al., 1983). The 110 kDa cytosolic DAG 
kinase of rat brain was also found to display a sigmoidal dependence on Mg2+ for 
activity, reaching maximal rates at 20.0 mM when assayed in a deoxycholate/5/2-
1,2-diacyl glycerol dispersion assay system (Kato & Takenawa, 1990). 
Nevertheless, such sigmoidal rate dependencies on magnesium haven't, however, 
been observed with the KCl-soluble DAG kinase.
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Fig 4.6. M g2+ C oncentration Dependence of DAG kinase A ctivity.
A. Concentration dependence on free Mg2+-
B. Concentration dependence on free Mg2+ compared to the sum of free Mg2+ 
and MgATP2-.
20 pi of the post-hydroxyapatite preparation of the KCl-soluble DAG kinase (1.2 
pg protein) was diluted to 50 pi with buffer E and assayed for DAG kinase 
activity. DAG kinase reaction velocity was determined in the presence of 1.0 mM 
ATP, 2.0 mM (3.7 mol%) jtf-l-stearoyl-2-arachidonylglyceol and the indicated 
concentrations of Mg2+ by the method described in Fig 4.2. The desired Mg2+ 
concentrations were established by increasing concentrations of Mg2+ in the 
presence of 2.0 mM EDTA and 1.0 mM EGTA in the reaction mixture. The total 
Mg2+ concentration required was calculated with the program React 2, a kind gift 
from Dr. G. Smith. The protein concentration of the DAG kinase preparation was 
determined by the Coomassie dye method (Section 2.2.3). [O, free Mg2+; • ,  free 
Mg2+ with MgATP2']
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Whilst this investigation of the Mg2+-dependency of the KCl-soluble DAG 
kinase is preliminary in nature, it would seen reasonable to conclude that inclusion 
of at least 7.0 mM MgCl2 in the reaction mixture allows the enzyme reaction to 
proceed under conditions where the Mg2+ concentration is not limiting. Thus, 
under the reaction conditions of the DAG kinase assay described in Section 2.4.3, 
enzyme activity is determined under conditions where reaction velocity is not 
limited by the Mg2+ concentstion.
4.7. Dependence on Calcium for Activity?
Cloning of the purified porcine 80 kDa DAG kinase revealed that the 
primary structure of this protein possessed two sequences with high levels of 
homology to the E-F hand motifs typical of calcium binding proteins (Sakane et al., 
1990), e.g. calmodulin; Ca2+-activated neutral protease, calpain; troponin C; and 
calcineurin B (Moncrief et al., 1990). Sakane and co-workers found the activity of 
the 80 kDa DAG kinase to be enhanced in vitro by lO7 - lO ^M  Ca2+ in the 
presence of deoxycholate or sphingosine. Furthermore, the porcine 80 kDa DAG 
kinase bound Ca2+ with high affinity (Kd = 0.3 pM) and a stoichiometry of two 
mol of Ca2+ per mol of enzyme (Sakane et al., 1991a). Binding was observed to 
be cooperative (Hill coefficient = 1.4), with both Ca2+ ions required to be bound 
for Ca2+ activation of the enzyme. Activation of the porcine DAG kinase by 10"5 M 
Ca2+, in an H-octyl-p,D-glucopyranoside mixed micellar assay, was much greater 
when in the presence of PtdSer. When measured by this method, activation was 
observed as a 4-fold elevation of the DAG kinase's Vmax and a 10-fold reduction in 
its Km for ATP , with no alteration in its apparent Km for s«-l,2-diacylglycerol 
(Sakane et al., 1991a).
Activation by Ca2+ is not restricted to the porcine 80 kDa DAG kinase, the 
reaction velocity of the 110 kDa cytosolic DAG kinase of rat brain is enhanced 
approximately 5-fold over the range 10‘5 - 10-3 M Ca2+ (Kato & Takenawa, 1990). 
Although requiring greater concentrations of ( lO 4- 10'3M), the 150 kDa
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membrane-associated DAG kinase is also elevated by Ca2+ (Kato & Takenawa, 
1990). It should be noted, however, that the measured reaction rates of the porcine 
80 kDa DAG kinase and both rat brain enzymes are apparently inhibited by greater 
than 10'3 M Ca2+. Therefore, the effect of Ca2+ on the reaction rate of the KC1- 
soluble DAG kinase was investigated. In particular, the effect of increasing the 
Ca2+ concentration through the physiological concentration range of the cation was 
investigated.
The reaction rate of the partially purified KCl-soluble DAG kinase was 
measured in the «-octyl-p,D-glucopyranoside/PtdSer mixed micellar assay system 
in the presence of 10~8 - 10'5 M free Ca2+ (Fig 4.7). Under these conditions, the 
enzyme was unresponsive to alterations of the free Ca2+ concentration within the 
assay mixture. Alteration of the free Ca2+ from 10’8 to 105M in a Ca2+/EGTA 
buffer system resulted in no significant alteration of the reaction velocity from that 
obtained at 10 nM Ca2+ (151 nmol/min/mg). However, this observation is from a 
single experiment conducted in triplicate at each Ca2+ concentration and, thus, any 
conclusions drawn must remain tentative.
As the reaction velocity of the KCl-soluble DAG kinase was determined in 
the presence of 2.0 mM sn -l-stearoyl-2-arachidonylglycerol and 2.0 mM ATP 
(both determined as near-saturating concentrations under identical assay 
conditions), it would appear that the Vmax of the enzyme is not altered by increasing 
the free Ca2+over the range 10-8 - 10-5 M. The effect of such Ca2+ concentrations 
on the Km of the enzyme for either sn -l-stearoyl-2-arachidonylglycerol or ATP has 
still to be determined. Therefore, it cannot be concluded that physiological 
concentrations of Ca2+ have no effect on the KCl-soluble enzyme, especially as 
10*5 M free Ca2+ was found to 10-fold reduce the Km of the porcine 80 kDa DAG 
kinase for ATP in a similar n -octyl-p,D-glucopyranoside/PtdSer assay system 
(Sakane et al., 1991).
In conclusion, no apparent alteration of the Vmax of the KCl-soluble DAG 
kinase was observed as the Ca2+ concentration was increased through the
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Fig 4.7. Effect of Calcium on the Reaction Velocity of the KCI- 
Soluble DAG Kinase.
20 pi of the post heparin-agarose preparation of the KCl-soluble DAG kinase (1.6 
|iig protein) was diluted to 50 pi with buffer E and assayed for DAG kinase activity. 
DAG kinase reaction velocity was determined in the presence 2.0 mM ATP, 2.0 
mM (3.7 mol%) sn - l-stearoyl-2-arachidonylglyceol and the indicated free Ca2+ 
concentrations by the method described in Fig 4.2. The free Ca2+ concentrations in 
the reaction mixture were achieved by the inclusion of Ca2+ and 1.0 mM EGTA. 
The total Ca2+ required was calculated from the program React 2, a kind gift from 
Dr. G. Smith. The protein concentration of the DAG kinase preparation was 
determined by the Coomassie dye method (Section 2.2.3).
161
physiological range of this ion. Although, the Km for either substrate was not 
determined, this would seem to indicate that the activity of the KCl-soluble DAG 
kinase of rat brain is not modulated by alterations in physiologically relevant free 
Ca2+. This conclusion does, however, assume that the Ca2+ responsiveness of 
KCl-soluble enzyme is not dependent on any phospholipids or other membrane- 
associated activators distinct from PtdSer. This also assumes that the activity of 
KCl-soluble DAG kinase is not modulated by physiological Ca2+ concentrations via 
a second protein, for example calmodulin, as this was not investigated further.
4.8. pH D ependence of Activity.
A preliminary investigation was made into the effect of pH on the reaction 
velocity of the KCl-soluble DAG kinase. The enzyme's rate of reaction was 
measured over the range pH 5.0 to 9.0 using an rc-octyl-p,D- 
glucopyranoside/PtdSer mixed micellar assay method modified from that described 
Section 2.4.3. The above range of pH in the reaction mixture was established with 
50 mM Mes/NaOH over the range pH 5.0 to 7.2 and 50 mM Tris/HCl from pH 7.2 
to 9.0, these buffers replacing the customary 50 mM Mops/NaOH, pH 7.2.
In the standard reaction mixture, replacing 50 mM Mops/NaOH, pH 7.2 
with either 50 mM Mes/NaOH, pH 7.2 or 50 mM Tris/HCl, pH 7.2 resulted in no 
significant alteration of the KCl-soluble DAG kinase's reaction rate (Fig 4.8A). 
Reduced reaction velocities compared to those measured at pH 7.2 were observed 
at pH 5.0 (Fig 4.8B). Increasing the pH of the reaction mixture from pH 5.0 to 
pH 6.5 resulted in a progressive increase in reaction rates to levels similar to those 
measured at pH 7.2. Further increasing the pH from pH 6.5 to pH 8.0 resulted in 
no further significant increase in DAG kinase reaction velocity. However, further 
increasing the pH from 8.0 to 9.0 did result in reaction rates that were greater than 
those measured at pH 7.2. Therefore, the reaction rate of the KCl-soluble DAG 
kinase does not fluctuate in the physiological pH range. Below this range the 
KCl-soluble enzyme's activity is reduced, whereas above pH 8 the reaction
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Fig 4.8A. Diacylglycerol Kinase Reaction Velocity at pH 7.2: Effect 
of Mes, Tris and Mops Buffers.
10 pi of the post heparin-agarose preparation of the KCl-soluble DAG kinase (0.8 
(Ltg protein) was diluted to 50pl with buffer E and assayed for DAG kinase activity. 
DAG kinase reaction velocity was determined in the presence 1.0 mM ATP and 2.0 
mM (3.7 mol%, at 7.5 mol% phosphatidylserine) sw-l-stearoyl-2- 
arachidonylglycerol by the method described in Fig 4.2. The reaction velocity was 
also determined under identical conditions except for substitution of the 50 mM 
Mops/NaOH in the reaction mixture with 50 mM Mes/NaOH, pH 7.2 and 50 mM 
Tris/HCl, pH 7.2. After 35 min, the reaction was terminated and the 
P 2P]phosphatidic acid quantitated as described in Fig 4.2. The protein 
concentration of the DAG kinase preparation was determined by the Coomassie dye 
method (Section 2.2.3).
Fig 4.8B. pH Dependence of Diacylglycerol Kinase Reaction 
V elocity .
DAG kinase reaction velocity was determined with 10 pi of the post heparin- 
agarose preparation (diluted to 50 pi with buffer E). Unless otherwise stated, the 
reaction velocity was determined in the presence of 1.0 mM ATP and 2.0 mM (3.7 
mol%) sn -l-stearoyl-2-arachidonylglycerol by the method described in Fig 4.2. 
The pH of the reaction mixture was established over the range pH 5.0 to 7.2, as 
indicated, with 50 mM Mes/NaOH and over the range pH 7.2 to 9.0, as indicated, 
with 50 mM Tris/HCl. The reaction was terminated after 35 min and the 
[32P]phosphatidic acid quantitated as described in Fig 4.2. The protein 
concentration of the DAG kinase preparation was determined by the Coomassie 
dye method (Section 2.2.1). [O, 50 mM Mes/KOH; • ,  50 mM Mops/KOH]
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velocity is enhanced (Fig 4.8B). This profile is different from the pH dependencies 
reported for the previously purified cytosolic and membrane-associated DAG kinase 
activities of rat brain. Both these enzymes displayed marked pH optima at 7.4, 
with reaction rates dropping rapidly above pH 7.5 (Kato & Takenawa, 1990). 
Similarly, the pH dependency of the KCl-soluble DAG kinase is also different from 
that of the 121 kDa cytosolic DAG kinase of rat liver, which displayed optimal rates 
between pH 8.0 and 8.5 (Kanoh & Ohno, 1981).
The profile of the pH dependency of the KCl-soluble DAG kinase's reaction 
velocity could indicate the presence of two enzyme activities, one with optimal 
activity at pH 6.5, the other with optimal activity at pH 8.5 (Fig 4.8B). This is 
unlikely as the enzyme preparation employed in this experiment was observed to 
elute as a single peak of activity both from heparin-agarose (Fig 3.9) and 
hydroxyapatite (Fig 3.10). This would indicate that the enzyme preparation 
contains a single DAG kinase activity. It is more likely, however, that the elevation 
of reaction rate observed above pH 8.0 is a result of the fourth ionisation of ATP. 
This suggests that the reaction velocity of the KCl-soluble DAG kinase is elevated 
when ATP is fully ionised.
4.9. Inorganic Phosphate: Effect on Determined Apparent K m and 
Vmax Values of KCl-soluble DAG kinase for ATP Substrate.
As discussed in Section 3.10, the inclusion of 20.0 mM potassium 
phosphate during measurement of the KCl-soluble DAG kinase rates of reaction 
was found to alter the measured rate from that determined in the absence of 
potassium phosphate. This was done in an attempt to assess what effect the 
presence of phosphate, used in the elution of KCl-soluble DAG kinase activity from 
hydroxyapatite, would have on the measurement of the DAG kinase activity present 
in the fractions obtained after hydroxyapatite chromatography. Using the 
deoxycholate/PtdSer dispersion assay, routinely employed in the measurement of 
DAG kinase activity in chromatography eluants, the presence of 20.0 mM
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potassium phosphate was found to reduce the measured rate of reaction to 54% of 
that measured in the absence of potassium phosphate. To further characterise the 
effect of potassium phosphate on the rate of reaction of KCl-soluble DAG kinase, 
the effect of 20 mM potassium phosphate on the determined Km and Vmax values 
of the enzyme was examined.
The ATP concentration dependence of the KCl-soluble DAG kinase reaction 
velocity was measured in the absence and presence of 20.0 mM potassium 
phosphate, using the «-octyl-|3,D-glucopyranoside/PtdSer mixed micellar assay 
system, and the Km and Vmax values determined (Fig 4.9A). In the presence of
20.0 mM potassium phosphate, pH 7.2 the apparent Km was found to fall from 
330 pM to 76.0 pM when fitted to a Michaelis-Menten kinetic model. Fitting the 
data to this model revealed no significant alteration of the apparent Vmax of the 
enzyme in the presence of potassium phosphate. Only a slight reduction of the 
determined Vmax value from 26.4 nmol/min/mg to 25.4 nmol/min/mg in the 
presence of potassium phosphate was observed for the post-gel filtration 
preparation. These values closely correlate to those obtained by graphical Eadie- 
Hofstee analysis of the data (Fig 4.9B). This would seem to suggest that 20.0 mM 
potassium phosphate acts as an activator of the KCl-soluble DAG kinase in this 
assay system, acting by reducing the apparent Km of the enzyme for ATP with no, 
or little, measurable effect on the Vmax obtained in such an assay system.
A preliminary investigation showed this effect to be localised to the ATP 
binding site of the enzyme with no effect on the apparent Km of the enzyme for sn 
-l-stearoyl-2-arachidonylglycerol substrate. At 2.0 mM ATP (Km =330 pM) a 
concentration found to produce near maximal rates of reaction, with respect to 
ATP concentration, the presence of 20.0mM potassium phosphate was found not 
to affect the rate of reaction at both saturating and limiting concentrations of sn-1- 
stearoyl-2-arachidonylglycerol (3.8 and 0.38 mol%, respectively). However, at 
50 pM ATP the presence of 20.0 mM potassium phosphate was found to increase
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Fig 4.9. Effect of 20 mM Potassium  Phosphate on the ATP
D ependence of DAG Kinase Reaction Velocity.
A. Comparison of the ATP dependence of the KCl-soluble DAG kinase in the 
presence and absence of 20 mM potassium phosphate.
B. Eadie-Hofstee plot of the data shown in A.
20 pi (1.95 pg protein) of the post gel filtration preparation of the KCl-soluble 
DAG kinase was diluted to 40 pi with buffer E and assayed for DAG kinase 
activity. DAG kinase reaction velocity was determined in the presence or absence 
of 20.0 mM potassium phosphate with 2.0 mM (3.7 mol%) sw-l-stearoyl-2- 
arachidonylglycerol and the indicated concentrations of ATP by the method 
described in Fig 4.2. The potassium phosphate was delivered to the reaction 
mixture as 10 pi of a lOx stock solution (200 mM potassium phosphate, pH 7.2 in 
buffer E). The protein concentration of the DAG kinase preparation was 
determined by the Coomassie dye method (Section 2.2.3). [ • ,  - 20 mM potassium
phosphate; O, +20 mM potassium phosphate]
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the rate of reaction at both 3.8 and 0.38 mol% sn -l-stearoyl-2-arachidonylglycerol. 
Therefore, it would seem that 20.0 mM potassium phosphate, in the n -octyl-p,D- 
glucopyranoside/PtdSer assay system, acts on the KCl-soluble DAG kinase at the 
ATP-binding site, lowering the £ m of the enzyme for this substrate without altering 
the Vmax of the enzyme or the Km for the sn -l-stearoyl-2-arachidonylglycerol 
substrate. It is difficult to reconcile the inhibitory effect of 20.0 mM potassium 
phosphate on the enzyme in the deoxycholate/PtdSer dispersion assay system with 
this result. However, it may suggest an additional effect of phosphate on the DAG 
substrate when presented at the sub-maximal concentration of 200 pM, apart from 
the effect of phosphate in reducing the apparent Km of the enzyme for ATP.
A phosphate concentration dependency of this activation of the KCl-soluble 
DAG kinase remains to be determined. Until this is undertaken, the effect of 
physiological concentrations of phosphate in brain, reported as 2.7 mM (Lehninger, 
1982), will remain unkown. In addition, the Kx for phosphate acting as an 
inhibitor, and indeed the nature of the inhibition of the KCl-soluble DAG kinase in 
the dispersion assay system has still to be determined.
What is the physiological role of such an activation, i.e. the reduction of the 
Km for ATP? It must of course be recognised that this effect may be secondary to 
the complex nature of the mixed micellar kinetic analysis of an enzyme with a lipid 
substrate. Mixed micellar systems allow kinetic characterisation of an enzyme 
towards lipid substrates or phospholipid activators without need for correlation to 
their solubility, orientation and, thus, presentation in an aqueous enviroment. It is, 
however, limited to being an artificial presentation of the physiological lipid 
substrates or activators and, thus, only limited a comparison can be made to the in 
vivo situation of the enzyme. This may explain the dual role of potassium 
phosphate as an activator in the mixed micellar assay system and as an inhibitor in 
the deoxycholate/PtdSer dispersion system. However, rather then being 
artefactual, the observed effect of potassium phosphate may identify the 
physiological interaction of another phosphorylated compound with KCl-soluble
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DAG kinase, which may be eliciting an alteration of the enzyme's for ATP. 
Moreover, such a physiological activator may do so at its physiological 
concentration, not at supraphysiological concentrations as appears to be the case for 
potassium phosphate. However, this is a tentative suggestion and requires further 
investigation.
4.10. Kinetic Characterisation of KCl-Solubilised Diacylglycerol 
Kinase: Summary.
After the preliminary characterisation of partially purified 
preparations of the KCl-soluble DAG kinase of rat brain, the following may be 
concluded: The Km for sn -l-stearoyl-2-arachidonylglycerol (1.7 mol%) is similar 
to that obtained for the arachidonyl-specific DAG kinase activity of Swiss 3T3 
fibroblast membranes (MacDonald et al., 1988b) when assayed under similar 
conditions. The KCl-soluble DAG kinase did not display a similar degree of 
specificity towards this substrate over other sn- 1,2-diacyl glycerols, as reported for 
the Swiss 3T3 fibroblast DAG kinase activity (MacDonald et al., 1988b) and the 
arachidonyl-specific DAG kinase isozyme of baboon brain (Lemaitre et al., 1990). 
The apparent Km of the KCl-soluble DAG kinase for ATP (330 pM) was similar to 
the apparent Km values for ATP obtained by other workers for pure or partially 
purified preparations of DAG kinase from various sources. The KCl-soluble DAG 
kinase was dependent on the presence of Mg2+ for activity, with maximal rates of 
reaction obtained at concentrations of 7.0 mM, or greater, total Mg2+. The KCl- 
soluble DAG kinase activity did not require the presence of either Ca2+ or PtdSer 
for activity with the activity remaining insensitive to any alteration of PtdSer 
concentration or the range found to activate the membrane-associated DAG kinase 
activity of Swiss 3T3 fibroblasts. It was also insensitive to alteration of the Ca2+ 
concentrations in vitro over the range demonstrated physiologically to be able to 
activate the porcine 80 kDa DAG kinase. Finally and curiously, the presence of 20 
mM potassium phosphate in the assay mixture resulted in the reduction of the
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apparent Km of the KCl-soluble DAG kinase for ATP from 330 pM to 76.0 pM 
without significant alteration of the determined Vmax and without any apparent 
alteration of the interaction of the sn- 1,2-diacyl glycerol substrae with the kinase. 
Although the significance of physiological concentrations of phosphate have still to 
be determined, the role of such a specific alteration of the apparent Km has still to 
reconciled.
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C hap ter 5
Concluding D iscussion.
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5.1. Characterisation of the DAG Kinase Involved in Receptor- 
Stim ulated PtdIns(4,5)P2 Turnover.
A specific DAG kinase isoenzyme is associated with the task of 
phosphorylating the sn-1,2-diacylglycerol produced on receptor-stimulated 
PtdIns(4 ,5)P2 hydrolysis. PDGF stimulation of Swiss 3T3 fibroblasts in the 
presence of cell-permeable sn- 1,2-didecanoylglycerol results in the preferential 
phosphorylation of the sn- 1,2-diacyl glycerol produced endogenously (MacDonald 
et al., 1988a). This is despite sn- 1,2-didecanoyl glycerol proving to be a substrate 
in unstimulated cells (MacDonald et al., 1988a). Employing the non-ionic 
detergent, «-octyl-p,D-glucopyranoside, in a mixed micellar assay system, the 
membrane-associated DAG kinase of Swiss 3T3 fibroblasts was observed to 
phosphorylate sn-1 -stearoyl-2-arachidonylglycerol with a reaction rate at least 2- 
fold greater than that recorded with other naturally occuring long-chain sn-1,2- 
diacyl glycerols also observed to accumulate on PDGF-stimulation, e.g. sn-1,2- 
dioleoylglycerol (MacDonald et al., 1988b). In comparison, the cytosolic activity 
prepared from Swiss 3T3 fibroblasts exhibited no such elevated reaction rates 
towards sw-l-stearoyl-2-arachidonylglycerol (MacDonald et al., 1988b). In 
contrast to the membrane-associated enzyme, the cytosolic DAG kinase catalysed 
the phosphorylation of sn- 1,2-didecanoyl glycerol with reaction rates greater than 
measured with sw-l-stearoyl-2-arachidonylglycerol. It remains to be defined if 
multiple DAG kinase isoenzymes are situated on the membrane of these cells. 
However, of the isoenzymes present within the cell, it is a solely membrane- 
associated activity that initiates the metabolism of PtdIns(4 ,5)P2-derived sw-1,2- 
diacyl glycerols (MacDonald et al., 1988a). Furthermore, the DAG kinase that 
participates in this phosphorylation event is identifiable by a unique substrate 
specificity, catalysing the phosphorylation of sw-l-acyl-2-arachidonylglycerol with 
reaction rates several-fold greater than non-arachidonyl 1,2-diacyl glycerols.
Furthermore, such catalytic specificity towards sw-l-acyl-2- 
arachidonylglycerol appears to be a wide-spread phenomenon. In rat brain
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microvessels, exogenously added sw-l-palmitoyl-2-arachidonylglycerol is 
phosphorylated at a rate 1.7-fold greater than sn- 1 -pal mi toy 1 -2-oleoyl glycerol, the 
enhanced rate remaining in homogenised tissue (Hee-Cheong et al., 1985). The 
reaction velocity of the DAG kinase activity present in the particulate and soluble 
fractions prepared from rabbit aortic endothelial cell homogenates increases 3.4-fold 
when Jw-l-palmitoyl-2-oleoylglycerol replaces 5«-l-palmitoyl-2- 
arachidonylglycerol as substrate (Severson & Hee-Cheong, 1986). Finally, ans/z-
l-acyl-2-arachidonylglycerol-selective DAG kinase activity can be resolved from 
the non-selective activities which are solubilised from baboon brain (Lemaitre et al., 
1990).
5.2. The DAG Kinase Linked to Receptor-Stimulated PtdIns(4,5)P2 
Turnover: Evidence of Substrate Specificity in Vivo.
s«-l,2-Diacylglycerol produced from Ptdlns(4,5)P2 hydrolysis differs in its 
subcellular site of accumulation from the sustained phase of sn- 1,2-diacyl glycerol 
generated from other phospholipd sources (see Section 1.4.7). It is, however, 
accepted that they are both produced at the same location, i.e. the plasma 
membrane, and only partition to a distinct cellular location after their production. 
Initially their metabolic compartmentalisation is not served by distinct intracellular 
location and must, therefore, be achieved by another mechanism.
The sn-1,2-diacylglycerol generated from stimulated hydrolysis of 
PtdIns(4 ,5)P2 and other phospholipids are distinguishable by their acyl-chain 
composition and such molecular species distribution betrays the precursor 
phospholipid. This property was employed by Pessin and colleagues (1989, 1990) 
to identify the prevalent source of sn-1,2-diacylglycerol at various times after 
mitogenic stimulation of IIC9 fibroblasts. These workers observed Ptdlns was the 
major source after 15 sec, while after 5 min and 60 min 1,2-diacyl glycerol was 
almost exclusively produced from PtdCho hydrolysis. Additionally, they reported 
that although receptor-stimulated hydrolysis of Ptdlns may be the major source,
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PtdCho does contribute significantly to the stimulated levels of s//-l,2- 
diacylglycerol 15 sec after stimulation. These results indicated that the sn- 1,2- 
diacyl glycerol generated from PtdIns(4 ,5)P2 hydrolysis shortly after receptor 
stimulation could be specifically removed, thus leaving a pool of sn-1,2- 
diacylglycerol with molecular species characteristic of other phospholipid sources. 
The possibility exists that the acyl-chain composition of a sn-1,2-diacylglycerol 
molecule identifies its requirement for DAG kinase catalysed phosphorylation and 
re-entry to the PI-cycle or, conversely, guarantees its exclusion from this route of 
phospholipid resynthesis and commits it to the resynthesis of PtdCho.
25 - 30 % of the total labelled sn- 1,2-diacyl glycerol in quiescent 
pH]glycerol-labelled Swiss 3T3 fibroblasts co-migrates with 16:0/18:1 and 
18:0/18:2 diacyl glycerols on HPLC analysis, while only 9.5 % of the sn- 1,2- 
diacyl glycerol popoulation migrated with sw-l-stearoyl-2-arachidonylglycerol 
(Divecha et al., 1991). Also, Divecha et al. (1991) reported a 2-fold increase in sn-
1,2-diacylglycerol concentration 5 min after bombesin stimulation of Swiss 3T3 
cells and that the acyl-chain distribution within this expanded sn- 1,2-diacyl glycerol 
pool was unchanged. Although this is different to the previously reported sn-1 - 
stearoyl-2-arachidonylglycerol predominance in PDGF-stimulated Swiss 3T3 cells 
(MacDonald et al., 1988a), it is, however, noteworthy that Divecha et al. (1991) 
investigated the acyl-chain distribution amongst PtdOH after 5 min and observed a 
50 % increase in the pH]glycerol-labelledsw-l-stearoyl-2-arachidonylglycero-3- 
phosphate. This proved to be the predominant labelled PtdOH they observed on 
bombesin stimulation and illustrated the marked differences between the molecular 
species profile of sn- 1,2-diacyl glycerol and PtdOH in bombesin-stimulated Swiss 
3T3 fibroblasts. Together with their measurement of 5/z-l-stearoyl-2- 
arachidonylglycerol-3-phosphoinositol contributing to 25 % of the Ptdlns pool 
within Swiss 3T3 cells, Divecha and colleagues (1991) postulated that sn-l- 
stearoyl-2-arachidonylglycerol was a significant component of sn- 1,2- 
diacyl glycerol derived from agonist-stimulated PtdIns(4,5)P2 hydrolysis and that
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DAG kinase did, indeed, selectively phosphorylate this acyl-chain molecular 
species.
Non-radiometric molecular species analysis of the PtdOH present in total 
cell lipid can be achieved by dephosphorylation of the PtdOH to sn-1,2- 
diacylglycerol followed by derivitisation and reverse-phase HPLC separation of the 
s/2- 1,2-diacylglycerol product (Lee et al., 1991). Using this approach, the 
molecular species composition of the PtdOH in quiescent human SK-N-SH 
neuroblastoma cells was found to be similar to PtdCho, while the PtdOH generated 
5 min after muscarinic stimulation more closely resembled the acyl-chain 
composition of Ptdlns (Lee et al., 1991). It was their conclusion that shortly after 
stimulation, PtdOH was formed solely by the phosphorylation of Ptdlns-specific 
sn- 1,2-diacyl glycerols and not by the phosphorylation of sn-1,2-diacylglycerol 
formed on PtdCho hydrolysis. It should, however, be noted that alkaline 
phosphatase-catalysed dephosphorylation of PtdOH, as employed in the study of 
Lee and co-workers (1991), has been observed to dephosphorylate poly­
unsaturated molecular species of PtdOH with greater efficiency than saturated acyl- 
chain molecular species (N. Thompson, personal communication). Obviously, the 
selectivity of the alkaline phosphatase-catalysed dephosphorylation may lead to 
erroneous identification of the phospholipid precursor of the muscarinic-stimulated 
levels of PtdOH in SK-N-SH cells. However, Lee and colleagues (1991) found 
that muscarinic-stimulation of SK-N-SH cells in the presence of 32Pj resulted in the 
rapid labelling of PtdOH followed by labelling of Ptdlns, suggesting a precursor- 
product relationship between PtdOH and Ptdlns. Furthermore, the apparent 
precursor-product relationship would appear to confirm the original conclusion that 
the PtdOH formed 5 min after muscarinic-stimulation of SK-H-SH neuroblastoma 
cells is the product of enzymatic phosphorylation of phosphoinositide-derived s/2-
1,2-diacylglycerol (Leee ta l., 1991).
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5.3. The DAG Kinase Linked to Receptor-Stimulated PtdIns(4,5)P2 
Turnover is Identified by its Subcellular Location?
It would appear that a specific component of total cellular DAG kinase 
activity is involved in the phosphorylation of sw-1,2-diacyl glycerol produced on 
receptor-stimulated PtdIns(4 ,5)P2 hydrolysis and, moreover, the activity 
responsible can be identified by its catalytic selectivity towards sw-l-acyl-2- 
arachidonylglycerol compared to other sn-1,2-diacylglycerols (see Section 5.1). 
Given that DAG kinase activity is ubiquitously distributed throughout the cell, can 
the s«-l-acyl-2-arachidonylglycerol-selective DAG kinase isoenzyme be localised to 
a subcellular compartment coincident with the site of PtdIns(4 ,5)P2 hydrolysis ?
The generation of sn- 1,2-diacyl glycerol from receptor-stimulated 
PtdIns(4 ,5)P2 hydrolysis is limited to the location of the receptor/G-protein/Ptdlns- 
PLC complex, i.e. the plasma membrane. Transient accumulation of sn-1,2- 
diacylglycerol in the plasma membrane has been observed with a similar time- 
course to phosphoinositide hydrolysis and its longevity identical to the period of 
PtdOH formation in TRH-stimulated GH3 pituitary cells (Rebecchi et al., 1983; 
Martin et al., 1990). This strongly indicates that the transient elevation of plasma 
membranesn-l,2-diacylglycerol levels is a product of the rapid metabolism of 
PtdIns(4 ,5)P2-derived second messenger in this intracellular location. However, 
the sustained accumulation of src-1,2-diacylglycerol in the intracellular membranes 
of TRH-stimulated GH3 cells (Martin etal., 1990) could, in turn, represent the 
inability of DAG kinase to phosphorylate the sn-1,2-diacylglycerol constituting the 
sustained phase of elevated sn- 1,2-diacyl glycerol levels. This most likely 
represents a combination of DAG kinase being unable to catalyse the 
phosphorylation of the molecular species present in the sustained phase of elevated 
sn- 1,2-diacyl glycerol levels and also translocation of the sn-l, 2-diacylglycerol from 
the site of its production away from the location of the activity delegated to its 
phosphorylation.
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In agreement with the suggested location of such DAG kinase activity to the 
plasma membrane, PtdOH has been shown to accumulate preferentially in the 
plasma membrane on receptor activation (Seyfred & Wells, 1984). However, the 
identification of the DAG kinase isoenzyme involved in the stimulated turnover of 
PtdIns(4 ,5)P2, i.e. the s«-l-acyl-2-arachidonylglycerol-selective enzyme, has not 
been achieved by identification of the differential localisation of individual 
isoenzymes to the plasma membrane. Previous investigations of the membrane- 
associated sh-1-acyl-2-arachidonyl glycerol-selective isoenzymes in baboon brain 
and Swiss 3T3 membranes were performed with crude particulate fractions, 
without further localisation of the activity to a particular subcellular compartment 
(Lemaitre et al., 1990; MacDonald et al., 1988a, b). Therefore, subcellular fraction 
and localisation of individual isoenzymes to the plasma membrane, although of 
possible benefit in the identification of the activity responsible for phosphorylation 
of PtdIns(4 ,5)P2-derived sn- 1,2-diacyl glycerol, has not, to date, been reported. It 
is noteworthy, however, that an sn- 1 -acyl-2-arachidonylglycerol-selective activity 
has been identified and solubilised from the dense membrane fraction of porcine 
testis homogenate (S. Gardner, A. Paterson & M.J.O. Wakelam, unpublished 
result).
5.4. Further Evidence of a Specific DAG Kinase Isoenzyme 
Dedicated to the Phosphorylation of PtdIns(4,5)P2-Derived s/i-1 ,2- 
D iacy lg lycero l.
Extraction of baboon brain homogenate with 2 % w-octyl~p,D- 
glucopyranoside/0.3 M KC1 resulted in the solubilisation of three distinct DAG 
kinase isoenzymes that could be resolved by hydroxyapatite chromatography 
(Lemaitre et al., 1990). Of these resolved activities, two exhibited similar rates of 
reaction with either s«-l,2-dioleoylglycerol or 5W-l-stearoyl-2-arachidonylglycerol 
substrates when assayed by Triton X-100 or w-octyl-p, D-glucopyranoside mixed 
micellar assay methods. The third isoenzyme was, however, selective for its sn-
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1,2-diacylglycerol substrate in either Triton X-100 or «-octyl-p,D-glucopyranoside 
assay systems, phosphorylatings/i-l-stearoyl-2-arachidonylglycerol with a reaction 
rate 3-fold greater than that observed with .sw-l,2-dioleoyl glycerol (Lemaitre et al., 
1990). The truly selective nature of the stt-l-acyl-2-arachidonylglycerol-selective 
isoenzyme was further demonstrated by the preferential phosphorylation of sn-1- 
stearoyl-2-arachidonyl glycerol when co-presented with sn- 1,2-didecanoyl glycerol 
in an «-octyl-p,D-glucopyranoside mixed micellar assay system (Lemaitre et al., 
1990). This is identical to the situation observed when sw-l-acyl-2- 
arachidonylglycerol is co-presented with sn-1,2-didecanoylglycerol to the DAG 
kinase activity of Swiss 3T3 cell lysates (MacDonald et al., 1988a).
The 5/z- l-acyl-2-arachidonyl selective DAG kinases of Swiss 3T3 mouse 
fibroblasts and baboon brain are both membrane-associated, indicating a high 
degree of functional homology and most likely suggesting they perform identical 
roles within the stimulated cell (Lemaitre et al., 1990). However, unlike the 
membrane-associated DAG kinase activity of Swiss 3T3 fibroblasts, multiple 
resolvable DAG kinase activities have been identified within the membrane- 
associated compartment of baboon brain (Lemaitre et al., 1990). Of the three 
isoenzymes solubilised from the particulate fraction of baboon brain, only one 
displays the catalytic selectivity towards sn- 1 -acyl-2-arachidonylglycerol. This 
would seem to indicate that it is, indeed, a single membrane-associated isoenzyme 
that is active in catalysing the phosphorylation of sn-l,2-diacylglycerol generated 
on receptor-stimulated PtdIns(4 ,5)P2 hydrolysis.
Unfortunately, it would seen that observation of such s/z-l-acyl-2- 
arachidonylglycerol-specific DAG kinase activity is restricted by the method of 
solubilisation of the sn-1 ,2-diacylglycerol substrate (Lemaitre et al., 1990). In the 
study that identified the presence of a sw-1-acyl-2-arachidonyl glycerol-specific 
DAG kinase activity in baboon brain homogenate, Lemaitre and co-workers 
demonstrated that such catalytic selectivity could only be observed if the sn- 1,2- 
diacyl glycerol substrate was solubilised in the non-ionic detergents, w-octyl-p,D-
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glucopyranoside and Triton X-100, and not when dispersed with deoxycholate, an 
anionic detergent (Lemaitre et al., 1990). Similarly, MacDonald et al. (1988a, b) 
employed an /z-octyl-p,D-glucopyranoside mixed micellar assay method in their 
identification of an sn- 1 -acyl-2-arachidonylglycerol-selective DAG kinase in Swiss 
3T3 fibroblast membranes. The method of sn- 1,2-diacyl glycerol presentation in 
vitro is, thus, extremely important in the observation of catalytic selectivity toward 
5/2- l-acyl-2-arachidonylglycerol substrates. If the physiological behavior of DAG 
kinase towards sn- 1,2-diacyl glycerol substrates is to be observed, it is necessary to 
present the sn- 1,2-diacyl glycerol in as near a physiological setting as possible. It 
may not be surprising, therefore, that the 5/2-l-acyl-2-arachidonylglycerol-selective 
DAG kinase of baboon brain does not catalyse the phosphorylation of sn-1- 
stearoyl-2-arachidonylglycerol with greater reaction velocity than sn-1,2- . 
dioleoylglycerol when dispersed at concentrations of 0.5 mM in the presence of 2.0 
mM deoxycholate (Lemaitre et al., 1990). However, sn -l-acyl-2- 
arachidonylglycerol-selectivity was observed when the sn-1,2-diacylglycerol 
substrate was solubilised as a minor component (7.4 mol%) of a /z-octyl-p,D- 
glucopyranoside/PtdSer mixed micelle (Lemaitre et al., 1990). Although not 
identical to the phospholipid bilayer of a cell membrane, this observation of 5/1-I- 
acyl-2-arachidonylglycerol-selectivity may indicate that sn-1,2-diacylglycerol 
intercalated in an /z-octyl-p,D-glucopyranoside/PtdSer mixed micelle more closely 
approximates to the physiological presentation of sn- 1,2-diacyl glycerol within the 
cell membrane than sn- 1,2-diacyl glycerol dispersed in aqueous solution with 2.0 
mM deoxycholate (c.m.c. = 5.0 mM).
5.5. DAG Kinase Assay Methodology Affects Measured Reaction 
V elo c ities .
5.5.1. DAG Kinase Reaction Velocities are Influenced by the j /i - 1,2- 
Diacylglycerol Substrate Environment in an Isoenzyme-Specific 
M anner.
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Generally, it has been demonstrated that individual DAG kinase isoenzymes 
display different rates of reaction depending on the method of sn-1,2-diacylglycerol 
substrate presentation in vitro. Presentation of sn-1,2-diacylglycerol either 
dispersed in aqueous solution or fully solubilised in a mixed micellar system 
employing detergent at concentrations above its c.m.c. to individual DAG kinase 
isoenzymes has been found to result in greatly altered reaction velocities. The 
soluble DAG kinase activity of rat brain can be separated to two distinct activities by 
heparin-agarose chromatography (Strathopoulos at al., 1990). Of these two 
activities, Strathopoulos et al. (1990) observed that one catalyses the 
phosphorylation of rac-1,2-dioleoylglycerol with similar rates of reaction in the 
presence of either 1.0 mM deoxycholate (c.m.c. = 5.0 mM) or 73 mM w-octyl-p,D- 
glucopyranoside (c.m.c. = 25 mM). The second soluble DAG kinase reported by 
these workers, however, phosphorylates rac- 1,2-dioleoylglycerol in the presence of 
1.0 mM deoxycholate with a rate 11-fold greater than that observed when the sn-
1,2-diacyl glycerol substrate was solubilised in 73 mM «-octyl~p,D- 
glucopyranoside. The first of the two rat brain soluble kinases apparently catalyses 
the phosphorylation of sn- 1,2-diacyl glycerol with equal velocity, regardless of 
substrate environment, whereas, the second isoenzyme displays increased reaction 
velocity towards sn- 1,2-diacyl glycerol dispersed in the presence of anionic 
detergent below its c.m.c. compared to sn- 1,2-diacyl glycerol fully solubilised in the 
mixed micellar environment provided by a non-ionic detergent above its c.m.c..
Coco-Maroney and Macara (1989) observed that the measured 
cytosol:membrane distribution of DAG kinase activity in Swiss 3T3 fibroblasts 
altered markedly depending on assay detergent conditions. Rates of reaction in 
both cytosolic and membrane fractions prepared from these cells was greatest when 
the 5«- 1,2-dioleoylglycerol substrate was present with 1.0 mM deoxycholate, with 
the cytosolic activity possessing greatest specific activity (Coco-Maroney &
Macara, 1989). In the presence of 52 mM w-octyl-p,D-glucopyranoside and 
absence of exogenous phospholipid, the cytosolic activity was again present with
greatest specific activity. However, in the presence of exogenous PtdSer or 
PtdCho (both at 6.9 mol%) the cytosolic and membrane-associated activities 
possessed identical specific activities, although, much reduced compared to the 
specific activities observed for both the cytosolic and membrane-associated 
activities when measured in the presence of PtdSer and deoxycholate (Coco- 
Maroney & Macara, 1989).
Clearly, DAG kinase isoenzymes maintain a specific requirement for the 
method of sn-1,2-diacylglycerol solubilisation/presentation in vitro in attaining 
maximal rates of phosphorylation and, by the same token, selectivity towards 
individual sn-1,2-diacylglycerol molecular species. This, however, obscures the 
physiological reaction that each DAG kinase isoenzyme catalyses, as the detergent 
and phospholipid conditions that can be employed to measure DAG kinase activity 
with the greatest rates of reaction may not necessarily allow the isoenzyme to 
display substrate selectivity. For example, the membrane-associated DAG kinase 
of Swiss 3T3 Fibroblasts has a specific activity of 148 pmol/min/mg when 
measured in the presence of 1.0 mM deoxycholate, 2.0 mM sn-1,2- 
dioleoylglycerol, 2.0 mM PtdSer, yet the specific activity for the same enzyme 
preparation is only 67 pmol/min/mg when the deoxycholate is replaced by 52 mM 
rc-octyl-p,D-glucopyranoside (Coco-Maroney & Macara, 1989). The sw-l-acyl-2- 
arachidonylglycerol-specific DAG kinase activity of baboon brain, however, 
catalyses the phosphorylation of s«-l,2-dioleoylglycerol and sn- 1 -stearoyl-2- 
arachidonylglycerol with similar rates of reaction in the presence of 
deoxycholate/PtdSer, but, phosphorylates s/z-l-stearoyl-2-arachidonylglycerol with 
a reaction rate 3-fold greater than 5«-l,2-dioleoyl glycerol when assayed with 73 
mM «-octyl-p,D-glucopyranoside/7.4 mol% PtdSer (Lemaitre et al., 1990). This 
provides a clear example where the sw-1-acyl-2-arachidonyl glycerol selectivity of a 
particular enzyme is compromised when the reaction rate has been measured by a 
method that provides the greatest reaction velocity.
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Employing identical Aj-octyl-p,D-glucopyranoside detergent conditions to 
those utilised in the characterisation of the Swiss 3T3 membrane-associated DAG 
kinase, MacDonald et al. (1988b) employed DAG kinase prepared from E. coli. and 
observed no increased rate of phosphorylation towards sn- l-acyl-2- 
arachidonylglycerol compared to non-arachidonyl 5/2- 1,2-diacylglycerols. The 
requirement for sn- 1,2-diacyl glycerol substrate presentation in an w-octyl-|3,D- 
glucopyranoside mixed mi cellar assay system would appear not to result in 
artefactual sn-1 -acyl-2-arachidonylglycerol specificity but, rather, permit the 
phenomenon, whereas presentation of sw-l,2-di acyl glycerol as a dispersion in the 
presence of deoxycholate does not. This observation is further consolidated by 
non-arachidonyl-specific DAG kinase activities catalysing the phosphorylation of 
sn- 1 -stearoyl-2-arachidonylglycerol, sn-1,2-dioleoylglycerol and sn-1,2- 
didecanoylglycerol with similar rates of reaction under identical assay conditions to 
those employed in the characterisation of the s«-l-acyl-2-arachidonylglycerol- 
specific activities (MacDonald et al. 1988b; Lemaitre et al., 1990).
5.5.2. DAG kinase Reaction Velocities are Influenced by 
P h osp h olip id .
Phospholipid has been reported to modulate the activity of DAG kinase in 
vitro. For example, the porcine 80 kDa cytosolic DAG kinase has been reported to 
be activated by PtdCho, lyso-PtdCho, PtdEtn, PtdSer and sphingomyelin (Kanoh 
et al., 1983), while the 121 kDa cytosolic activity of rat liver is not affected by the 
presence of PtdSer, PtdCho, PtdEtn and phosphatidylglycerol in vitro (Kanoh & 
Ohno, 1981). As with the observation of s/i-l-acyl-2-arachidonyl-selective activity 
this is unlikely to represent the physiological requirements of DAG kinase for 
phospholipid. Rather, such modulation of DAG kinase activity in vitro is more 
liable to represent alteration of the sn- 1,2-diacyl glycerol's environment within the 
assay system.
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Dispersed sn- 1,2-diacyl glycerol has been employed by many workers in the 
measurement of phospholipid modulation of DAG kinase reaction velocity (Kanoh 
& Ohno, 1981; Kanoh et al., 1983; Sakane et al., 1989) and sn-1,2-diacyl glycerol 
dispersed with deoxycholate employed for the same purpose by others (Ide & 
Weinhold, 1982; Lin et al., 1986; Kato & Takenawa, 1990). Yet, the porcine 
cytosolic 80 kDa DAG kinase poorly utilises dispersed s/2- 1,2-diacyl glycerol as 
substrate compared to sn- 1,2-diacyl glycerol dispersed with 1.0 mM deoxycholate 
or 0.5 mM PtdCho (Kanoh et al, 1983). Furthermore, the porcine DAG kinase 
reaction velocity was also observed to be increased when the sn-1,2-diacylglycerol 
substrate was dispersed in other anionic amphiphiles, e.g. 300 pM PtdSer and 10 
pM - 20 pM sphingosine. However, at greater concentrations the DAG kinase 
reaction velocity returned to levels similar to those obtained in the presence of 
dispersed 5/2- 1,2-di acyl glycerol alone (Sakane et al., 1989). This evidence may 
suggest that sn- 1,2-diacyl glycerol dispersed with anionic amphiphiles is more 
accessible as substrate than dispersed 5/2-1,2-diacylglycerol alone. Also, it may 
suggest that the previously reported phospholipid modulation of DAG kinase 
activity per se is artefactual and, alternatively, represents the increased suitability of
1,2-diacyl glycerol as substrate for the kinase when dispersed with amphiphiles, 
such as phospholipids. This is qualified by the measurement of increased rates of 
phosphorylation catalysed by the porcine 80 kDa DAG kinase when sn-1,2- 
dioleoylglycerol is solubilised in 50 mM /2-octyl- p,D-glucopyranoside (c.m.c. = 25 
mM, [5«-l,2-dioleoylglycerol] = 8 mol%) compared to those recorded with sn-1,2- 
dioleoylglycerol dispersed at a concentration of 0.5 - 1.0 mM in the absence of 
amphiphilic activator (Sakane et al., 1991). Attention must, therefore, be paid to 
the environment of the 5/2-1,2-diacylglycerol substrate and the effect added 
amphiphiles may have on the nature of the water/5/2-1,2-diacyl glycerol interface 
before increased reaction velocity is attributed to a physiological modulation of the 
activity by phospholipid.
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It may, however, be possible to draw conclusions on the modulation of 
DAG kinase activity by phospholipid if both the phospolipid and 5/2-1,2- 
diacylglycerol are solubilised in the mixed micellar enviroment provided by a 
detergent above its c.m.c. This approach has been successfully employed in the 
characterisation of the lipid requirements of both rat brain PKC and the 14 kDa 
DAG kinase of E. coli (Hannun et al., 1985, 1986; Walsh & Bell, 1986a, b). 
Employing such mixed micellar methodology, PtdSer was identified as an activator 
of the porcine 80 kDa DAG kinase in the presence of 10 pM Ca2+, although it is 
slightly inhibitory in the absence of free Ca2+ (Sakane et al., 1991a). Such 
activation of the porcine DAG kinase in the presence of both PtdSer and Ca2+ was 
the result of approximately 4-fold greater Vm ax and 10-fold reduced Km for ATP 
(Sakane et al., 1991a). Similarly, employing mixed micellar assay methodology, 
MacDonald and co-workers found PtdSer activated the5«-l-acyl-2- 
arachidonyl glycerol-selective DAG kinase of Swiss 3T3 fibroblast membranes by 
elevating the Vmax and decreasing the apparent Km for 5/2-1,2-diacylglycerol 
(MacDonald et al., 1988b). Cardiolipin and phosphatidyl glycerol were also 
observed to activate the Swiss 3T3 membrane-associated enzyme under mixed 
micellar conditions, but to a lesser extent than PtdSer (MacDonald et al., 1988a).
The effect of phospholipid on DAG kinase activity in vivo has still to be 
approached and extrapolation of in vitro data to the physiological state is limited by 
the methodology available at present for the solubilisation/presentation of 5/2-1,2- 
diacylglycerol in aqueous solution. The use of mixed micellar methodology 
eliminates the possibility that alteration of DAG kinase reaction velocity is a product 
of altered solubility or orientation of 5/2-1,2-diacylglycerol and has been employed 
to identify some modulatory role of phospholipids for the Swiss 3T3 and porcine 
80 kDa DAG kinases (see above). The interpretation of such data must be 
qualified. The PtdSer-dependent Ca2+ activation of the porcine enzyme is of 
unknown function within the cell and follows a shorter time-course than the Ca2+- 
dependent translocation of 80 kDa DAG kinase immunoreactivity from the cytosolic
183
to particulate fraction of porcine thymocyte homogenate (Sakane et al., 1991a). 
Also, the PtdSer-dependency of the Swiss 3T3 enzyme can be reduced by elevating 
the sn-1,2-diacylglycerol concentration within the mixed micelle, thus resulting in 
the reduction of the Ka from 0.56 mol% (with 3 mol % 5//-l-stearoyl-2- 
arachidonylglycerol) to 0.24 mol% (with 6 mol% 5/2-l-stearoyl-2- 
arachidonylglycerol). This may indicate that the enzyme has a non-specific 
requirement for glycerolipid, rather than a specific dependence on PtdSer for 
increased reaction rates.
5.6. An s/i-l-A cyl-2-A rachidonyl-Selective DAG Kinase Has Not 
Been Purified?
Identification of the DAG kinase isoenzyme involved in the metabolism of 
PtdIns(4,5)P2-derived 5 / 2- 1,2-diacyl glycerol has been prevented by the specific 
detergent and phospholipid requirements of the sn- 1 -acyl-2-arachidonylglycerol- 
specific enzyme (see Section 5.5). To date, several DAG kinases have been 
purified to homogeneity (Kanoh et al., 1983; Kato & Takenawa, 1990; Yada et al.,
1990). Several other DAG kinases have been partially purified or separated from 
other isoenzymes (Kanoh & Ohno, 1981; Lin et al., 1986; Besterman et al., 1986b; 
Sakane et al., 1989; Lemaitre et al., 1990; Kahn and Besterman, 1991; Inoue et al., 
1992). Unfortunately, the kinetic characterisation of these enzymes has been 
wholly performed with dispersed 5/2-1,2-diacylglycerol/deoxycholate methods and 
not with the /2-octyl-(3,D-glucopyranoside mixed micellar method employed in the 
identification of 5/2-l-acyl-2-arachidonylglycerol-selective activities in Swiss 3T3 
fibroblasts and baboon brain (MacDonald et al., 1988a; Lemaitre et al., 1990). Not 
surprisingly, none of the purified DAG kinases has been reported to phosphorylate 
5/2-1-acyl-2-arachidonylglycerol with reaction velocities greater than other5/2-l,2- 
diacylglycerols. This does not rule out the possibility that an 5/2-l-acyl-2- 
arachidonylglycerol-selective enzyme has been purified already, it hasn't, however, 
been identified. This is especially pertinent to the 150 kDa DAG kinase purified
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from the membranes of rat brain (Kato and Takenawa, 1990), as MacDonald and 
co-workers located the DAG kinase active in the phosphorylation of receptor­
generated 5/2-1,2-diacylglycerol in Swiss 3T3 cells to the membrane-associated 
fraction (MacDonald et al., 1988a). However, until the detergent and phospholipid 
requirements of each individual enzyme are characterised this possibility remains 
unanswered.
5.7. The Substrate Specificity of the DAG Kinase Involved in 
Stimulated Phosphoinositide Tunover is Not Limited to sn -I-A cy l-2 -  
A rach idonylglycerol.
To date, the DAG kinase active in the phosphorylation of PtdIns(4,5)P2- 
derived 5/2-1,2-diacylglycerol has been characterised by its phosphorylation of sn-
l-acyl-2-arachidonylglycerol with reaction rates greater than other long-chain sn-
1,2-diaclgycerols, e.g. sn- 1,2-dioleoylglycerol (MacDonald et al., 1988a).
However, present molecular species analysis is capable of separation and 
identification of sn- 1,2-diacyl glycerols previously unobserved in stimulated cells. 
MacDonald et al. (1988a) did not identify 18:0/20:3(n-9) or 16:0/20:3(n-9) 
diacylglycerol in PDGF-stimulated Swiss 3T3 cells, yet, they are significant 
components of the PtdIns(4,5)P2-derived 5/2-1,2-diacylglycerol that is present 5 
min after carbachol-stimulation of SK-N-SH cells (Lee et al., 1991). However, 
together with 5/2-l-stearoyl-2-arachidonylglycerol and 5/2-1,2-dipalmitoylglycerol, 
18:0/20:3(n-9) and 16:0/20:3(n-9) molecular species contribute towards greater than 
55 mol% of the the PtdOH formed shortly after muscarinic stimulation (Lee et al.,
1991). Other 5/2-1,2-diacylglycerol products of receptor-mediated PtdIns(4,5)P2 
hydrolysis, distinct from sn- l-acyl-2-arachidonylglycerol, are also phosphorylated 
in reactions catalysed by the DAG kinase involved in stimulated PtdIns(4,5)P2 
turnover. It would seem likely that the DAG kinase linked to stimulated 
phosphoinositide hydrolysis catalyses the phosphorylation of most, if not all, the 
5/2-1,2-diacylglycerol molecular species derived from PrtdIns(4,5)P2.
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This may not be a surprising conclusion as, typically, the agonist-elevated 
levels of 5/2-1,2-diacylglycerol at times shortly after stimulation (15 sec - 25 sec) are 
composed of molecular species characteristic of both PtdIns(4,5)P2 and PtdCho 
hydrolysis (Pessin & Raben, 1989; Pessin e ta l ., 1990; Pettit & Wakelam, 1993). 
However, after more prolonged stimulation, for example 5 to 60 min, the molecular 
species present in the stimulated levels of 5/2-1,2-diacylglycerol are mainly, if not 
totally, representative of PtdCho hydrolysis (Pessin & Raben, 1989; Lee et al., 
1991; Pettit & Wakelam, 1993), suggesting quite selective removal of 
PtdIns(4,5)P2-derived sn-1,2-diacylglycerol.
Although the ability of the DAG kinase isoenzyme, active in initiating the 
metabolism of PtdIns(4,5)P2-derived sn- 1,2-diacyl glycerol, to selectively 
phosphorylate 5/2- 1-acyl-2-arachidonylglycerol is diagnostic of this particular 
enzyme, its catalytic selectivity towards other molecular species characteristic of 
PtdIns(4,5)P2 hydrolysis, e.g. 5/2-1,2-diacylglycerols with unsaturated fatty acids 
with 3 or more double bonds in the 5/2-2-position (Pessin & Raben, 1989; Pettit & 
Wakelam, 1993) must be borne in mind.
For the purposes of the discussion within this thesis, although it is 
acknowledged that the DAG kinase linked to receptor-stimulated PtdIns(4,5)P2 
turnover is active in catalysing the phosphorylation of many molecular species of 
5/2-1,2-diacylglycerol typical of PtdIns(4,5)P2 hydrolysis, the DAG kinase 
identified in this role will be refered to as the 'sn-1-acyl-2-arachidonylglycerol- 
selective DAG kinase1.
5.8. The sre-l-Acyl-2-A rachidonylglycerol-Selectivity of the KC1- 
Soluble Diacylglycerol Kinase of Rat Brain.
Since the initiation of this project it has become apparent that several DAG 
kinase activities are present within the cell and careful consideration of the assay 
conditions is required in order that catalytic selectivity towards 5/2-1-acyl-2- 
arachidonylglycerol may be observed. As discussed in Section 5.5, the 5/2-l-acyl-
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2-arachidonyl-selective DAG kinase would appear to require quite specific assay 
conditions in order that it may display catalytic selectivity similar to that observed in 
Swiss 3T3 fibroblasts. A mixed-micellar assay system employing w-octyl-p,D- 
glucopyranoside and PtdSer has been succesfully employed to identify sn- l-acyl-2- 
arachidonyl-selective catalytic enzymes Swiss 3T3 mouse fibroblasts and baboon 
brain (MacDonald et al., 1988a, b; Lemaitre et al., 1990). Under identical assay 
conditions, the KCl-soluble DAG kinase, partially purified in the work towards this 
thesis, would appear to display no catalytic selectivity towards s«-l-acyl-2- 
arachidonylglycerol and, thus, would seem not to be the DAG kinase involved in 
receptor-stimulated Ptdlns(4,5)P2 turnover in rat brain. As discussed in Section
4.3.2, it should be noted that this study was conducted without a positive contol, 
such as the 5/i-l-acyl-2-arachidonylglycerol-selective DAG kinase of Swiss 3T3 
fibroblast membranes (MacDonald et al., 1988b). However, subsequent to the 
completion of the work towards this thesis, an sn- l-acyl-2arachidonylglycerol- 
selective DAG kinase from porcine testis membranes was characterised within this 
laboratory while employing identical assay conditions (S.D. Gardner, personal 
communcation). This may still identify the need for different assay conditions in 
order that such selectivity may be observed with the rat brain KCl-soluble enzyme 
as individual isoenzymes have proven to retain specific detergent and phospholipid 
requirements (see Section 5.5). Alternatively, it may identify the loss of a 
regulatory factor during the purification of the KCl-soluble DAG kinase. The 110 
kDa DAG kinase of rat brain purified to homogeneity by Kato & Takenawa (1990) 
was recovered with greater than 100 % yield on ATP-agarose chromatography, 
suggesting the separation of the catalytic activity from a modulatory factor or 
subunit. Typically, the DAG kinases purified to date exist as single polypeptide 
chains on SDS-PAGE analysis and no precedent exists for the involvement of a 
regulatory subunit in the modulation of DAG kinase reaction velocities. However, 
Sakane and co-workers (1989) did report the purification of a DAG kinase with 
apparent molecular mass of 150 kDa from porcine thymus cytosol. SDS-PAGE
analysis of the purified protein resulted in the resolution of two proteins (75 and 50 
kDa). The nature of this heterodimeric DAG kinase preparation was not 
investigated further. Other regulatory factors, distinct from regulatory subunits, 
may also be lost on successive chromatographic steps. Given the modulatory role 
of phospholipids on the reaction rates catalysed by DAG kinase in vitro (see Section 
5.5.2), the possibility may exist that the sn-1 -acyl-2-arachidonyl-selectivity 
displayed by the mouse fibroblast and baboon enzymes requires the presence of a 
phospholipid distinct from PtdSer. Of the two sn- l-acyl-2-arachidonyl-selective 
enzymes previously reported, both had been examined in crude homogenates and 
lysates or detergent extracts. Neither enzyme had undergone multiple 
chromatographic steps which would remove the enzyme from a 
phospholipid/detergent mixed micellar environment (MacDonald et al., 1988a, b; 
Lemaitre et al., 1990). This may be pertinent, as the DAG kinase of E. coli 
displays altered sw-l,2-di acyl glycerol substrate concentration dependence in the 
presence of phospholipid, when assayed in a non-ionic detergent mixed micellar 
system (Walsh & Bell, 1986b). These workers observed the sn-1,2- 
dioleoylglycerol substrate concentration dependence of the E. coli DAG kinase to be 
highly cooperative, with a Hill Coefficient of 4.4 - 4.5 in the absence of 
phospholipid, whereas in the presence of phosphatidyl glycerol, double-reciprocal 
plots of the sn- 1,2-diacyl glycerol concentration dependence were linear at all 
concentrations of phospholipid examined (Walsh & Bell, 1986b). Protection of the 
E. coli DAG kinase from inactivation during reconstitution by incubation with 
cardiolipin (Loomis et al., 1985) led to the suggestion that delipidation was at least 
partly responsible for the loss of enzyme activity during inactivation (Walsh & Bell, 
1986a). To avoid such problems, membranes prepared from an E. coli strain that 
over-expressed the DAG kinase 100-fold were employed to investigate the 
enzyme's 5w-l,2-di acyl glycerol substrate and phospholipid co-factor dependence 
(Walsh & Bell, 1986a, b). The possibility that the sw-l-acyl-2-arachidonyl glycerol - 
selectivity of mammalian DAG kinase isoenzymes could similarly alter during
purification remains to be investigated. Irrespective of these possibilities, the KCl- 
soluble DAG kinase discussed within this thesis would appear not to be 5/z-l-acyl-
2-arachidonyl-selective.
5.9. An Alternative Strategy to the Purification of the sw -l-A cyI-2- 
A rachidonylglycerol-Selective DAG Kinase.
Of the DAG kinases purified to date, none have been reported to selectively 
phosphorylate sn-1,2-diacylglycerol characteristic of PtdIns(4,5)P2 hydrolysis with 
increased rates of reaction, compared to substrates typical of PtdCho hydrolysis.
As discussed in Section 5.5, this may indicate the use of improper assay 
methodology during such assessment. Alternatively, it may simply indicate that all 
the purifications, to date, involve isoenzymes distinct from the 5«-l-acyl-2- 
arachidonylglycerol-selective enzyme. As the majority of purifications involve 
cytosolic enzymes, this may not be a surprising finding due to localisation of the 
sn-1 -acyl-2-arachidonylglycerol-selective enzyme to the particulate fraction 
(MacDonald et al., 1988a, b; Lemaitre et al., 1990). To date, in addition to the 
purification reported within this thesis, only two membrane-associated DAG 
kinases have been purified, from rat brain and Drosophila melanogoster head, and 
neither appear to display selectivity amongst sn- 1,2-diacyl glycerol substrates (Kato 
& Takenawa, 1990; Inoue etal., 1992, respectively).
The purification of membrane-associated DAG kinase has, typically, 
employed solubilisation of the enzyme by increasing ionic strength and not 
detergent solubilisation (Kato & Takenawa, 1990; Inoue et al., 1992; Section
3.2.1, this thesis). The continued association of DAG kinase activity with the 
membranes of rat brain after treatment with 2.0 M NaCl has been reported (Kato & 
Takenawa, 1990). However, the use of non-ionic detergent above its c.m.c. has 
been reported to completely solubilise the membrane associated DAG kinase from 
Swiss 3T3 fibroblast membranes (MacDonald et al., 1988a) and the use of non­
ionic detergent above its c.m.c., in conjunction with increased ionic strength, has
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resulted in the complete solubilisation of the membrane-associated activity of 
baboon brain (Lemaitre et al., 1990). It is noteworthy that both reports highlighting 
the requirement for non-ionic detergent to achieve fully efficient solublisation of 
membrane-associated DAG kinase are concerned with the successful identification 
of 5 / 1- 1-acyl-2-arachidonyl glycerol-specific activities. This could easily be 
interpreted as the identification of the s/z-l-acyl-2-arachidonylglycerol-selective 
DAG kinase as an integral membrane-associated protein, which requires detergent 
for solubilisation. Whereas, the salt-solubilised DAG kinases purified to date 
represent extrinsically-associated proteins without catalytic selectivity towards sn-
1,2-diacylglycerol substrates.
Indeed, since the termination of the work conducted towards this thesis, 
work within this laboratory has identified such an sn-1-acyl-2-arachidonylglycerol- 
selective DAG kinase. Employing a plasma-membrane enriched particulate fraction 
prepared from porcine testis, it has been possible to solubilise a membrane- 
associated DAG kinase activity with non-ionic detergent. Moreover, this enzyme 
catalyses the phosphorylation of 5 / 2-  l-stearoyl-2-arachidonylglycerol with greater 
rates of reaction than those observed with 5/2-1,2-dioleoylglycerol (S. Gardner, A. 
Paterson & M.J.O. Wakelam, unpublished results).
5.10. Purification of the 5/1-1-A cyl-2 -A rach id on ylg lycero l-S elective  
DAG Kinase: Long-Term Aim of Project.
The ultimate aim of purifying sn- l-acyl-2-arachidonylglycerol-selective 
DAG kinase was to provide protein sequence data that would allow the construction 
of oligonucleotide probes and screening of rat brain cDNA libraries in order that a 
full length cDNA could be isolated and sequenced. Comparison of the cDNA 
sequence determined for the 5/2-1-acyl-2-arachidonylglycerol-selective DAG kinase 
to those previously determined for the porcine 80 kDa DAG kinase (Sakane et a l, 
1990) and human white blood cell DAG kinase (Schaap et a l ,  1990) would allow 
the initiation of structure/function studies and the possible identification of protein
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motifs common to all DAG kinases, e.g. the s«-l,2-di acyl glycerol binding site. 
Furthermore, such structure function studies would possibly allow the identification 
of motifs unique to the s?i- l-acyl-2-arachidonylglycerol-selective DAG kinase and 
may identify the nature of the catalytic selectivity characteristic of the isoenzyme. 
Additionally, the information gained from these comparative studies of the isolated 
cDNA may allow the isolation of further related cDNA coding for other DAG 
kinase isoenzymes after the construction of oligonucleotide probes to regions of 
homology shared between the DAG kinases.
Finally, the purification of the sn- 1-acyl-2-arachidonylglycerol-selective 
DAG kinase would allow the production of antisera. The antisera would possibly 
be raised from direct immunisation with the protein if the yield on purification was 
great enough or, alternatively, the antisera would be raised against peptides 
corresponding to sequence data generated during protein sequencing of the purified 
enzyme or deduced amino-acid sequence generated during the sequencing of cDNA 
isolated after oligonucleotide probing of cDNA libraries. Nevertheless, generation 
of antisera against the j«-l-acyl-2-arachidonyl glycerol-selective DAG kinase would 
allow further investigation of the enzyme's role in the agonist-stimulated or 
quiescent cell by means of a range of immunological techniques, e.g. 
immunoprecipitation, uncoupling of DAG kinase activity in permeabilised cells, 
immunohistochemistry, etc.
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